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Medium ring (8-12 members) and benzannulated medium heterocycles represent a class of synthetically 
challenging targets. Although natural products containing medium ring N- and O- heterocycles offer 
beneficial biological properties, there is a stark absence of medium rings in active pharmaceutical 
ingredients, potentially highlighting the difficulties associated with their synthesis. Typical methods of 
synthesis include transition metal-catalysed processes, such as ring closing metathesis and ring 
expansion techniques, which require pre-organisation of the precursors to ensure a thermodynamic 
driving force. 
Research by the Clayden group has shown that the poor reactivity between carbanions and unactivated 
Csp2 ‘electrophiles’ can be overcome by tethering the two through a urea linkage. The principles of this 
unique protocol have been applied to the research within this thesis. Firstly, the N→C rearrangement 
chemistry has been applied to cyclic systems where the urea nitrogen is tethered as part of a ring, 
ultimately resulting in ring expansion after aryl migration, as shown in 1. This ring expansion 
methodology has been optimised and applied to a wide range of urea precursors, allowing access to 
complex structural architectures in few steps from simple starting materials.  
 
Secondly, when benzylic indole precursors were investigated, rather than obtaining the expected ring 
expansion products from the N→C aryl migration route, lithiation instead resulted in dearomative 
cyclisation, generating a range of polycyclic indoline structures, shown in 2. Finally, an n to n-2 ring 
contraction protocol has been developed to access privileged tetrahydroisoquinoline and 
tetrahydrobenzazepine structures from medium ring nitrogen heterocycles, shown in 3. Furthermore, 
this ring contraction methodology has been developed for applications in flow, for the efficient multi-
gram synthesis of 1-aryl tetrahydrobenzazepine. 
The different synthetic methods disclosed within this thesis enables rapid access to a wide range of 
biologically and medicinally relevant scaffolds, from which further diversification is possible for 
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1. Introduction  
 
1.1 Importance of Medium-Sized Rings 
 
Medium-sized rings (8-12 members), particularly benzannulated medium rings (BMR) are important 
scaffolds in medicinal chemistry and are prevalent in a number of natural products, figure 1-1.1 
 
Figure 1-1. Medium-sized rings in natural products. 
This class of compounds have been investigated as potential drug candidates. For example, rhazinilam 
1-1 has been shown to demonstrate anti-cancer properties2 and heliannuol A 1-2 exhibits allelopathic 
activity.3 These positive biological properties have been attributed to the conformational constraints 
imposed by the cyclic structures. Such conformational restriction can offer enhanced binding affinities4 
that may correlate with improved bioavailability, and in some cases enhanced cell permeability.5 This 
effect is observed because of the high degree of structural pre-organisation that facilitates the interaction 
of functional groups across binding sites in proteins, without a significant entropic loss upon binding.                      
1.2 Conformational Analysis of Medium-Sized Rings 
 
The main challenge with the exploration of these scaffolds as therapeutic agents is the difficulties 
associated with their syntheses. Whilst the corresponding 5- and 6- membered ring derivatives can be 
readily accessed from relatively simple cyclisation and cycloaddition strategies, methods to generate 
medium-sized rings are obstructed by unfavourable enthalpic and entropic effects, which is reflected in 











Table 1-1. Ring strain of cycloalkanes.6 










Unlike smaller ring sizes (5-, 6- and 7- membered rings) conformational analysis of medium-sized rings 
is complicated.6 In the majority of cyclic compounds strain is a compromise between minimising angle 
and torsional strain. However, in medium-sized rings angle and torsional strain are relatively low as the 
molecule can adopt a conformation to avoid these, instead introducing transannular strain. This is where 
substitutents, usually methylene hydrogen atoms, point “into” the ring consequently bringing them into 







Figure 1-2. Transannular strain shown in cyclodecane. Unfavourable interactions highlighted by the triangle. 
Overall, the strain of medium-sized rings is a combination of transannular strain, bond angle distortion 
and partial eclipsing of hydrogen atoms.7 Minimising the strain from a single conformation is not 
possible, hence it is unlikely that medium-sized rings have a single low energy conformation. As a 
result, they usually have several conformations in equilibrium which are separated by low energy 
barriers. As a ring size gets larger, strain is reduced as the molecule can adopt a conformation like that 
of an acyclic linear alkane, avoiding eclipsing hydrogen atoms. 
There is a clear absence of medium-sized rings in the database of FDA approved pharmaceuticals, 
owing in great deal to the difficulties associated with their synthesis.7 Therefore, a general method for 
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the preparation of these molecular frameworks would be highly desirable as it would permit access to 
unexplored chemical space.  
1.3 Synthesis of Medium Rings and Benzannulated Medium Rings 
 
Despite the challenges associated with the synthesis of medium rings, the prevalence of such structures 
in natural products with positive biological activities has driven chemists to explore ways of accessing 
these structural motifs. The examples discussed below show some of the methods developed to access 
these challenging molecular architectures.  
1.3.1 Medium Rings by Lactonisation 
 
The generation of medium ring lactones by intramolecular attack of a hydroxyl group on an activated 
carbonyl has been investigated thoroughly. Early pioneering work by Corey and Nicolaou demonstrated 





Scheme 1-1. Corey-Nicolaou lactonisation to synthesise recifeiolide 1-9.9 
 
Using this cyclisation protocol as the key step, the total synthesis of 12-membered macrolide 
recifeiolide 1-9 was successfully carried out in only a few steps.9 Since then, numerous other methods 
of carbonyl activation have been employed for the synthesis of medium ring lactones by lactonisation. 
An alternative method of lactonisation via intramolecular trapping of a ketene intermediate was 








This method, which exploits dioxolenones 1-10 as masked activated carbonyls allows the formation of 
β-acyl ketenes 1-11 upon heating. The ketene is then trapped by the nucleophilic hydroxyl group under 
mild, neutral conditions to generate 10-membered lactone 1-13 in 68% yield. 
 
Utilising a similar Boeckman lactonisation procedure, Porco et al. reported the synthesis of 8-membered 




Scheme 1-3. ‘Boeckman-type’ lactonisation to synthesise benzannulated medium rings.11,12 
 
In contrast to the neutral conditions initially employed by Boeckman, Porco et al. used basic conditions 
to promote the lactonisation. Similarly, the same conditions were applied to the synthesis of 
salicylihalamide A 1-18, a highly cytotoxic macrolide, scheme 1-3 b.12 When using these conditions, it 
was particularly important to run the reaction at high dilution to avoid competing intermolecular 
reactions. Likewise, in 2004 Paneck et al. demonstrated that the same base-promoted lactonisation 
could be applied to the synthesis of 10-membered lactone 1-20, scheme 1-4.13 
 
Scheme 1-20. Lactonisation utilising cyanomethyl ester to activate carbonyl.13  
 
The use of a cyanomethyl ester 1-19, which has previously been reported in transesterification reactions, 
was effective in activating the carbonyl towards nucleophilic attack by the hydroxyl group. Using this 
strategy, lactone 1-20 was synthesised in 63% yield and was used as an intermediate in the synthesis of 




1.3.2 Medium Rings by Transition Metal-Catalysed Couplings 
 
Transition metal-catalysed cross coupling reactions are an essential synthetic tool for generating new 
carbon-carbon, carbon-oxygen and carbon-nitrogen bonds.1 Of all the transition metals, palladium is 
arguably the most versatile with regard to the synthesis of medium ring and benzannulated medium ring 
structures. 
1.3.2.1 Heck Reaction 
 
Although there is a plethora of palladium-catalysed Suzuki-Miyaura couplings applied to the synthesis 
of benzannulated macrocycles,14-16 Heck coupling appears to be the method of choice for the synthesis 
of medium-sized rings. The Heck reaction involves the coupling of an aryl or vinyl halide with an alkene 
in the presence of a palladium catalyst and base. The reaction can be both inter- and intramolecular, 
with intramolecular Heck reactions being most successful for the synthesis of medium rings.  
The synthesis of 8-membered dibenzo[b,f]azepines, -oxacine and -thiocine 1-24 was achieved by the 





Scheme 1-21. Intramolecular Heck coupling to form benzannulated medium rings.17,19 
Guy et al. demonstrated that alkylation followed by Heck coupling using the general phosphine-free 
reaction conditions developed by Buchwald,18 allowed access to a range of tricyclic 8-endo products 1-
24 exclusively in moderate to good yields. Similar phosphine-free conditions were employed for the 
synthesis of medium ring oxa-heterocycles 1-26 and 1-27, scheme 1-21 b.19 The optimal conditions 
were reported to be 10 mol% Pd(OAc)2, KOAc and tetrabutylammonium bromide (TBAB) as an 
additive in DMF for 4-6 hours at 120 °C. The 8-exo cyclised products 1-26 were isolated as the major 
products with only one substrate (where R = H) giving the 9-endo Heck product 1-27 via 9-endo-trig 
cyclisation. The same authors later reported that milder conditions and lower catalyst loadings could be 
used to achieve cyclisation by intramolecular Heck reaction to access different medium ring oxa-




Scheme 1-22. Synthesis of benzannulated 9-membered oxa-heterocyclic ring systems and lactone derivatives via 
intramolecular Heck reaction.20 
In all examples, the 9-endo-trig products were isolated exclusively with no conversion to the 8-exo 
Heck products. This phosphine-free method offers a convergent synthesis of tricyclic scaffolds. 
1.3.2.2 Cyclocarbonylation 
 
It is widely recognised that the catalytic cyclocarbonylation reaction is an important synthetic strategy 
for accessing cyclic carbonyl compounds from their acyclic precursors.21 As a result, the palladium-
catalysed cyclocarbonylation reaction has been applied to the synthesis of many benzannulated medium 
ring structures. 
Homogeneous catalysis often displays excellent activity; however, the main disadvantage is the 
difficulty associated with the separation of the resulting product from the catalyst. Lu et al. addressed 
this issue by reporting the synthesis of 12-membered ring scaffolds 1-34 utilising recyclable palladium 
complexed dendrimers on silica gel, scheme 1-23.22 
 
Scheme 1-23 Palladium-catalysed intramolecular cyclocarbonylation using dendritic catalyst.22 
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The authors reported that the heterogeneous dendritic catalyst 1-33 not only enhances the substrate’s 
reactivity but is also able to tolerate a wide array of functional groups. Various oxygen-, nitrogen- and 
sulfur-containing heterocycles were afforded in good to excellent yields. Use of this heterogeneous 
dendritic catalyst is particularly appealing due to facile isolation of products and recyclability of the 
catalyst without significant loss of activity. This methodology was later applied to the asymmetric 
synthesis of 8- 9- and 10-membered lactams 1-37 with high regioselectivity, scheme 1-24.23 
 
Scheme 1-24. Intramolecular carbonylation-asymmetric hydrogenation to form medium ring tricyclic lactams.23 
Using the dendritic palladium catalyst 1-33 to promote an intramolecular regioselective 
cyclocarbonylation followed by asymmetric hydrogenation of the resulting exo-methylene with a 
rhodium catalyst gave a range of 8-, 9- and 10-membered rings 1-37. The resulting tricyclic products 
were obtained in excellent yields and enantioselectivities irrespective of the electronic nature of the 
aromatic rings. Again, the dendritic palladium catalyst was easily recovered after the reaction was 
complete by filtration, demonstrating its potential for industrial use.  
More recently, Gabriele et al. reported a palladium-catalysed oxidative carbonylation route to medium-
ring lactam derivatives.24 A series of 2-(2-ethynylphenoxy)anilines 1-38 were subjected to PdI2/KI 
catalytic oxidative carbonylation conditions to yield the desired tricyclic medium ring lactams 1-42 in 





Scheme 1-25. Proposed mechanism for oxidative-carbonylation.24 
The mechanism is proposed to start with N-palladation, which is stabilised by coordination to the 
pendant alkyne chain, followed by CO insertion to give carbamoyl-palladium iodide intermediate 1-40. 
1-40 could then evolve through an intramolecular syn 8-exo-dig triple bond insertion to yield 
vinylpalladium iodide intermediate 1-41. Finally, alkoxycarbonylation of this intermediate delivers the 
desired 8-membered lactam derivatives 1-42. These benzo-fused medium ring structures have shown 
antitumor activity against oestrogen receptor-positive (MCF-7) and triple negative (MDA-MB-231) 
breast cancer cell lines. 
1.3.2.3 Miscellaneous Metal-Catalysed Coupling Reactions 
 
Cobalt, copper, nickel, chromium and gold have also been used in coupling reactions to synthesise 
benzannulated medium-sized rings.25-29 Lovely et al. reported the synthesis of bridged medium rings 
via an intramolecular N-methylmorpholine oxide (NMO)-mediated Pauson-Khand reaction.25 
Conversion of enynes 1-43 to their cobalt complexes was firstly achieved by addition of Co2(CO)8. 
These complexes were then treated with NMO which allowed the generation of medium rings 1-45 and 
1-46 scheme 1-26.  
 
Scheme 1-26. NMO-mediated intramolecular Pauson-Khand reaction for the synthesis of medium rings.25 
The authors noted that the O-allyl substrates delivered the desired fused products 1-44, whereas the O-
butenyl and O-pentenyl derivatives resulted in bridged systems 1-45 and/or 1-46. ‘Steric buttressing’, 
the introduction of substituents ortho to a conformationally flexible side chain in aromatic systems, was 
reported to aid in the formation of medium rings by mitigating the entropic cost to cycloaddition. 
Copper has also been used to synthesise benzannulated medium rings, scheme 1-27. Spring et al. 
demonstrated that copper (I) catalysis could be used to synthesise 7-, 8- and 9-membered nitrogen linked 
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diaryls26 and later applied this methodology to the synthesis of C-O bonds in the formation of cyclic 
diaryl ethers.27 
 
Scheme 1-27. Synthesis of N- and O- linked tricyclic scaffolds by copper-catalysed coupling.26,27 
The authors proposed a mechanism involving activation of the catalyst through chelation of the 
nitrogen, thereby acting as a ligand to copper, 1-48. This chelation was thought to assist in the oxidative 
addition step of the catalytic cycle by bringing the copper in close proximity to the aryl halide, 
facilitating ring closure.27 The reaction was able to tolerate many different functional groups, allowing 
the synthesis of an array of nitrogen- and oxygen- linked tricyclic structures 1-49. 
In contrast, a mixture of two transition metals was used by Popik et al. for the synthesis of medium ring 
aza-enediynes 1-51, scheme 1-28.28 
 
Scheme 1-28. Synthesis of aza-enediynes 1-51 via the Nozaki-Hiyama-Kishi reaction.28 
Subjecting aldehyde 1-50 to standard Nozaki-Hiyama-Kishi conditions,30 CrCl2 and NiCl2, allowed the 
generation of the 10-, 11-, 12- and 13-membered benzannulated rings 1-51 in good yields.  
Gold has been utilised successfully in the synthesis of medium-sized rings. Toste et al. reported the 
asymmetric synthesis of 7- and 8-membered rings by an intramolecular Au(I)-catalysed 




Scheme 1-29. Asymmetric intramolecular Au(I)-catalysed cyclopropanation.31 
Treatment of acetate 1-52 with the optimal conditions of AuCl2, xylyl-BINAP in nitromethane at −25 
°C gave products 1-53 with the highest enantioselectivities. The reaction tolerated substitution at the 
propargylic position, however substitution at the internal position of the alkene gave products with 
diminished enantioselectivities. It was stated that this could be overcome by substituting the catalyst for 
difluorophos(AuCl)2.  
 
Scheme 1-30. Proposed mechanism for Au-catalysed cyclopropanation showing isomeric carbenoid 
intermediates.31 
The mechanism is suspected to proceed through isomeric Au-stabilised vinyl carbenoid intermediates 
1-55 or 1-56, scheme 1-30, which are generated following a 1,2- shift of the propargyl ester. Previously 
published computational studies indicate that under kinetic control the syn-intermediate is formed, 
while the anti-intermediate is thermodynamically more favourable.31 It is suggested that an equilibrium 
may exist between the two intermediates as the stereochemical outcome of the reaction is dependent on 
the nucleophile used. To test this hypothesis the reaction was conducted in the presence and absence of 
1,1-diphenylethylene 1-58. In the absence of 1,1-diphenylethylene the intramolecular reaction occurred 
to give the desired 7- membered product as the E-isomer 1-57, which was expected to proceed through 
intermediate 1-55. However, in the presence of 1,1-diphenylethylene an intermolecular 
cyclopropanation reaction occurred to form 1-59 as the Z-isomer. This suggests that the gold (I)-
stabilised vinyl carbenoids are fluxional.  
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1.3.3 Ring-Closing Metathesis  
 
Since Grubbs first published conditions for the ring closing metathesis (RCM) in 1995,32 there has been 
a plethora of literature demonstrating its use as a powerful synthetic tool for the formation of new C=C 
bonds. Indeed, it is often the key step in the synthesis of natural products containing medium-sized 
rings.1 RCM is highly attractive due to its broad functional group tolerance and the possibility of further 
functionalisation of the products. Consequently, many have employed RCM in the synthesis of 
benzannulated medium ring structures. 
The mechanism of ring-closing metathesis has been extensively studied and proceeds as shown in 
scheme 1-31.33  
 
Scheme 1-31. RCM catalytic scheme and common catalysts.33 
First, the catalytically active metallocarbenoid complex 1-60 undergoes a [2+2] cycloaddition with the 
diene precursor 1-61. A metallocyclobutane intermediate 1-63 is formed and is then opened in a retro 
[2+2] manner, generating metallocarbenoid 1-65 as an intermediate. This then undergoes re-cyclisation 
to form a new metallacyclobutane 1-66 that opens to deliver the desired cycloalkene product 1-67 and 
regenerates the catalyst. The reaction is fully reversible and entropically driven due to the release of an 
alkene, usually ethylene 1-64.33 
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In 2004, Guillaumet et al. reported the synthesis of 2,5-dihydro-1,6-benzodioxocin derivatives 1-72, 
scheme 1-32 a.34 Subjecting bis-allyl ether derivatives 1-71 to RCM conditions afforded the 
corresponding benzannulated medium ring in good to excellent yields. Grubbs II 1-69 catalyst was 
found to give enhanced activity over Grubbs I 1-68.  
 
Scheme 1-32. RCM to form 2,5-dihydro-1,6-benzodioxocin derivatives and bisoxepine and bisoxocines.34, 35 
In contrast, Grubbs I catalyst 1-68 was proven to be the most effective catalyst for the RCM of bisdienes 
1-73, when stirred in dichloromethane at room temperature, scheme 1-32, b.35 The authors described a 
sequential double-Claisen rearrangement and two-directional RCM to generate bisoxepine and 
bisoxocine derivatives 1-74 in good to excellent yields.  
Due to the simplicity and excellent functional group tolerance of the ring closing metathesis reaction, 
many have exploited RCM in the synthesis of natural products.36,37,38 In particular, RCM was used as a 
key step in the synthesis of (R)-(+)-lasiodiplodin 1-77, which exhibits antileukemic properties, scheme 
1-33.  
 
Scheme 1-33. RCM applied in the synthesis of (R)-(+)-lasiodiplodin by Feringa et al.36 
Fürstner37, Feringa36 and Faber38 all found that using Hoveyda-Grubbs second generation catalyst 1-70 
in toluene gave the desired benzannulated medium ring 1-76 with varying E:Z ratios.   
Furthermore, Fürstner et al. reported the first total synthesis of (+)-aspercyclide 1-80 with the key step 




Scheme 1-34. RCM employed in total synthesis of (+)-aspercyclide.39 
With the knowledge that the less active first-generation catalyst 1-68 will most likely deliver the kinetic 
isomer provided the isomers are sufficiently different in energy, this catalyst was trialled first. Although 
the reaction did not go to completion (<50% conversion after 5 days), analysis of the crude product 
revealed that the E-isomer 1-79 had selectively formed, indicating that this must be kinetically favoured. 
Grubbs second-generation catalyst 1-69 was also investigated. Despite the potential for forming the 
thermodynamically favoured isomer, the reaction proceeded with good selectivity suggesting a high-
kinetic barrier towards isomerisation. 
1.3.4 Mitsunobu Reaction 
 
The Mitsunobu reaction is another powerful synthetic method that has been studied and applied to the 
synthesis of benzannulated medium rings. In 2009, Gallagher et al. reported the synthesis of substituted 
1,4-tetrahydrobenzoxazepines, benzothiazepines, and benzodiazepines 1-83 by nucleophilic cleavage 
of enantiomerically enriched 1,2-cyclic sulfamidates 1-81, followed by a Mitsunobu reaction, scheme 
1-35.40  
 
Scheme 1-35. Synthesis of medium rings via Mitsunobu reaction.40 
Ring opening of the sulfamidates with phenol, aniline and thiophenol nucleophiles allowed the 
successful formation of products 1-82. Treatment of 1-82 with PPh3 and diethyl azodicarboxylate 
(DEAD) permitted the cyclisation, providing access to the medium rings 1-83 in moderate to excellent 
yields. This methodology was further applied to 1,3-cyclic sulfamidates to afford the analogous 
substituted 1,5-benzoxazocines and 1,5-benzodiazocines. 
Similar 7- and 8-membered medium ring core structures were synthesised in an asymmetric fashion 




Scheme 1-36. Asymmetric synthesis of benzannulated medium rings via Mitsunobu reaction.41 
These scaffolds are particularly interesting due to their prevalence as core structural motifs in many 
biologically active molecules. The intramolecular cyclisation under standard Mitsunobu conditions 
generated the enantiomerically enriched bicyclic structures 1-86 in good yields and excellent 
enantioselectivities. 
Herb et al. employed a Mitsunobu lactonisation as the key step in the total synthesis of salicylihalamides 
1-88, a family of natural products with potent activity against human cancer cell lines, scheme 1-37.42  
 
Scheme 1-37 Synthesis of salicylihalamides 1-88.42 
Due to the steric encumbrance around the carboxylic acid group and the presence of the alkene in 1-87 
a classic lactonisation procedure was expected to be difficult. As a result, a Mitsunobu 
macrolactonisation was chosen due to literature precedence.43-45 Performing the Mitsunobu 
macrolactonisation under high dilution gave a 25% yield of the 12-membered lactone 1-88. However, 
the yield was significantly improved by utilising immobilised triphenylphosphine. This allowed the 
reaction to be performed at a higher concentration and subsequently resulted in an improved yield of 
43%. 
1.3.5 Medium Rings by Ring Expansion 
 
Ring expansion reactions are a popular way of forming larger ring sizes as they avoid the difficulties 
associated with cyclisation strategies. For a ring expansion reaction, the cyclised precursors required 
are often small ring sizes, e.g. 5- and 6-membered rings, which are significantly easier to form. 
Typically, the medium rings are then formed from the smaller rings in one of three ways; fragmentation 
of fused bicyclic systems, radical ring expansions or pericyclic reactions.46  
1.3.5.1 Fragmentation of Fused Bicyclic Systems 
 
Provided that the appropriate fused bicyclic system can be readily synthesised, subsequent access to the 
medium ring structures can be obtained by a fragmentation reaction.46 The reactions tend to be 
irreversible processes meaning they are suitable for the synthesis of unstable systems such as medium 




1.3.5.1.1 Elimination Fragmentation Reactions 
 
Pioneering work by Grob47 and Wharton48 showed that molecules of type 1-89 with electron donating 
groups and leaving groups can undergo fragmentation, scheme 1-38.  
 
Scheme 1-38. Grob/Wharton-type fragmentation.  
This fragmentation protocol can be applied to the fragmentation of smaller ring bicycles to generate 
larger rings by ring expansion. For example, Paquette et al. exploited a Grob/Wharton type 
fragmentation in the total synthesis of jatrophatrione 1-96, a medium ring compound with anti-leukemic 
properties, scheme 1-39.49 
 
Scheme 1-39. Synthesis of jatrophatrione by Grob fragmentation.49 
To affect the ring expansion, polycyclic diol 1-93 was treated with mesyl chloride to selectively 
mesylate the secondary alcohol. Subsequent treatment with potassium tert-butoxide caused 
deprotonation of the tertiary alcohol initiating fragmentation and subsequent elimination of the O-
mesylate generating 9-membered tricycle 1-95 in near quantitative yield.  
Similar to the Grob/Wharton-type fragmentations are the Eschenmoser fragmentation reactions, 
typically called the Eschenmoser-Tanabe fragmentations.50 The Eschenmoser-Tanabe fragmentation 
describes the reaction of α,β-epoxyketones 1-97 with aryl sulfonylhydrazines 1-100 to synthesise 




Scheme 1-40. Eschenmoser-Tanabe fragmentation.  
Both Grob/Wharton type fragmentations and Eschenmoser-Tanabe fragmentations rely on the extrusion 
of a stable leaving group as the thermodynamic driving force for the ring expansion reaction. Due to 
the elimination of nitrogen gas and a stabilised arylsulfinate, the Eschenmoser fragmentation has a 
stronger thermodynamic driving force than the Grob fragmentation. Consequently, this driving force 
can counteract the destabilising effects of forming a medium ring with a strained alkyne within its 
structure, allowing efficient ring expansion.  
Reese,51 and later Danishefsky,52 exploited an Eschenmoser-Tanabe fragmentation for the synthesis of 
medium ring alknyl ketones 1-105, scheme 1-41. 
 
Scheme 1-41. Eschenmoser fragmentation of epoxy ketones 1-103 to synthesise 9- and 10-membered alkynyl 
ketones 1-105.51 
Treatment of epoxy ketone 1-103 with mesitylene-2-sulfonyl hydrazide 1-104 under acidic conditions 
allowed the formation of 1-105 by ring expansion via fragmentation. 
Elimination fragmentation reactions offer a powerful technique for the synthesis of medium ring 
structures providing they have a strong thermodynamic driving force for ring expansion. However, it is 
worth noting that although these reactions have their benefits, the fragmentation precursors must be 
pre-organised to undergo facile fragmentation. The synthesis of the requisite starting materials is not 
always a simple procedure and therefore should be considered.  
1.3.5.1.2 Redox-Mediated Fragmentation Reactions 
 
Oxidative cleavage of a double bond across a fused bicyclic system is an alternative way of achieving 
ring expansion by fragmentation. The fragmentation process is closely related to those of the Grob and 
Eschenmoser fragmentations previously discussed, however the fragmentation precursor is formed by 
a redox process.  
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Borowitz et al. described the use of meta-chloroperbenzoic acid (mCPBA) to activate bicyclic enol 
ether 1-106 towards fragmentation, scheme 1-42.53  
 
Scheme 1-42. Oxidative fragmentation of bicyclic enol ether 1-106.53 
Oxidation of 1-106 by treatment with mCPBA allowed the generation of intermediate 1-107 in situ, 
which underwent fragmentation to generate 10-membered ring lactone 1-108 in low yield. Others have 
reported the use of ozonolysis to oxidise the alkene bridges in bicyclic systems to give the ring 
expansion product.54 This methodology has been applied to the synthesis of complex macrocyclic 
systems.55 
Ikeda et al. demonstrated the application of sequential ring expansions, involving first a Grob-type 
fragmentation followed by an oxidative fragmentation in the synthesis of natural product (±)-
phoracantholide 1-114, scheme 1-43.56 
 
Scheme 1-43. Sequential Grob fragmentation and oxidative fragmentation for in the synthesis of (±)-
phoracantholide 1-114.56 
Treatment of cyclobutane 1-109 with mesyl chloride allowed mesylation at the secondary alcohol. This 
initiated a Grob-type fragmentation to generate 6-8 fused enol ether 1-111 that was subsequently 
oxidised upon addition of mCPBA. Oxidation of the bridged alkene promoted fragmentation and ring 
expansion generating 12-membered lactone 1-113, an intermediate in the synthesis of (±)-
phoracantholide.56 
A different oxidative fragmentation approach was reported by Brauer et al. with the aim of creating a 
novel medium-ring library for drug discovery.57 In contrast to oxidising the bond which is cleaved in 
the fragmentation, such as has been discussed previously, the authors reported a strategy involving 





Scheme 1-44. Synthesis of benzannulated medium ring ethers and lactones via oxidative ring expansions.57 
Oxidation of phenol by treatment with (diacetoxyiodo)benzene initiates cyclisation to generate 1-116, 
which undergoes fragmentation on addition of an appropriate Brønsted or Lewis acid to yield 
benzannulated rings 1-118. Quenching with MeOH or deprotonation allowed cyclic ether scaffolds 1-
119 or 1-120 to be isolated in good to excellent yields. To avoid the undesired competing dienone-
phenol rearrangement, three reagent classes (Brønsted acid, Lewis acid and sulfonyl anhydride) were 
chosen to facilitate the desired ring expansion. The driving force was the rearomatisation of a phenol 
adjacent to the scissile bond. This methodology was applied to the synthesis of cyclic benzolactones of 
type 1-123, scheme 1-44 b. To investigate the potential for further functionalisation of the scaffolds, 
the synthesis of the BMR was performed on gram scale, highlighting the industrial potential of these 
scaffolds. Cheminformatic analysis showed that these benzannulated medium rings had structural and 
physicochemical properties mimicking those found in natural products containing similar cores.  
In contrast, ring expansions of bicyclic systems via a reductive method have also be reported. In 1980 
Wasserman demonstrated the synthesis of 9-membered lactam 1-127 by reductive cleavage of an N-N 
bond, scheme 1-45.58 
 
Scheme 1-45. Reductive fragmentation to synthesis medium ring lactam 1-127.58 
The reaction of ethyl cinnamate 1-124 and cyclic hydrazine 1-125 allowed the generation of bicycle 1-
126 which underwent reductive cleavage of the N-N bond on addition of sodium and liquid ammonia. 
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The desired 9-membered lactam was isolated in excellent yield. A similar reductive fragmentation 
procedure was demonstrated by Bonjoch and co-workers for the synthesis of core structures of alkaloid 
natural products.59 For this transformation the authors employed lithium instead of sodium for the 
reductive cleavage. Alongside the synthesis of medium ring structures, reductive fragmentation 
reactions have also been applied to the synthesis of macrocycles.60 
1.3.5.1.3 Ring Expansion by Side-Chain Insertion 
 
The synthesis of medium-sized rings by ring expansion via side-chain insertion can be a challenging 
strategy due to the reversibility of the reaction. Therefore, a strong thermodynamic driving force is 
necessary to ensure successful ring expansion. This has been achieved in several ingenious ways, some 
of which are described below. 
Buchwald reported a tandem copper-catalysed C-N bond formation/ ring expansion sequence for the 
synthesis of 7-10 membered rings 1-131, scheme 1-46 a.61  
 
Scheme 1-46. Ring expansion by side-chain insertion to synthesise medium ring structures.61-63 
Aryl bromides/iodides containing pendant amines 1-128 were heated with β-lactams 1-129 in the 
presence of a copper catalyst, scheme 1-46 a. The strong thermodynamic driving force due to relieving 
Baeyer strain in the β-lactam was sufficient to yield benzannulated medium ring products in good to 
excellent yields. Alternatively, Unsworth et al. reported the ring expansion of cyclic β-keto esters under 
neutral hydrogenation conditions, scheme 1-46 b.62 The sequence consists of first tethering on the 
pendant protected alcohol giving 1-133 which then undergoes ring expansion under hydrogenative 
conditions. Also using a pendant alcohol for ring expansion, Corey and co-workers demonstrated that 
a ring expansion transesterification reaction could be used to access medium ring structures, scheme 1-
46 c.63 Unlike the other examples discussed, there is no overall change of functional group composition 
rendering the reactions reversible. As a result, the outcome of the reactions is a direct reflection on the 
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stability of the ring size being generated. For the ring expansion of 9-memebered lactone 1-135 (n=3), 
the reaction proceeded well and yielded the desired 12-membered ring in near quantitative yield. This 
can be rationalised due to the release of Pitzer strain present in the 9-membered ring on going to a larger 
ring system. For the 8-membered lactone (n=2), the ring expansion was significantly slower and resulted 
in a lower yield of 11-membered ring 1-136, presumably due to a weaker thermodynamic driving force. 
Finally, the ring expansion of 7-membered lactone 1-135 (n=1) was unsuccessful with no 10-membered 
ring being observed. The 10-membered lactone would be significantly more strained than the 7-
membered starting material, therefore making the ring expansion energetically unfavourable.  
1.3.6 Ring Expansions by Radical Reactions 
 
Ring expansions exploiting high energy radical intermediates has been investigated in the synthesis of 
medium ring structures.64 One of the most common methods for ring expansion by radical reaction is 
the Dowd-Beckwith reaction.65-69 The Dowd-Beckwith reaction describes a ring expansion of a cyclic 
β-keto ester by up to four carbons via a free radical intermediate through an α-alkylhalo substituent, 
scheme 1-47.  
 
Scheme 1-47. Ring expansion by the Dowd-Beckwith reaction.46 
This reaction was exemplified by early pioneering work by Dowd, where he demonstrated that a 
primary alkyl radical on a chain pendant to a β-keto ester allowed reversible cyclisation to a high energy 
oxyradical 1-139. This radical initiates fragmentation leading to ring expanded structure 1-140, where 
the radical is now both tertiary and stabilised by conjugation with the ester, providing a driving force 
for the fragmentation. Finally, C-H abstraction from Bu3SnH yields the desired medium ring structure 
1-141 in 75% yield.  
Like the Grob-fragmentation described previously (see section 1.3.5.1.1), Baldwin reported a radical 
fragmentation reaction to stereoselectively access alkene containing medium ring structures, scheme 1-
48.70  
 
Scheme 1-48. Ring expansion by ‘Grob-like’ fragmentation using radicals.70 
The alkene geometries obtained in the products are dictated by the stereochemistry of the starting 
materials. Homolytic cleavage of the C-Se bond upon addition of Bu3SnH and AIBN results in 
cyclisation onto the cyclic ketone to give oxyradical 1-143. This then initiates a fragmentation process 
similar to the Grob-fragmentation leading to medium ring structure 1-144 with a Z:E ratio of 90:10. The 
defined geometry is formed due to the bulky Bu3Sn group preferentially adopting an equatorial position 
31 
 
on the cis-decalin framework, 1-143. An advantage of this strategy is the ability to use only catalytic 
quantities of Bu3SnH due to the generation of a tributylstannyl radical following fragmentation.  
The synthesis of medium rings by radical reactions is not limited to the attack of a radical at a carbonyl 
group. Harrowven et al. demonstrated the synthesis of dibenzo- 8- and 9-membered rings by a radical 
ipso-substitution process, scheme 1-49.71  
Scheme 1-49. Synthesis of medium rings 1-148 by radical ipso-substitution.71 
The driving force for the reaction is based on the increasing stability of the radical species generated. 
The high energy aryl radical species 1-146 initiates cyclisation and subsequent rearomatisation which 
forms a more stable α-keto, α’-carboxy radical. C-H abstraction from Bu3SnH gives the benzannulated 
medium rings 1-148 in varying yields. Importantly, the highest yields obtained were for the 8-membered 
products from the indanone (n=1) precursors. It was noted that for the tetralone (n=2) precursors, a 
competing ortho-cyclisation pathway was active, leading to lower yields of the desired 9-membered 
products. Although not discussed here, ring expansion reactions initiated by oxygen72,73 and nitrogen74,75 
centred radicals have also been investigated for the synthesis of medium ring structures. 
1.3.7 Ring Expansions by Sigmatropic Rearrangements 
 
For the synthesis of medium-sized rings and macrocyclic structures, the most common pericyclic 
reaction employed is ring expansion by sigmatropic rearrangement.46 Similarly to other ring expansion 
methodologies described previously, the success of the reaction depends greatly on the thermodynamic 
driving force. As a result, the most common pericyclic mediated ring expansions result from 
rearrangements of charged intermediates, where quenching of the charge to form a neutral species offers 
the driving force for the reaction.    
Opatz et al. reported a ring expansion method utilising a [1,4]-sigmatropic rearrangement to synthesise 
benzannulated medium rings 1-151, scheme 1-50.76 
Scheme 1-50. Benzannulated medium rings by [1,4]-sigmatropic rearrangement.76 
Deprotonation of 1,2,3,4-tetrahydroisoquinolinium salts 1-149 with 1,8-diazabicyclo[5.4.0]undec-7-
ene (DBU) resulted in ammonium ylides 1-150. Instead of undergoing the expected [1,2]-Stevens 
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rearrangement, ammonium ylide 1-150 participated in a [1,4]-sigmatropic rearrangement yielding 1-
151 after rearomatisation.  
Ring expansion by a [2,3]-sigmatropic rearrangement was reported by Hauser et al. for the synthesis of 
9-membered benzannulated ring 1-155, scheme 1-51.77  
 
Scheme 1-51. Ring expansion by Sommelet-Hauser [2,3]-sigmatropic rearrangement.77 
This strategy, commonly known as the Sommelet–Hauser rearrangement, involved the deprotonation 
of quaternary ammonium salt 1-152 by treatment with sodium amide in liquid ammonia to yield a 
benzylic ylide 1-153. This is in equilibrium with a second ylide 1-154 that is formed by deprotonation 
of one of the methyl groups. Despite this ylide being present in lower concentrations, it participates in 
a [2,3]-sigmatropic rearrangement, yielding the 9-membered ring after rearomatisation. 
[3,3]-Sigmatropic rearrangements have also been exploited in ring expansion reactions to synthesise 
medium ring structures. In 1993, the Taylor group utilised the zwitterionic Malherbe–Bellus–Claisen 
rearrangement in a ring expansion reaction, enabling access to 9-membered cyclic lactones containing 
an E-alkene, scheme 1-52.78 
 
Scheme 1-52. Medium ring lactones by [3,3]-sigmatropic rearrangement.78 
The authors noted that dechlorination of 1-158 with Bu3SnH and AIBN also resulted in trans-cis 
isomerism affording the Z-alkene exclusively. A similar [3,3]-sigmatropic rearrangement of tertiary 
cyclic α-vinylamines was reported by Back and co-workers.79 The authors demonstrated a 3-aza-Cope 
rearrangement under mild conditions for the synthesis of medium ring and macrocyclic structures. 
Despite the many methods reported for the synthesis of medium rings by ring expansion and other 
strategies, the key disadvantage associated with all the methods described is the synthesis of the 
requisite starting materials. For the transformations to be successful there needs to be a strong driving 
force for the reaction to proceed, and this typically necessitates the synthesis of appropriate precursors 
containing carefully arranged functional groups. This is not always a trivial process and in some cases 
the synthesis of the starting materials is the most challenging part of the process. As a result, a general 
system which allows access to medium ring structures from simple, easily synthetically accessible 
starting materials is highly desirable.  
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1.4 Intramolecular N→C Aryl and Vinyl Migration  
 
1.4.1 Initial Discovery and Mechanistic Insight 
 
In 2007, whilst studying the regioselective lithiation of N-aryl ureas, the Clayden group discovered a 
new reaction which involved a stereospecific aryl transfer from a urea nitrogen to an sp3 carbon centre, 
scheme 1-53.80 
 
Scheme 1-53: Aryl migration from a lithiated urea. 
The discovery was made whilst investigating the site of deprotonation of 1-160. To probe the 
deprotonation, N-benzyl urea 1-160 was treated with s-BuLi and methyl iodide. Purification of the 
reaction mixture yielded an unstable compound identified as 1-161, where the 2,6-dimethylphenyl 
aromatic ring had migrated to the benzylic carbon position. On replacing the methylation with an 
aqueous ammonium chloride quench the rearranged product 1-162 was isolated in excellent yield.  
The rearrangement of a series of N-benzyl ureas, 1-163 was performed under similar conditions to 
demonstrate the generality of the method, table 1-2.  
Table 1-2. Aryl migration in lithiated N-benzyl ureas, 1-163.80 
 
Entry R1 R2 1-164 yield, % 1-165 yield, % (method) 
1 Ph 2,6-diMe 89 - 
2 Ph 4-Me 85 - 
3 p-Tol H 85 - 
4 Me H 78 84 (B) 
5 Me 2-Me 76 72 (A) 
6 Me 2-OMe 75 78 (A) 
7 Me 2,6-di-Me 82 84 (A) 
8 Me 4-Cl 69 - 
9 Me 4-OMe 76 - 
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The results showed that the reaction proceeds in good to excellent yields irrespective of the steric and 
electronic nature of the substituents on the migrating ring. Subjecting compound 1-164 to DIBAL or 
hydrolysis of its N-nitroso derivative allowed cleavage of the urea yielding the diarylmethylamines 1-
165 in good to excellent yields. 
With the optimal conditions in hand, the efforts of the group turned to the synthesis of quaternary 
stereocenters through the rearrangement of tertiary lithiated ureas, scheme 1-54. 
Scheme 1-54. Enantioenriched α-tertiary amines by aryl migration.80 
Subjecting enantioenriched α-methylbenzylurea 1-166 to the optimal conditions resulted in a slower 
reaction with significant amounts of the starting material still present after 2 hours at –78 °C. With the 
aim of driving the reaction to completion, the temperature was raised, and the reaction time was 
lengthened. However, this resulted in the formation of olefinic products arising from elimination of the 
urea. The addition of additives to deprotonations with organolithium bases can dramatically alter their 
resulting reactivity.81,82 Therefore, DMPU (N,N’-dimethylpropylene urea) was chosen as an additive to 
increase the reactivity of the resulting organolithium, as DMPU is a lithium-coordinating solvent which 
is assumed to work by promoting dissociation of the organolithium to an ion pair.83 Reactions were 
accelerated and the resulting migrated ureas 1-169 were isolated in good to excellent yields. Substrates 
with electron-donating and electron-withdrawing substituents on the aromatic rings migrated in good 
to excellent yields, including more sterically hindered substrates. In all cases there was minimal loss of 
enantiopurity demonstrating that the reaction proceeds through a configurationally stable organolithium 
intermediate 1-167. Cleavage of the urea afforded the enantioenriched amines 1-170 in good to excellent 
yields. 
Clayden et al. offered a mechanism to rationalise the stereospecificity of the aryl migration reaction.84 
They proposed that on treatment of enantioenriched α-methyl urea 1-166 with s-BuLi an unusual 
intramolecular ipso SNAr reaction takes place, proceeding through a 5-membered Meisenheimer 
complex 1-168. Evidence of a dearomatised intermediate was supported by the isolation and 
crystallisation of enone 1-171 when the reaction was carried out under aerobic conditions. Most 
importantly, the authors reasoned that the highly stereospecific aryl migration was a consequence of 




Since then, further mechanistic studies have been carried out, including in situ NMR and IR and 
computational DFT calculations.85 In situ NMR analysis of the aryl migration when using a naphthyl 
migrating group supported the theory of proceeding through a transient dearomatised intermediate. 
Despite this, results from the ReactIR performed in the absence of DMPU did not show any observable 
dearomatised intermediate. DFT calculations provided key information regarding the mechanism, 
notably highlighting the importance of the coordinated lithium cations, and their migration from one 
site to another during the reaction. The conformation of the urea is also thought to assist in the unusual 
reactivity observed. It is suggested that for reaction to occur the dipole-stabilised organolithium 1-172 
rotates, adopting a conformation where the carbanion is in close proximity to the remote aromatic ring 
1-173. This rotation allows much of the electronic repulsion to be bypassed, which would prevent an 
analogous intermolecular arylation from occurring.  The solvated lithium cation sandwiches itself 
between the two aromatic rings, allowing it to stabilise the transfer of negative charge to the migrating 
aromatic ring, permitting retentive migration. 
 
Scheme 1-55. Bond rotation in benzyl ureas allowing retentive migration of aryl group. 
Further calculations also revealed that the 1,4-aryl shift was preferred over a 1,2-acyl shift due to having 
a lower energy transition state.  
1.4.2 Substrate Scope  
 
1.4.2.1 N→C Aryl migration Utilising Benzylic Anions 
 
With the knowledge that N→C aryl migration is possible utilising benzylic anions, the scope was 
extended to other systems bearing benzylic centres. The methodology was applied to the α-pyridylation 
of chiral amines by substituting the migrating ring with a pyridine, scheme 1-56.86  
 
Scheme 1-56. Synthesis and rearrangement of N-pyridyl ureas 1-176.86 
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Synthesis of the N-pyridyl ureas 1-176 was achieved by initial phosgenation and treatment with 
methylamine. Subsequent palladium-catalysed coupling of the bromopyridine with the urea using 
standard conditions reported for amides87 afforded the pyridyl ureas 1-176 in good to excellent yields. 
Under the conditions previously reported, treatment with s-BuLi in THF did not lead to successful 
rearrangement. Instead, nucleophilic attack of the organolithium base onto the pyridyl ring was 
observed. To circumvent this issue, LDA, a bulkier less nucleophilic base was chosen, and the reaction 
proceeded cleanly with excellent stereospecificity. The rearrangement was proposed to occur through 
a mechanism like that shown in scheme 1-56, where the Li cation ‘sits’ on the pyridine nitrogen in the 
intermediate 1-180. The absence of regioisomeric pyridine products demonstrates that even the 3-
pyridyl substitutents are attacked at the ipso position, overriding the usual regiochemistry of 
nucleophilic attack on the pyridine ring. Attempts at removing the urea using conditions previously 
reported failed to deliver the desired amines 1-178. However, an alternative strategy of heating the 
mixture in n-butanol proved successful and yielded the desired aminopyridines 1-178 in good yields. 
Studies were reported on the application of this aryl migration reaction to cyclic amines, both 
heterocyclic and carbocyclic.88 α-Aryl pyrrolidines 1-181 were shown to undergo the desired aryl 
transfer under standard lithiation conditions with DMPU, generating the desired quaternary arylated 
pyrrolidine 1-182 in excellent yields, scheme 1-57 a. 
 
Scheme 1-57. Aryl migration of pyrrolidine derivatives.88 
The stereospecific migration of enantiomerically enriched pyrrolidine derivatives 1-181 failed, giving 
only racemic products. The authors stated that the rearrangement of these substrates was notably slower 
than the acyclic systems because of a more constrained bicyclic transition state for aryl migration, which 
allowed racemisation of the organolithium intermediate. A series of carbocyclic compounds with the 
nitrogen in an exocyclic benzylic position were also trialled using the aryl migration conditions, scheme 
1-57 b. Aminoindane (n=1) and aminotetralin (n=2) were converted to the ureas via standard methods 
of coupling with an isocyanate followed by methylation. All ureas trialled gave the desired rearranged 
products when subjected to either s-BuLi or LDA in a THF/DMPU mixture in good to excellent yields.  




Scheme 1-58. Synthesis of 2,2- and 2,6- diarylpiperidines by N→C aryl migration.89 
Depending on the position of unsaturation within the tetrahydropyridine ring 1-186, N→C aryl 
migration by either deprotonation of the benzylic proton, allylic proton or carbolithiation across the 
alkene double bond led to a range of polysubstituted piperidine derivatives.  
This methodology is not limited to ureas and can be applied to alternative heteroatoms α- to the benzylic 
position. Carbamates90, 91 and thiocarbamates92 have also been extensively studied, allowing access to 
arylated alcohols and thiols respectively. As with their urea counterparts, benzylic carbamates undergo 
facile N→C aryl migration, providing an alternative synthetic route to α,α-arylated secondary or tertiary 
alcohols 1-192 in good to excellent yields, scheme 1-59 a.90 
 
Scheme 1-59. Aryl migration of benzylic carbamates.90, 91 
The results were similar in the sense that migration occurred irrespective of the electronic or steric 
nature of the migrating ring. The authors noted that the decreased stability of the intermediate O-
substituted benzyllithium in strongly lithium coordinating solvents led to diminished enantioselectivity 
in the products. Therefore, THF was replaced with Et2O, which led to a significant improvement in the 
product er. In contrast to ureas, carbamates undergo the rearrangement with overall inversion of 
stereochemistry. DFT calculations showed that due to the high affinity of lithium for oxygen, the lithium 
cation remains bonded to the carbamate oxygen in the lowest energy transition state. Consequently, the 
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carbamate O-Li bond positions itself away from the incoming arene, resulting in aryl migration and 
inversion of stereochemistry. To highlight the utility of the methodology, it was used in the first 
enantioselective synthesis of antihistamine agent (-)-(S,S)-clemastine 1-195, scheme 1-59 b.91 
The aryl transfer reaction has also been extended to analogous thiocarbamates utilising benzylic 
anions.92 Lithiation of N-aryl S-α-alkylated thiocarbamates led to N→C migration of the aryl ring to the 
carbon centre α to sulfur. Like ureas, the migration proceeded with retention of overall stereochemistry 
and delivered chiral benzylic tertiary thiols 1-198 in good to excellent enantioselectivities, scheme 1-
60.  
 
Scheme 1-60. Aryl migration in benzylic thiocarbamates to synthesise tertiary thiols.92 
Similar to carbamates, the benzyllithium intermediate is less configurationally stable than the urea 
analogue leading to poor ers when lithiating with s-BuLi/LDA in THF/DMPU. This problem was 
overcome by replacing the organolithium base with a bulkier base, LiTMP and lithiating in the absence 
of DMPU, which resulted in almost complete stereospecific rearrangement. 
1.4.2.2 Aryl Migration Utilising Other Nucleophiles 
 
With regards to the anion stabilising group, groups other than benzyl groups have been shown to be 
successful in the rearrangement. Allyl groups have also shown promise as anion stabilising groups for 
the N→C aryl migration reaction, scheme 1-61.93, 94  
 
Scheme 1-61. N→C aryl migration exploiting allyl ureas.93, 94 
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1,1-Diarylallyamine derivatives were generated exploiting a sequential double α-arylation starting from 
N-allyl-N′-aryl ureas 1-199.93 N-Allyl-N′-aryl ureas were deprotonated on addition of LDA yielding an 
allyl lithium which rapidly rearranged by intramolecular N→C aryl transfer generating arylated vinyl 
ureas 1-200. The products, after introducing a new aryl group via Buckwald Hartwig amination can 
then undergo a second N→C aryl migration reaction yielding 1,1-diarylallylamine products 1-202 after 
γ-protonation of the allylic anion. 
It was also possible to make the second aryl transfer enantioselective using a chiral lithium amide, which 
generated highly enantioenriched diarylallyl ureas 1-202. Allyl ureas 1-203 were also shown to undergo 
N→C aryl migration, scheme 1-61 b.94 Lithiation at the allylic carbon allowed access to a range of α-
quaternary urea derivatives 1-204 in varying yields. The utility of the method was demonstrated by 
performing the reaction on a multi-gram scale. 
Dianionic enolates formed from N-aryl urea derivatives of amino acids undergo the same intramolecular 
N→C migration, scheme 1-62 a.95, 96 
 
Scheme 1-62. Aryl migration in amino acid enolates.95, 96 
In the cases reported, aryl migration was quickly followed by cyclisation to the corresponding hydantoin 
1-207, which could then be converted to biologically important quaternary amino acids. Interestingly, 
the reaction used a non-stabilised enolate nucleophile, unlike the previous work which required a group 
to stabilise the anion prior to rearrangement. A series of natural and unnatural amino acids were 
derivatised as ureas and subjected to the optimised conditions for the aryl migration. Quenching with 
dilute HCl solution delivered the desired hydantoins 1-207. Hydrolysis of a hydantoin allowed the 
isolation of a quaternary amino acids as its methyl esters 1-208. Since the deprotonation to form an 
enolate proceeds through a planar enolate anion, the previously reported migration generated only 
racemic products 1-207.  
In 2015, Atkinson et al. reported the asymmetric α-arylation of α-amino acid derivatives using a 
pseudoephedrine chiral auxiliary, scheme 1-62 b.96 In situ silylation and enolisation induced the 
diastereoselective migration of an aryl group to the α-amino acid carbon. This was rapidly followed by 
ring closure to the hydantoin, which expelled the auxiliary. The enantiomerically enriched hydantoins 
were then hydrolysed affording the α-arylated quaternary amino acids 1-211 in good enantiomeric 
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ratios. This method provides an alternative to metal-catalysed α-arylation of amino acids which has 
potential industrial importance.  
The efforts of the group then turned to applying this chemistry to the asymmetric synthesis of α-aryl 
proline derivatives.97 The synthesis of α-aryl proline derivatives has not been widely explored and those 
that have investigated it have scopes limited to electron-deficient aryl rings.98 Prolines substituted in 
positions 3- or 5- underwent successful aryl migration, delivering the desired bicyclic or tricyclic 
hydantoin derivatives in high diastereoselectivity. Aryl migrations were successful for both electron-
rich and electron-deficient aryl rings. Subsequent hydrolysis of the hydantoins with 4 M sodium 
hydroxide generated the enantiopure quaternary proline derivatives which hold potential as scaffolds 
for medicinal chemistry. 
1.4.3 N→C Vinyl Migration 
 
Due to the N→C aryl migration working efficiently even with the most electron-rich aromatic rings, 
investigations were carried out to see if the analogues vinyl migration was possible. Indeed, successful 
vinyl migration was achieved on lithiated benzylic ureas, carbamates and thiocarbamates, scheme 1-
63.99 
 
Scheme 1-63. Vinyl migration of ureas, carbamates and thiocarbamates.99 
For urea substrates the migration was possible with s-BuLi. However, LDA was needed for both 
carbamates and thiocarbamates to avoid nucleophilic attack of the organolithium base. A one-pot 
reaction (urea formation, rearrangement and deprotection) for the urea analogues was carried out, 
followed by crystallisation of the resulting amine by addition of anhydrous HCl. This allowed the 
determination of stereochemistry by X-ray crystallography and showed that the migration had occurred 
with retention of stereochemistry. 
ReactIR was used to probe the reaction mechanism further, scheme 1-64. To avoid obscuring the 




Scheme 1-64. Proposed intermediates in vinyl migration probed by ReactIR.99 
The starting urea 1-218 displayed two absorptions at ν =1660 and 1620 cm-1 at −78 °C in THF. On 
lithiation with s-BuLi, these absorptions disappeared and were replaced with an absorption at ν = 1575 
cm-1, which was assigned to rearranged product 1-222. No obvious intermediates were detectable. 
Knowing that the migration reactions were slower in Et2O, experiments were conducted in Et2O with 
or without LiCl as an additive. Addition of s-BuLi to 1-218 gave a transient absorption at ν = 1646 cm-
1, which disappeared over a period of seconds to a new intermediate with two absorptions at ν = 1608 
and 1593 cm-1. Quenching at this point returned starting material, so it was assumed that this 
intermediate may be a pre-lithiated complex 1-219, which is converted to an intermediate lithiated urea 
1-220. The authors stated that slow warming of the reaction mixture to room temperature encouraged 
the rearrangement and the ν = 1608 and 1593 cm-1 absorptions decreased in intensity. At −15 °C a new 
absorption appeared at ν = 1575 cm-1, which was previously assigned to 1-222 due to confirmation by 
treating the product 1-223 with s-BuLi and obtaining the same spectrum. It was suggested that the 
mechanism proceeded through a cyclic structure 1-221, although there was no evidence for this by 
ReactIR.  
DFT calculations showed the coordination of the Li cation to the π system of the phenyl ring. On 
formation of the carbon-carbon bond the transition state is proposed to have the Li cation on the terminal 
carbon of the vinyl group to help stabilise the build-up of negative charge resulting in retention of 
stereochemistry. Following this, it is proposed that the breakage of the carbon-nitrogen bond has the Li 
cation coordinating to the urea functionality to stabilise the negative charge.  
More recently, the group extended the vinylation to tertiary amino nitriles, allowing the synthesis of 
alkenylated hydantoins, scheme 1-65.100 
 
Scheme 1-65. Stereodivergent alkenylation by N→C vinyl migration.100 
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Lithiation of ureidonitrile 1-224 with s-BuLi in DMPU and THF promoted migration of the N’-alkenyl 
group with retention of double bond geometry. The method is stereodivergent with both the E and Z 
isomers being accessed from the same allyl starting material by alkene isomerisation. Upon basic 
hydrolysis of the hydantoin products 1-225, quaternary α-alkenyl amino acids 1-226 were afforded as 
single E or Z isomers.  
1.4.4 Tandem Carbolithiation – Rearrangement 
 
N-Alkenyl ureas 1-227 possess umpolung reactivity, undergoing addition of organolithiums to their 
otherwise nucleophilic β-carbons.101 This carbolithiation step can be coupled with the N→C aryl 
migration reaction generating two new C-C bonds in a single pot, scheme 1-66. Products were isolated 
in good to excellent yields with diastereoselectivities greater than 95:5. Both the carbolithiation and 
rearrangement steps were stereospecific, since inverting the double bond geometry in the starting 
material or exchanging the aromatic rings changed the configuration of the product. 
 
Scheme 1-66. Carbolithiation-rearrangement of N-vinyl ureas 1-227 and potential reaction mechanism.101 
The reaction was presumed to occur by syn-carbolithiation, which forms a configurationally stable 
organolithium 1-231. This undergoes retentive migration of the aryl ring from N→C, delivering 
rearranged product 1-234 after a methanol quench scheme 1-66 b. This methodology has been applied 
to both alkenylcarbamates102 and alkenylthiocarbamates103 for the synthesis of heavily substituted 
alcohols and thiols respectively. 
This tandem carbolithiation-rearrangement methodology has been applied to β-unsubstituted ureas 1-




Scheme 1-67. Asymmetric tandem carbolithiation-rearrangement using (+)-sparteine surrogate.104 
The initial carbolithiation proceeded stereoselectively by employing (-)-sparteine or (+)-sparteine 
surrogate as a chiral diamine ligand. The subsequent stereospecific retentive aryl migration allowed 
access to the enantiomerically enriched ureas 1-237 in high yields. The corresponding amines 1-238 
were isolated basic hydrolysis.  
In summary, Clayden and co-workers have developed an efficient method for the synthesis of racemic 
and heavily substituted and enantioenriched amines, alcohols and thiols. Nucleophiles such as benzylic 
and allylic anions, enolates and nitrile anions were successful in achieving migration of an aryl or vinyl 
group from nitrogen to an sp3 carbon centre. This unique method overcomes the challenge of coupling 
an anion with an unactivated aryl or vinyl ‘electrophile’.  
Due to the vast array of substrates this N→C aryl migration protocol has been successfully applied to, 
it was hoped that an extension of this methodology would allow a general approach towards 
















2. Results and Discussion 
 
2.1 Aims of the Project  
 
As described in section 1.4, Clayden and co-workers have developed an intramolecular N→C aryl 
migration reaction on ureas, carbamates and thiocarbamates, utilising different nucleophiles.  However, 
until now only acyclic systems have been investigated, where the migrating aromatic ring is bonded 
solely to the urea nitrogen and the urea nitrogen is typically substituted with a methyl.  
The aim of this project was to investigate the possibility of using this N→C aryl migration protocol for 
the synthesis of medium ring structures by tethering the urea nitrogen as part of a ring, scheme 2-1. It 
was hypothesised that N→C aryl migration by ipso SNAr at the migrating ring and cleavage of the aryl 
carbon-nitrogen bond would lead to a n+3 ring expansion of the starting ring size.  
 
Scheme 2-1. Potential ring expansion exploiting N→C aryl migration. 
If viable, it was hoped that this would offer an efficient and general synthesis of benzannulated medium 
ring structures, while addressing the challenges facing other ring expansion methods, where pre-
organisation of the fragmentation precursors through typically lengthy syntheses is essential for 
successful ring expansion (see section 1.3.5). 
The initial aim of the project was to utilise benzylic anions for the ring expansion before exploring 
alternative nucleophiles. Firstly, a simple general method for the synthesis of the ring expansion 
precursors would need to be developed, where possible exploiting commercially available nitrogen 
heterocycles with varying electronic and steric parameters. The ring expansion of more complex 
structures would also be studied, allowing factors such as diastereoselectivity and stereospecificity of 
the reaction to be investigated. It was hoped that if possible, the ring expansion could be applied to both 
carbamate and thiocarbamate precursors, allowing a range of benzannulated medium ring structures to 








2.2 Medium Ring Nitrogen Heterocycles by Migratory Ring Expansion of Lithiated 
Ureas 
 
N.B. The work described herein (section 2.2) is documented in the first author publication, J. E. Hall*.; 
J. V. Matlock.; J. W. Ward.; K. V. Gray, J. Clayden. Angew. Chem. Int. Ed. 2016, 55, 11153. 
 
2.2.1 Previous Work 
 
Preliminary work investigating the ring expansion of nitrogen heterocycles by N→C aryl migration 
showed that this route was viable and yielded medium rings in good to excellent yields, scheme 2-2.  
 
Scheme 2-2. Preliminary ring expansion results.* 
5- To 7-membered commercially available nitrogen heterocycles were transformed into their benzyl 
urea counterparts by a two-step procedure involving coupling of the parent nitrogen heterocycles with 
isocyanate followed by N-methylation, scheme 2-3. The yield of the methylation step significantly 
reduced on increasing the size of the nitrogen heterocycle and therefore presented a problem for using 
this synthetic procedure for the synthesis of larger ring sizes.  
 
Entry n Yield 2-6 % Yield 2-7 % 
1 1 60 99 
2 2 93 65 
3 3 86 33 
 
Scheme 2-3. Synthesis of urea starting materials via isocyanate coupling and methylation. 
Due to the ease of synthesis, indoline urea 2-7 was chosen as a model substrate to explore optimisation 
of the reaction conditions. Using the reported conditions for the N→C aryl migration in acyclic systems, 
s-BuLi in THF at −78 °C for two hours, the desired 8-membered ring was isolated in 62% yield, (scheme 
2-4, entry 1). 
                                                          




Entry n Base, eq. Additive, eq. Temp °C Time, h  2-4, %a 2-8, %a 
1 1 s-BuLi, 2 - −78 2 62 25 
2 1 s-BuLi, 2 - −78 4 12 69 
3 1 LDA, 2 - −78 4 94 - 
4 2 LDA, 2 DMPU, 5 −78 4 74 - 
5 3 LDA, 2 DMPU, 5 −78 4 90 - 
aRatios reported as observed in the 1H NMR of the crude material.  
Scheme 2-4. Ring expansion of 5-membered indoline precursor 2-7 and optimisation of conditions. 
Analysis of the 1H NMR spectrum of the crude material showed that a side product arising from initial 
ring expansion and subsequent nucleophilic attack of the s-BuLi at the carbonyl was also present in the 
reaction mixture (scheme 2-4, entry 1). Leaving the reaction for longer only increased the amount of 
this side product thereby reducing the amount of the desired 8-membered ring 2-4 (scheme 2-4, entry 
2). Pleasingly, on replacing s-BuLi with LDA, a bulkier non-nucleophilic base, the undesired ring 
opened side product was not observed and the reaction gave the desired 8-membered ring expansion 
product in 94% as a ratio from the 1H NMR of the crude material (scheme 2-4, entry 3). Subjecting 6- 
and 7-membered urea precursors to the optimised reaction conditions gave the corresponding 9- and 
10-membered rings in good yields, albeit requiring longer reaction times. With the knowledge that 
DMPU can increase the reactivity of the organolithium by aiding deaggregation of the LDA,81 DMPU 
was added to the reaction mixture. The desired 9- and 10-membered rings were isolated in 74% and 
90% respectively, (scheme 2-4 entries 4 and 5). 
2.2.2 Synthesis of Ring Expansion Urea Precursors 
 
Having already showed that 8-, 9- and 10-membered nitrogen heterocycles were accessible by this 
methodology (see section 2.2.1), it was hoped that we could extend this to the synthesis of the full range 
of medium sized rings (8- to 12-members). Hence, it was essential to synthesise the 8- and 9- membered 
urea precursors, which after N→C aryl migration would allow access to the previously unexplored 11- 
and 12- membered cyclic ureas. In contrast to the smaller ring precursors investigated thus far, the 8- 
and 9-membered cyclic precursors are not commercially available and therefore needed to be 
synthesised prior to attempting the ring expansion. 
2.2.2.1 Synthesis of 8-Membered Ring Expansion Precursor 
 
A synthetic strategy commencing from commercially available benzosuberone 2-9 utilising a 




Scheme 2-5. Synthesis of 8-membered rearrangement precursor, 2-14. 
Following a literature procedure,105 treatment of benzosuberone 2-9 with hydroxylamine hydrochloride 
and pyridine in ethanol resulted in oxime 2-10 in near quantitative yield. Heating oxime 2-10 in 
polyphosphoric acid (PPA) gave the desired Beckmann rearrangement lactam product 2-11, which was 
reduced to the corresponding amine upon treatment with lithium aluminium hydride, with both reactions 
proceeding in good yields. Coupling of the 8-membered cyclic amine 2-12 with benzyl isocyanate 
afforded the desired urea in 76% yield. However, as anticipated, the methylation step was low yielding. 
This prompted us to investigate an alternative, more efficient strategy for tethering on the urea that 
could then be applied to all substrates, regardless of ring size.  
2.2.2.2 Devising a General Strategy for Tethering on Urea 
 
With the prior knowledge that the methylation of the urea nitrogen after isocyanate coupling is 
significantly hindered by ring size of the starting precursor, an alternative route to the urea starting 
materials was of interest. 8-Membered cyclic amine 2-12 was chosen as the model substrate for these 
studies. It was thought that reacting amine 2-12 with benzyl(methyl)carbamoyl chloride 2-15 would 
generate the urea precursor in one step, scheme 2-6.  
 
Scheme 2-6. Alternative strategy to precursor 2-14. 
Unfortunately, subjecting amine 2-12 to carbamoyl chloride 2-15 in the presence of triethylamine and 
4-dimethylaminopyridine (DMAP) in dichloroethane, resulted in the desired urea in a disappointing 
yield of 14% after four days. This can be attributed to the reduced nucleophilicity of the 8-membered 
amine ring 2-12, due to steric hindrance. To overcome this, the synthetic strategy was modified, and 




Scheme 2-7. Modified strategy for synthesis of 8-membered ring expansion precursor 2-14. 
Urea formation was achieved in two steps from 2-12. Phosgenation with triphosgene and pyridine gave 
carbamoyl chloride 2-16 in good yield without the need for further purification. The resulting carbamoyl 
chloride was reacted with N-benzylmethylamine in the presence of triethylamine and catalytic DMAP 
in dichloroethane (conditions A, scheme 2-7). Pleasingly, the desired cyclic urea precursor was afforded 
in 77% yield. The amination step was further modified by removing DMAP and dichloroethane and 
using acetonitrile as the solvent at room temperature (conditions B, scheme 2-7). This gave the desired 
urea in a slightly higher yield of 80%. As a result, conditions B were chosen for tethering on the urea 
to the cyclic amine precursors. 
2.2.2.3 Synthesis of 9-Membered Ring Expansion Precursor 
 
As was the case with the 8-membered cyclic amine, the 9-membered cyclic amine was not commercially 
available and therefore needed to be synthesised prior to ring expansion to access the 12-membered 
ring. Unfortunately, the 8-membered cyclic ketone analogous to benzosuberone 2-9 was also not 
available from commercial sources. Given that the Beckmann rearrangement proved to be an efficient 
strategy, synthesis of the corresponding 9-membered cyclic ketone was undertaken, scheme 2-8.  
 
Scheme 2-8. Planned synthetic strategy to access 9-membered ring expansion precursor 2-22. 
The first step involved in situ formation of an acyl chloride by subjecting 6-phenylhexanoic acid 2-17 
to oxalyl chloride in dichloromethane. Attempts were made towards the intramolecular Friedel-Crafts 
acylation to form cyclic ketone 2-19. Aluminium trichloride was added to the acyl chloride in 
dichloroethane and heated to reflux. Unfortunately, the desired 8-membered cyclic ketone was not 




Scheme 2-9. Dimer formation under Friedel-Crafts acylation conditions. 
Although repeating the reaction at high dilution and using syringe pump addition of the acyl chloride 
avoided the formation of a dimeric species, mass balance was poor, and the product was isolated in a 
15% yield. The work-up procedure was altered in the hope of gaining an improved yield as it was 
speculated that the formation of aluminium salts hindered product isolation. The water quench was 
replaced with pouring the reaction mixture onto an ice and concentrated HCl mixture. Despite this, the 
yield for the desired product was 20% by examination of the 1H NMR spectrum with an internal 
standard. As a result, this route was abandoned and an alternative synthetic strategy exploiting ring 
closing metathesis as a key step was devised, scheme 2-10. 
 
Scheme 2-10. Synthesis of 9-membered ring expansion precursor 2-22. 
The lengthy synthesis required to access 2-22 highlights the difficulties associated with the synthesis of 
medium-sized rings. The first steps towards the synthesis of 2-22 involved amine protection of 2-
iodoaniline 2-24, followed by alkylation to append the first alkene tether. Stille coupling allowed the 
introduction of another alkene tether to prepare the di-alkene compound 2-27, which is then set up for 
the ring closing metathesis step. Treatment of the alkene 2-27 with Grubbs’ first-generation catalyst led 
to cyclic amine 2-28, which after hydrogenation resulted in the protected 9-membered cyclic amine 2-
29. Finally, a deprotection step was needed to afford the desired cyclic amine, to which the urea could 
then be attached.  
Careful choice of a protecting group at the start of the synthesis was required to avoid unnecessary 
deprotection steps. As a result, a benzyl group was selected to protect the aniline nitrogen as it was 
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envisaged that this would be removed under hydrogenation conditions needed to reduce the internal 
alkene later in the synthesis.  
 
Scheme 2-11. Alternative amine protecting groups and subsequent alkylation.  
Although protection proceeded cleanly following literature procedure,106 the alkylation that followed 
was problematic and efficient separation of the desired product 2-32 from unreacted starting material 
was not possible. As a result, 2-iodoaniline was protected with an alternative protecting group, 
carboxybenzyl (Cbz), which can also be cleaved by hydrogenation. As before, the protection step 
proceeded smoothly107, however once more the alkylation was found to be low yielding and the 
alkylated product 2-32 was unable to be isolated cleanly. Lastly, a benzoyl protecting group was 
utilised. Facile protection108 was followed by alkylation resulting in the formation of 2-32 in a higher 
yield of 67%, which was separable from starting material. Although the benzoyl group cannot be 
cleaved by hydrogenation, it was hoped that it could be easily removed by acidic or basic hydrolysis. 
With alkylated product 2-32 in hand, effort was directed towards the Stille coupling to install the second 
alkene tether. The Stille reaction involves the coupling of an organohalide with an organostannane to 
obtain a coupled product via the use of a palladium catalyst. Subjecting 2-32 to Stille conditions, 
Pd(OAc)2, PPh3, LiCl and finally tributylallyltin allowed successful generation of di-alkene 2-27 in 
excellent yield. It was found that the optimal work-up technique involved washing the reaction mixture 
with 1 M KF solution,109 which promoted the precipitation of tin by-products, allowing the mixture to 
be further purified by flash column chromatography. The Stille cross-coupling catalytic cycle is shown 





Scheme 2-12. Mechanism of Stille coupling. 
The reaction proceeds with initial oxidative addition of the organohalide 2-34 to the Pd0 species 2-33 
to form Pd2+ complex 2-35. Subsequent transmetallation of 2-35 with the organostannane allows the 
formation of species 2-38, where the alkyl group of the organostannane has replaced the halide anion 
on the palladium complex. Reductive elimination delivers the desired cross-coupled product 2-39 and 
regenerates the palladium catalyst.  
 
Having appended the allyl group onto the aromatic ring, the ring closing metathesis of 2-37 was 
explored. The optimal conditions were reported in the literature to be 10 mol% Grubbs’ first-generation 
catalyst in toluene.110 Subjecting diene 2-27 to these conditions allowed the formation of cyclic amine 
2-28 in 54% yield. Successful hydrogenation of the alkene resulted in protected 9-membered amine 2-
29, which was hydrolysed under acidic conditions to yield the desired unprotected 9-membered cyclic 
amine 2-30. Urea formation was achieved by subjecting 2-30 to the general procedure described in 
section 2.2.2.2.  
2.2.2.4 Starting Material Substrate Scope 
 
With the advantage of the ring expansion methodology being that complex scaffolds can be generated 
from simple starting materials, efforts were directed towards selecting simple commercially available 
starting materials. Starting materials with varying electronic and steric parameters on the migrating 
aromatic ring, including examples that incorporated heteroatoms were selected. The scope of the 




Scheme 2-13. Ring expansion starting material scope.* 
N.B. Yields calculated over two steps of phosgenation and amination. aYield calculated over amination step 
only. bStarting cyclic amines not commercially available and synthesised according to procedures in section 
2.2.2.1 and 2.2.2.3. cAlternative method of isocyanate coupling and methylation used. dFrom indole starting 
materials. 
Several different indoline and tetrahydroquinoline derivatives were available with varying electronic 
and steric demands. Substrate 2-53 where the benzyl group is part of a ring was synthesised simply by 
coupling two isomers of the same molecule together (tetrahydroquinoline and tetrahydroisoquinoline). 
A methyl group at the benzylic centre can be introduced by coupling the tetrahydroquinoline carbamoyl 
                                                          
* Experiments performed in collaboration with Dr Johnathan Matlock. 
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chloride with 1-methyl-1,2,3,4-tetrahydroisoquinoline. Structures with additional heteroatoms in their 
structures were also obtained 2-55-2-57 from commercial sources. Two examples where the anion 
stabilising group was not benzyl but instead a heterocycle, 2-pyridyl and 2-thiophenyl (substrates 2-57 
and 2-58), were also synthesised to study their effect on migration. 
For enantioenriched examples 2-59 and 2-60, the general procedure for urea formation was modified 
by reacting the appropriate carbamoyl chloride with enantioenriched (S)-N-methyl-1-phenylethan-1-
amine. Racemic indoline substrates with substituents on the tether 2-61-2-64 were synthesised by 
Sn/HCl reduction of their parent 2-substituted indoles.111 All substrates were converted into their urea 
counterparts in good yields over both steps, scheme 2-13.  
2.2.3 Ring Expansion Substrate Scope 
 
Initial studies focused on repeating the preliminary work carried out previously (see section 2.2.1). 
Indoline urea 2-65 was treated with LDA (2 eq.) in THF at −78 °C and allowed to react for 2 hours. The 
ring expansion reaction was also repeated with DMPU in the reaction mixture. Interestingly, both 
reactions gave different products as determined by 1H NMR analysis of the isolated compounds, 
although HRMS analysis indicated that both had the same mass. A key difference in the 1H NMR spectra 
was a singlet corresponding to the benzylic proton in the 1H NMR spectrum of the product isolated in 
the reaction without DMPU, this singlet appeared at δ = 4.27 ppm compared to δ = 6.25 ppm when the 
reaction was run with DMPU, see figure 2-1. 
 
  
Figure 2-1. 1H NMR spectra of product from rearrangement of 2-65: without DMPU (top) with DMPU 
(bottom). Highlighted resonance of suspected benzylic proton. 
X-ray crystal 
structure of 2-67 
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In both reactions, when run with and without DMPU, diastereotopic protons were observed indicating 
the formation of a chiral centre. Crystallisation of the product isolated from the reaction in the absence 
of DMPU allowed for X-ray analysis and the unambiguous assignment of the product as 2-67. It was 
proposed that product 2-67 results from initial deprotonation at the benzylic position to form 
organolithium 2-68, followed by nucleophilic attack at the urea carbonyl carbon centre, leading to a 
1,2-acyl shift which after protonation delivers the secondary amine, scheme 2-14. 
 
Scheme 2-14. Proposed mechanism for formation of acyl shift product 2-67.  
Pleasingly, the addition of DMPU in the reaction mixture completely suppressed the formation of the 
acyl shift product 2-67 and the desired ring expansion occurred resulting 8-membered ring product 2-
66 in 70% yield. The ring expansion of tetrahydroquinoline and tetrahydrobenzazepine ureas 2-45 and 
2-46 were also repeated in good to excellent yields.  
The ring expansion was attempted on all the precursors synthesised (see section 2.2.2.4). Excellent 
yields were obtained for the 11- and 12-membered cyclic ureas 2-75 and 2-76, demonstrating that this 




Scheme 2-15. Migratory ring expansion to synthesise 8- to 12-membered rings.aReaction conducted on 0.4 
mmol scale. bReaction conducted on 3 mmol scale. 
The optimised conditions (LDA, 2 eq.; DMPU, 5 eq.; THF, –78 °C, 1-16 h) were applied successfully 
to a series of ureas 2-77 derived from commercially available 6-membered heterocycles, yielding a 
variety of substituted 9-membered benzannulated nitrogen heterocycles 2-79-2-86 in good to excellent 
yield, scheme 2-16.  Ring expansion of tetrahydroquinoline benzyl urea 2-45 generated 2-73 in good 
yield on a scale of both 0.4 mmol and 3 mmol, with X-ray crystallography confirming the structure of 
2-73, scheme 2-15. The ring expansion reaction appears to be insensitive to both electronic and steric 
demands, giving the ring expansion products with electronically diverse (2-80, 2-81) and ortho-




Scheme 2-16. Ring expansion to yield 9-membered nitrogen heterocycles.* 
aReaction run at −10 °C. bReaction run at −60 °C. cReaction run at −30 °C.dReaction run at −40 °C without 
DMPU.  
Heteroaromatic (2-pyridyl and 2-thiophenyl) rings may be incorporated into the migrating aryl ring (2-
83) or alpha to the benzylic anions (2-84, 2-85). For the pyridyl-containing substrates 2-55 and 2-57, 
higher temperatures were required for the reaction to reach completion. By contrast, the 2-thiophenyl-
stabilised anion derived from 2-58 rearranged successfully to 2-85 in the absence of DMPU.  
Incorporation of a heteroatom into the tether by expansion of a urea 2-56 derived from commercially 
available benzomorpholine gave the benzoxadiazonine 2-86 in good yield. Although a substantial 
decrease in the rate of reaction was observed when replacing the N-methyl with a tert-butyl group in 2-
53, a good yield of ring expanded product 2-82 was obtained when warming the temperature to −10 °C. 
Chiral substrates 2-59 and 2-60 were made from enantiopure (S)-α-methylbenzylamine and underwent 
ring expansion under the same conditions, each giving products, 2-89 and 2-90, with a new quaternary 
centre within the expanded 8- or 9-membered ring, scheme 2-17.   
                                                          




Scheme 2-17. Ring expansion products with quaternary centres and fused rings.  
aer determined by HPLC on chiral stationary phase. bStarting material (S)-2-87 (99:1 er), (S)-2-88 (99:1 er). 
Like previous N→C aryl migrations studied in the group, both rearrangements were stereospecific, with 
only slight erosion of er in the case of 2-90 and must proceed through a configurationally stable 
organolithium intermediate.80, 85 The ring expansion methodology was also amenable to the synthesis 
of bicyclic structures by migratory ring fusion, scheme 2-17 b.  Ureas 2-91 and 2-92, formed by 
coupling two isomeric 6-membered nitrogen heterocycles, underwent ring expansion by insertion of the 
tetrahydroisoquinoline ring into the tetrahydroquinoline. For the ring expansion to be successful, it was 
essential to warm to the reaction mixture to –40 °C. This allowed access to 
diazabicyclo[7.4.0]tetradecane products 2-93 and 2-94 in excellent yields. Chiral starting materials with 
substituents on the tether of the expanding ring 2-61-2-64 underwent migratory ring expansion with 




Scheme 2-18. Diastereoselective ring expansions.* 
aReaction run without DMPU. 
Ring expansion of methyl-substituted 2-61 gave 2-97 in good yield of 71% and as a single diastereomer. 
X-ray crystallography showed a 1,5-anti relationship between the phenyl ring and methyl group on the 
tether. The related substrates 2-62 and 2-63 also underwent ring expansion to a single diastereomer of 
the 8-membered products. A fourth indoline-derived substrate 2-101 was formed by coupling of racemic 
2-phenylindoline with its own carbamoyl chloride derivative, scheme 2-18. Interestingly, although 
potential for four diastereomers, a single diastereomer of the symmetrical urea was formed, which X-
ray crystallography showed to be the meso diastereomer 2-101.  Migratory ring-fusion of 2-101 allowed 
one indoline ring to insert into the other, resulting the diazabicyclo[6.3.0]undecane 2-102 as a single 
diastereomer, with an anti- relationship between the two phenyl rings determined by X-ray 
crystallography, scheme 2-18.  
2.2.4 Mechanistic Insight 
 
Although there have been investigations reported into the mechanism of the rearrangement of acyclic 
systems in the Clayden group,85 prior to this work no insight has been gained into the ring expansion 
reaction. Assuming the reaction proceeds in a similar way to the acyclic systems, the proposed 
mechanism is outlined in scheme 2-19. 
                                                          




Scheme 2-19. Proposed mechanism for the ring expansion of benzylic ureas. 
Initial deprotonation at the benzylic position of 2-45 generates a dipole stabilised organolithium. It can 
be postulated that the presence of DMPU and clustering of LDA forces the breakage of the lithium-
oxygen interaction, allowing the molecule to adopt a conformation where the Li cation is sandwiched 
between the two aromatic rings, with the naked anion situated in close proximity to the migrating ring. 
Carbanion attack at the ipso- position of the aromatic ring in a ‘SNAr-type’ fashion and ring opening 
generates the ring expanded products 2-105 and 2-106. A possible transition state 2-104 for the reaction 
is shown in scheme 2-19, which resembles an associative substitution mechanism. Quenching the 
reaction with a proton source generates the desired ring expanded product 2-73.  
In attempt to study the mechanism of the ring expansion of 2-45, the reaction was followed by in situ 
infrared spectroscopy (ReactIR). It was hoped that the intermediates of the ring expansion reaction 
could be followed by monitoring changes in the carbonyl stretching frequencies.  
 
Scheme 2-20. Carbonyl stretching frequencies of rearrangement precursor and product. 
With the carbonyl stretching frequencies of the starting material 2-45 (1652 cm-1) and product 2-73 
(1656 cm-1) being extremely similar it was important to run the experiments at high concentration, so 
any slight changes could be monitored. Unfortunately, the presence of DMPU caused issues due to 




Figure 2-2. Monitoring of carbonyl stretching frequency at ν = 1652 cm-1 of starting material 2-45 throughout 
reaction. 
Figure 2-2 illustrates how the carbonyl stretching frequency at ν = 1652 cm-1, which corresponds to the 
C=O stretch in the starting material 2-45 changes over the course of the reaction. Upon addition of 
DMPU the frequency at ν = 1652 cm-1 becomes more intense due to the overlap in carbonyl stretching 
frequencies of DMPU and the starting material. The reaction mixture was then cooled to −78 °C. Once 
a stable IR spectrum had been obtained LDA was added dropwise at −78 °C resulting in rapid 
consumption of the starting material within less than a minute, evidenced by the loss of the IR signal at 
ν = 1652 cm-1. Due to the close carbonyl stretching frequency of the product, in situ IR spectrometry 
was unable to distinguish between that of the product and starting material and as a result it appeared 
that the starting material is being regenerated. However, the starting material was not being regenerated 
and it is likely that 2-105 or 2-106 was observed.  
After analysing a narrow wavelength window, the carbonyl stretching frequency between ν = 1500-
1700 cm-1 was monitored over the course of the reaction. Figure 2-3 shows the IR spectrum, from two 
angles. 
 
Figure 2-3. IR spectrum of the ring expansion reaction mixture over time shown from a front view 
(left) and birds-eye view (right). 
Upon addition of LDA there is a dip in the spectrum where the starting material is consumed, and a 
peak appears briefly at ν = 1604 cm-1. Within a minute this disappears and forms a new peak at ν = 1634 
cm-1 which remains until the ReactIR probe was removed and the reaction mixture was quenched with 
LDA addition 
DMPU added at RT 
Start cooling to −78 °C 
Addition of LDA 




ammonium chloride. It can be postulated that the peak at ν = 1604 cm-1 corresponds to the lithiated 
starting material 2-103, which rapidly reacts, and forms ring expanded products 2-105 and 2-106. 
Alternatively, the peak at ν = 1604 cm-1 might correspond to the anion formed after ring expansion, 
which either shuttles the anion to the doubly benzylic position to give the peak at 1634 cm-1 or forms a 
dianion.  
Additional in situ IR experiments were carried out analysing the deprotonation of the product with s-
BuLi and LDA, in the absence of DMPU to prevent overlap of carbonyl stretching frequencies, as this 
would provide insight into the IR spectrum of the anion formed after ring expansion.  
 
 
Scheme 2-21. 3D ReactIR trace monitoring peaks at various wavenumbers over the course of the deprotonation 
with s-BuLi. Peaks are tentatively assigned to the intermediates shown. 
Prior to deprotonation, the absorption at ν = 1661 cm-1 was assigned to the νC=O of the urea of 2-73. 
Treatment of 2-73 with 1 eq. of s-BuLi gave a new absorption at ν = 1611 cm-1 which is assigned to the 
νC=O of the deprotonated species 2-107, scheme 2-21. The shifting of the urea carbonyl absorption to a 
lower wavenumber is indicative of a resonance stabilisation of the negative charge on nitrogen by the 
adjacent carbonyl group, which would be greater than in the case with the uncharged urea. This 
observation is consistent with previously reported work on related systems.95 Given that complete 
deprotonation of the urea nitrogen was not achieved with only 1 eq. of base, a second equivalent of s-
BuLi was introduced, with complete deprotonation of 2-73 being confirmed by the disappearance of 
the absorption at ν = 1661 cm-1, 2-108. The absorption at ν = 1611 cm-1 then begins to decrease in 
intensity with the appearance of two new absorptions at ν = 1626 cm-1 and 1589 cm-1 respectively, 
scheme 2-21. Assignment of these two absorptions to the dianion 2-108 is consistent with related acyclic 
systems previously studied.84 Despite dianion formation, no deuterium was incorporated when 






Scheme 2-22. 3D ReactIR trace monitoring peaks at various wavenumbers over the course of the 
deprotonation with LDA. Peaks are tentatively assigned to the intermediates shown. 
Monitoring the deprotonation of 2-73 with s-BuLi allowed us to assign absorptions observed by in situ 
IR to specific mono- and dianion species 2-107 and 2-108. With this in mind, the same was repeated 
with LDA as base. Deprotonation of 2-73 with 1 eq. of LDA led to complete consumption of the 
absorption at ν = 1667 cm-1 with a new absorption appearing immediately at ν = 1652 cm-1. Since 
monoanion formation on addition of s-BuLi entailed a much larger shift in wavenumber to ν = 1611 
cm-1 (see scheme 2-21) we tentatively assigned this peak as a pre-lithiation complex 2-109. This type 
of pre-lithiated species and the associated shift of the carbonyl absorption is like those reported by 
O’Brien and co-workers during the lithiation of N-Boc piperidines.112 A peak at ν = 1615 cm-1 gradually 
forms, which was assigned to the monoanion 2-110, based on the wavenumber of the absorption being 
similar to that observed on deprotonation by s-BuLi. The formation of a pre-lithiated species and 
gradual but incomplete appearance of 2-110 is indicative of a slower rate of deprotonation with LDA. 
Unlike with s-BuLi, complete monoanion formation 2-110 was not achieved with LDA even after 3 eq. 
were added. Importantly, no dianion was observed with 3 eq. of LDA at −78 °C, suggesting that the 
brief absorption at ν = 1604 cm-1 observed when monitoring the ring expansion reaction is likely to 
correspond to lithiated starting material 2-103 and not anion of the product 2-105 or 2-106. Again, no 
deuterium was incorporated when quenching the anion at –78 °C with deuterated methanol.  
 
2.2.5. Investigating the Practicality and Robustness of the Methodology 
 
To improve the practicality of the methodology it was hoped that the urea formation and ring expansion 
procedures could be streamlined into an even simpler protocol. A ‘one-pot’ urea formation/ring 
expansion procedure would allow access to complex molecular architectures in a single step from 




Scheme 2-23. ‘One-pot’ urea formation/ring expansion. 
Initial experiments focused on the reaction of commercially available tetrahydroquinoline 2-111 with 
benzyl(methyl)carbamoyl chloride 2-15 in the presence of 3 eq. LDA. To encourage the reaction to go 
to completion the reaction mixture was warmed to room temperature after deprotonation at −78 °C, 
affording the desired ring expansion product 2-73, albeit in moderate yield. An alternative strategy of 
reacting tetrahydroquinoline carbamoyl chloride 2-112 with N-benzylmethylamine 2-113 and 3 eq. 
LDA was also attempted and yielded the desired ring expansion product in excellent yield after 2 hours 
on a gram scale. 
The effect of using non-distilled reagents and solvents was examined on the ring expansion of 
tetrahydroquinoline urea 2-45. Interestingly, no difference in yield was observed when using 
commercial LDA, DMPU and THF on a small scale. Furthermore, the reaction was attempted without 
DMPU in the reaction mixture. Again, no difference in yield was observed when the reaction was 
carried out in the absence of DMPU, although the reaction did appear to take longer to reach completion, 
which contrasts with the 5-membered indoline urea 2-43 that does require DMPU to suppress the acyl 
shift pathway to allow ring expansion (see section 2.2.3). Although many industrial processes run 
reactions at cryogenic temperatures on scale, it would be advantageous to avoid these temperatures, 
making the process more applicable to standard laboratory-based apparatus and plant vessels. As a 
result, the reaction was repeated in a jacketed vessel at −10 °C with and without DMPU, giving the 
products in lower yields of 47% and 40% respectively.  In both cases, when run with and without 
DMPU, a side product was isolated from the reaction mixture and identified to be 2-116, potentially 
arising from oxidation of the benzylic carbanion, as the reaction was not carried out in strictly inert 
conditions, scheme 2-24.113 
 
Scheme 2-24. Potential oxidative pathway to generate 2-116.113 
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On addition of LDA to 2-45 a dipole stabilised carbanion is generated 2-114. However, if oxidation is 
quicker than ring expansion, the carbanion can be oxidised to the hemi-aminal which fragments 
resulting in a formal dealkylation of 2-45. 
Finally, whilst in a process chemistry laboratory the potential of scaling up the ring expansion reaction 
in a jacketed vessel was explored. With the knowledge that the warmer reaction temperature of −10 °C 
facilitates the formation of oxidative side products, the reaction was carried at −50 °C, this being the 
maximum cooling capacity of the vessel chiller. The reaction was performed on a six-gram scale using 
all commercial, non-distilled reagents. It was found that simple filtration of the crude reaction mixture 
through a pad of silica was enough to obtain pure compound after the reaction, therefore eliminating 
the need for flash column chromatography. The ring expansion product 2-73 was isolated in a good 
yield of 67%, highlighting the robustness of the methodology and its potential to be used on an industrial 
scale.  
2.2.6. Investigating Alternative Nucleophiles for Ring Expansion 
 
It has been demonstrated in this work that benzylic anions are suitable nucleophiles for the ring 
expansion reaction. To further extend the substrate scope, the possibility of alternative nucleophiles was 
explored. Nucleophiles containing different functionalities would deliver products containing 
alternative synthetic handles for further functionalisation.  
2.2.6.1 Amino Acid Enolates  
 
2.2.6.1.1 Tethered Amino Esters 
 
Amino acid enolates have previously shown to be successful nucleophiles in the urea-mediated 
intramolecular N→C aryl transfer, which followed by cyclisation yields synthetically useful 
hydantoins.95, 96 Subsequent hydrolysis of the hydantoins allows access to quaternary amino acids. With 
this basis, it was decided to investigate amino acid enolates as nucleophiles for our ring expansion, 
scheme 2-25.  
 
Scheme 2-25. Potential ring expansion using tethered amino acid enolates. 
If successful, this ring expansion reaction would involve the transformation of natural amino acids into 
complex medium ring structures. Studies within the group have demonstrated that high yields can be 
obtained for the N→C aryl migration using amino esters as precursors, as such our initial studies focused 
on the ring expansion of amino esters.114 Similar to the method devised for the synthesis of benzyl ureas 
(see section 2.2.2.2), the synthesis of the ring expansion precursors was achieved by coupling of the 






Entry n R1 R2 R3 Yield, % 
1 1 Me H tBu 2-223a, 73 
2 2 Me H tBu 2-223b, 93 
3 2 Me H Et 2-223c, 80 
4 2 H Me Et 2-223d, 78 
5 2 Me Me Me 2-223e, 67 
 
Scheme 2-26. Synthesis of amino ester ring expansion precursors. 
The coupling was achieved in good to excellent yields for all substrates and allowed access to glycine 
(scheme 2-26, entries 1-3) and alanine amino acid derivatives (scheme 2-26, entries 4-5). 
The first substrate trialled in the ring expansion was tert-butyl glycine derivative 2-224. The milder 
base potassium bis(trimethylsilyl)amide (KHMDS) was found to be successful for the N→C aryl 
migration of linear amino acid esters,114 and thus it was our starting point for optimisation. Treatment 
of 2-224 with KHMDS in THF at 0 °C and warming to room temperature resulted in small amounts of 
unreacted starting material and a complex mixture of products, none of which appeared to be the desired 
ring expansion product. Additionally, mass balance was poor after purification. Next, the optimised 
conditions for the ring expansion of benzyl ureas were attempted, i.e. LDA (2 eq.) and DMPU (5 eq.) 
in THF, scheme 2-27.  
 
Scheme 2-27. Attempted ring expansion of tert-butyl ester glycine amino acid derivative. 
LDA was added to the urea 2-224 and DMPU in THF at −78°C and the reaction mixture was gradually 
warmed to RT, scheme 2-27. Analysis of the reaction progression by TLC analysis showed only starting 
material at −78 °C. Warming the reaction mixture to room temperature did not lead to ring expansion 
and only unreacted starting material and products 2-226 and 2-227 were observed.  
Hypothesising that the sterically bulky tert-butyl group was hindering the attack of the enolate at the 
ipso-position of the migrating aromatic ring, attention was turned to the less bulky tetrahydroquinoline 
ethyl ester derivative 2-228. However, treatment of 2-228 with LDA and DMPU in THF showed similar 
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results to the tBu derivative, with no consumption of starting material below room temperature, scheme 
2-28. The reaction mixture was therefore heated to reflux and allowed to stir for four hours until TLC 
analysis indicated consumption of starting material. Despite the use of anhydrous solvents and reagents, 
the previously observed hydrolysed and fragmented products were isolated together with traces of the 
intermolecular acyl transfer product 2-231, scheme 2-28. 
 
Scheme 2-28. Attempted ring expansion of ethyl ester glycine amino acid derivative. 
Previous work in the group has shown that N→C aryl migration is possible from free urea acids using 
LDA and LiCl as an additive.96, 114 Acid hydrolysis of 2-232 and 2-233 using TFA afforded the 
corresponding acids in excellent yields, scheme 2-29.  
 
Scheme 2-29. Acidic hydrolysis of esters 
However, subsequent treatment of urea acids 2-234 and 2-235 with LDA and LiCl gave only unreacted 
starting material and traces of fragmented products arising from oxidation of the anion, highlighting 
that ring expansion is not possible utilising enolates derived from glycine amino acids under these 
conditions. It can be postulated that the lack of substitution at the α-position means that the molecule is 
unable to adopt a ‘reactive conformation’ where the enolate is in close proximity to the migrating 
aromatic ring. In attempt to overcome this limitation, efforts turned towards investigating alanine ester 
derivatives 2-223d and 2-223e, where a methyl group is at the α-position. Unfortunately, for both the 
ethyl and methyl esters explored, the major products isolated were the hydrolysed starting materials.  
In summary, it can be concluded that tethered amino acid enolates are not appropriate nucleophiles for 
ring expansion. Despite using anhydrous conditions, the esters are either hydrolysed to the 
corresponding acids or remain as unreacted starting material. It appears that in the case for amino acid 
enolates the tether between the migrating aromatic ring and the urea nitrogen has a considerable effect 
on reactivity.  
2.2.6.1.2 Imidazolidinones 
 
Recent work within the group has demonstrated an efficient asymmetric arylation of amino acids 
exploiting the principles of Seebach’s self-regeneration of stereocentres strategy.115-118 This 
methodology uses imidazolidinones 2-236 as enolate precursors for the N→C aryl migration reaction 
67 
 
and has been applied to a range of amino acid derivatives.115 The introduction of a chiral centre in the 
starting material allowed for a highly diastereoselective arylation, proceeding through chiral enolate 2-
237. Subsequent hydrolysis of the imidazolidinone resulted in chiral quaternary amino acids 2-239, 
scheme 2-30.  
 
Scheme 2-30. α-Arylation of amino acids using imidazolidinones.115 
Relatively little attention had been placed on extending this methodology to ureas where the nitrogen 
is tethered as part of a ring, such as in indoline and tetrahydroquinoline derivatives. Proposing that 
conformational restriction prevented the ring expansion reaction on tethered amino acid enolates (see 
section 2.2.6.1.1), it was reasoned that imidazolidinones could be alternative precursors for the ring 
expansion of amino acid-based substrates. If successful, this migration would permit access to fused 
tricyclic ring systems of the type 2-242, scheme 2-31.  
 
Scheme 2-31. Potential ring expansion using imidazolidinones. 
The synthesis of cis and trans imidazolidinones 2-248 and 2-249 was achieved following literature 
procedures, scheme 2-32.115 The synthesis started with conversion of commercially available L-alanine 







Scheme 2-32. Synthesis of imidazolidinone indoline ureas 2-248 and 2-249. 
2-244 Underwent condensation with pivaldehyde to yield imine 2-245, which was isolated and 
subsequently treated with triphosgene to effect acylative cyclisation. This resulted in a mixture of cis 
and trans diastereomers, which were separable by flash column chromatography. The carbamoyl 
chlorides 2-246 were then coupled separately with indoline 2-247 resulting in the desired cis and trans 
indoline imidazolidinone ureas 2-248 and 2-249.  
Once in hand, imidazolidinone 2-250 was subjected to basic conditions to attempt the ring expansion, 
scheme 2-33. 
 
Entry 2-250 Base (eq.) Additive (eq.) Temp, °C Yield 2-252, % Comment 
1 cis KHMDS (1.5) - 0-RT 90 - 
2 trans KHMDS (2) 18-Crown-6 (10) 0-RT 60 - 
3 cis LDA (2) DMPU (5) −78-RT traces Complex 
mixture of 
products 
4 cis LDA (2) - 0-RT 20 Complex 
mixture of 
products 
Scheme 2-33. Attempted ring expansion using imidazolidinones. 
On treatment of cis-2-248 with KHMDS in THF, urea 2-248 failed to undergo the desired ring 
expansion and imine 2-252 was generated in 90% yield with retention of stereochemistry (scheme 2-
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33, entry 1). The formation of imine 2-252 is suspected to proceed by the mechanism shown below, 
scheme 2-34.  
 
Scheme 2-34. Possible mechanism for the generation of imine 2-252. 
Upon formation, the potassium enolate attacks the urea carbonyl performing a 1,2-acyl shift. This 
transformation leads to concomitant opening of the imidazolidinone, giving imine 2-252. 18-Crown-6 
was chosen as a suitable additive as it has recently proven to supress the 1,2-acyl shift pathway for a 
related aryl migration reaction. Although imine 2-252 was isolated in a lower yield, the ring expansion 
product 2-251 was not observed (scheme 2-33, entry 2). 
The optimised conditions for the ring expansion of benzyl ureas were then trialled. Addition of LDA to 
a solution of the substrate in THF at –78 °C in the presence of DMPU did not lead to any reaction. The 
reaction mixture was gradually warmed to room temperature. Once TLC analysis indicated 
consumption of starting material, the reaction was quenched. Unfortunately, 1H NMR of the crude 
reaction mixture showed a complex mixture of products with trace amounts of imine 2-252 being 
isolated after purification. Despite our best attempts, the desired ring expansion product was not 
observed in all cases. It can be assumed that the ring expansion is particularly unfavourable for this 
substrate class, perhaps due to having to proceed through a highly strained tetracyclic intermediate 2-
254, scheme 2-35.   
 
Scheme 2-35. Potential unfavourable intermediate for the ring expansion reaction. 
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In summary, imidazolidinones are not appropriate amino acid enolate precursors for the ring expansion 
reaction. In most cases a 1,2-acyl shift pathway dominated leading to imine 2-252. Unlike benzyl ureas 
(see section 2.2.3), LDA and DMPU did not supress this pathway and the imine was isolated along with 
a complex mixture of unidentified products.  
2.2.6.2 Allyl Anions 
 
With the previous success of allyl organolithiums as nucleophiles for the rearrangement of linear acyclic 
systems,93, 120 it was anticipated that an allyl group could replace the benzyl group in the ring expansion 
reaction, scheme 2-36. 
 
Scheme 2-36. Ring expansion using an allyl organolithium nucleophile. 
Deprotonation of N-allyl urea 2-256 would result in a configurationally stable allyl lithium 2-257, which 
after N→C aryl migration would generate ring expanded product 2-258.  
N-allyl urea 2-256 was synthesised from commercially available tetrahydroquinoline 2-111 using the 
standard method for tethering on a urea (see section 2.2.2.2), scheme 2-37.  
 
Scheme 2-37. Synthesis of N-allyl urea 2-256. 
Replacing N-benzylmethylamine with N-allylmethylamine 2-259 allowed for the generation of allyl 
urea 2-256 in 73% yield. Subjecting 2-256 to the optimal ring expansion conditions of LDA (2 eq.), 
DMPU (5 eq.) in THF at –78 °C for 1 hour resulted in a complex mixture of products and only trace 
amounts of the desired ring expansion product was isolated after purification. Due to the isolation of a 
small amount of starting material following purification, the reaction time was extended to 16 hours. 
Although the product was observed in trace amount by 1H NMR analysis of the crude reaction mixture, 
isolation of the product from an unknown impurity proved problematic. The effect of temperature was 
then explored, and a reaction was conducted which involved initial deprotonation at −78 °C followed 




Scheme 2-38. Ring expansion of allyl urea 2-256. 
1H NMR Analysis of the crude reaction mixture showed a mixture of isomers 2-258 and 2-260 along 
with other unidentified impurities. Despite our best attempts, separation of the ring expanded products 
from the unidentified compounds was unsuccessful. Previously it was observed that the ring expansion 
of thiophene substrate 2-58 only proceeded in the absence of DMPU, therefore the allyl anion-mediated 
ring expansion reaction was then repeated on 2-256 at −78 °C without the addition of DMPU. However, 
purification proved problematic, with isomer 2-260 and a mixture of unidentified side products being 
isolated. Speculating that the nature of the organolithium base might be influencing the outcome of the 
reaction, N-allyl urea 2-256 was then treated with s-BuLi in place of LDA at –78 °C and slowly warming 
to –40 °C. However, this resulted in only trace amounts of products 2-258 and 2-260 with a complex 
mixture of side products.  
Knowing that allyl anions were potentially suitable nucleophiles for the ring expansion if the products 
could be separated from side products, other allyl systems were subsequently tried. Pyrolline substrate 
2-261 was reacted under the optimised conditions for the ring expansion. TLC analysis of the reaction 
mixture showed full consumption of starting material and the presence of many new compounds. 
Purification by flash column chromatography revealed that 2-263, which was isolated in a 35% yield, 
was the major product of the reaction, scheme 2-39.  
 
Scheme 2-39. Attempted ring expansion of indoline substrate 2-261. 
The formation of 2-263 presumably arises from deprotonation of 2-261 to generate an allyl 
organolithium that reacts intermolecularly with another molecule of 2-261. Nucleophilic attack of the 
allyl organolithium at the carbonyl of 2-261 and subsequent elimination of indoline gives product 2-
263.  
The final substrate trialled was allyl substrate 2-264. The ring expansion of indoline substrate 2-264 





Scheme 2-40. Attempted ring expansion of indoline substrate 2-264 to access spirocyclic compounds. 
Although full consumption of starting material 2-264 was observed at –78 °C after 2 hours, analysis of 
the 1H NMR spectrum of the crude reaction mixture showed a complex mixture of products. Purification 
allowed the isolation of 2-266 as the major product, which results from deprotonation at the benzylic 
position of the indoline ring followed by ring opening.  
In summary, allyl anions have shown potential to be used as alternative nucleophiles for the ring 
expansion reaction. However, reactivity appears to be substrate specific and therefore not general to 
different model systems. Future work on investigating allyl anions as nucleophiles should avoid the use 
of the indoline system where benzylic deprotonation and elimination competes with ring expansion.  
2.2.6.3 Benzylic Anions of Carbamates and Thiocarbamates 
 
Previous work in the Clayden group has shown that N→C aryl migration on acyclic systems is possible 
utilising benzylic carbamates and thiocarbamates, allowing access to tertiary arylated alcohols and 
thiols.90-92 Consequently, we were interested to see whether the ring expansion methodology was 
applicable to carbamates and thiocarbamates, scheme 2-41.  
 
Scheme 2-41. Potential ring expansion utilising benzylic carbamates and thiocarbamates. 
Initial studies focused on the ring expansion of benzyl carbamates. Tetrahydroquinoline carbamate 2-
269 was chosen as the model substrate and was synthesised in good yield from tetrahydroquinoline 
carbamoyl chloride and benzyl alcohol. The ring expansion reaction was then attempted using the 
optimised conditions for the ring expansion of benzyl ureas, scheme 2-42. Unfortunately, the desired 
ring expansion product 2-270 was not observed, instead carbamate 2-269 was found to react in an 
intermolecular manner to generate dimer 2-273 in 30% yield. Alongside dimer formation, unreacted 




Scheme 2-42. Attempted ring expansion of tetrahydroquinoline benzyl carbamate 2-269. 
Due to the differing outcomes of reactions of the benzyl ureas with and without DMPU (see section 
2.2.3), the reaction was repeated in the absence of DMPU, to see if this had an effect on the reactivity. 
However, the dimerised product 2-273 was observed, in 23% yield, with no sign of the ring expansion 
product 2-270. The reaction was repeated with the optimised conditions for N→C aryl migration of 
carbamates previously reported in the group,90 LDA (2.5 eq.) in THF:DMPU 4:1 v/v; however, these 
conditions generated dimeric product 2-273 in similar yield. The use of different organolithium bases 
was explored, however both s-BuLi as well as the bulkier base Li-TMP did not affect the outcome of 
the reaction. In an attempt to avoid the undesired intermolecular dimerisation reaction, the reaction was 
carried out with inverse addition of reagents. Carbamate 2-269 and DMPU were added dropwise by 
syringe pump over an hour to a solution of LDA in THF at −78 °C, ensuring a high concentration of 
LDA with respect to the concentration of carbamate. Disappointingly, this did not prevent the 
intermolecular reaction and 2-273 was formed preferentially in 40% yield. As a final attempt to avoid 
the intermolecular reaction the reaction was run at a more dilute concentration of 0.015 M. Despite this, 
2-273 formed with no signs of the desired ring expansion product.  
Unlike the benzyl ureas that have a methyl group bonded to the urea nitrogen, the corresponding 
carbamates lack any form of steric bulk at the oxygen centre. Given the markedly different reactivity 
observed between ureas and carbamates, it can be postulated that for ureas, the methyl group on nitrogen 
is essential for achieving the ‘reactive conformation’ necessary for ring expansion. Therefore, it was 
proposed that introducing steric hindrance adjacent to the oxygen atom may help firstly in allowing the 
molecule to adopt the correct conformation for ring expansion, but also by making the anion less 
reactive for the competing intermolecular reaction. To test this hypothesis, carbamate 2-274 was 
synthesised according to literature procedure and the ring expansion was attempted using the conditions 




Scheme 2-43. Ring expansion of α-methyl benzyl carbamate 2-274. 
Treatment of α-methyl benzyl carbamate 2-274 with LDA and DMPU in THF afforded the desired ring 
expansion product 2-275, albeit in low yield. The acyl shift product 2-276 was also isolated from the 
reaction mixture, in a slightly higher yield of 38%. Installing the α-methyl group completely suppressed 
the intermolecular reaction, instead favouring the intramolecular reaction, indicating that steric bulk 
adjacent to the oxygen is essential for ring expansion of carbamates. The reaction was then repeated 
with s-BuLi in THF, however the yield of ring expansion product 2-275 was reduced to 25%. With a 
low yield for the ring expansion it was wondered if it was possible to incorporate steric hindrance on 
the anion stabilising ring instead of alpha to the oxygen atom. Therefore, ortho- methyl carbamate 2-
277 was synthesised by coupling of tetrahydroquinoline carbamoyl chloride with 2-methylbenzyl 
alcohol. Carbamate 2-277 was subjected to the conditions for ring expansion, scheme 2-44. 
 
Scheme 2-44. Attempted ring expansion of 2-277. 
Unfortunately, for carbamate 2-277 the acyl shift pathway dominated and resulted in acyl shift product 
2-278 being isolated in 45% yield, along with cleaved tetrahydroquinoline. No signs of the dimeric 
product were observed, suggesting that there was enough steric hindrance to avoid the intermolecular 
reaction. This result also highlights the necessity of substitution adjacent to the oxygen atom for the 
ring expansion to occur.  
In summary, the ring expansion methodology developed for benzyl ureas is not applicable to 
carbamates. It appears that there are alternative reaction pathways depending on the steric environment 
near the anionic centre. Installing a methyl group adjacent to oxygen suppresses the formation of dimer 
2-273 and does allow access to the ring expanded product 2-275. However, the outcome of the reaction 
is substrate dependent and therefore does not allow a general method for the access of medium ring 
carbamate structures.  
To explore the feasibility of thiocarbamates being utilised in the ring expansion reaction, 
tetrahydroquinoline benzyl thiocarbamate 2-279 was synthesised in a similar manner to the analogous 
carbamates and ureas. Thiocarbamate 2-279 was then subjected to various conditions for the ring 




Entry Base (eq.) Additive (eq.) Temp, °C Time, h Yield 2-281, % Comment 
1 LDA (2) DMPU (5) −78 2 - Unreacted SM 
2 LDA (2) DMPU (5) −78 16  - Unreacted SM 
3 LDA (2) DMPU (5) −78 - −60 2 41 Remaining unreacted  
SM 
4 LDA (2) - −78 - −60 16 95 - 
5 LDA (5) - −78 16 - Unreacted SM 
6 LDA (2.5) DMPU (5) 0 16 55 Traces of unknown 
side products 
7 LDA (2.5) - 0 16 42 Traces of unknown 
side products 
8 s-BuLi (2.5) DMPU (4:1 
THF: DMPU) 
−60 16 28 Unreacted SM and 
THQ isolated 
 
Scheme 2-45. Attempted ring expansion of thiocarbamate 2-279.  
The reaction was first attempted using the optimised conditions for the ring expansion of benzyl ureas, 
(scheme 2-45, entry 1). After leaving the reaction for 2 hours at −78 °C before being quenched with 
ammonium chloride, no reaction had occurred, and unreacted starting material remained. The reaction 
was repeated and left overnight at −78 °C to identify if longer reaction times would yield the ring 
expansion product 2-280 (scheme 2-45, entry 2). Unfortunately, unreacted starting material remained. 
The reaction was repeated but with warming of the reaction to −60 °C after deprotonation at −78 °C 
(scheme 2-45, entry 3). Although starting material remained, TLC analysis of the reaction mixture 
showed an additional product after the temperature was increased to −60 °C. After purification acyl 
shift product 2-281 was isolated in 41% yield, with no signs of the desired ring expansion product. The 
reaction was repeated in the absence of DMPU, (scheme 2-45, entry 4) and left overnight. The longer 
reaction time and warmer temperature allowed the acyl shift product 2-281 to be isolated in 95%, even 
in the absence of DMPU. It was hypothesised that similarly to carbamates, thiocarbamates did not adopt 
the reactive conformation for ring expansion and instead the molecule prefers to adopt the conformation 
where the anion is in close proximity to the carbonyl, giving rise to the acyl shift product 2-281. It was 
reasoned that a large excess of LDA may assist in achieving the correct conformation by coordinating 
to the thiocarbamate carbonyl and anionic centre, causing a bond rotation to avoid steric clash, hence 
putting the anion near the migrating aromatic ring. However, treatment of 2-279 with five equivalents 
of LDA at −78 °C in THF resulted in no reaction (scheme 2-45, entry 5). Carrying out the reaction at 0 
°C with and without DMPU resulted in a reduced yield of 2-281 along with a complex mixture of 
unknown side products (scheme 2-45, entries 6 and 7). 2-281 was isolated in a further reduced yield of 
28% when subjecting 2-279 to the conditions used for the N→C aryl migration of lithiated carbamates 
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(scheme 2-45, entry 8).90 Acyl shift product 2-281 was isolated along with unreacted starting material 
and tetrahydroquinoline. The formation of the acyl shift product was only observed at temperatures 
above −78 °C, as such we decided to avoid increasing the temperature of the reaction and opted to 
explore the use of other stronger bases which would affect deprotonation at −78 °C.  
Superbases are extremely basic compounds that lead to irreversible proton abstraction.121, 122 Two 
examples of super bases commonly used in organic synthesis are butyllithium-lithium 
dimethylaminoethanol (BuLi-LiDMAE) 2-284 and Schlosser’s base (LICKOR) 2-286. The synthesis 
of which are shown in scheme 2-46. 
 
Scheme 2-46. Synthesis of superbases.  
Butyllithium-lithium dimethylaminoethanol 2-284 is a unimetal superbase and is commonly used for 
the deprotonation of aromatic heterocycles.123 It is synthesised by the addition of dimethylaminoethanol 
2-282 to n-BuLi 2-283 in hexane at 0 °C. LICKOR describes various super basic mixtures of a 
potassium alkoxide with an alkyl lithium species. The most commonly used mixture is Schlosser’s base 
2-286 which is formed by the combination of potassium tert-butoxide 2-285 with n-BuLi 2-283 in a 
one to one ratio.  
The ring expansion of 2-279 was first investigated with BuLi-LiDMAE 2-284. BuLi-LiDMAE was 
formed in situ and then added to the reaction mixture at −78 °C. The reaction was monitored by TLC 
analysis and showed only starting material at −78 °C. The reaction mixture was gradually warmed to 
room temperature and monitored by TLC at the different temperature increments. Unfortunately, only 
unreacted starting material remained. 
The reaction was repeated with Schlosser’s base 2-286. LICKOR was generated in situ and added to 
the reaction mixture at −78 °C. The reaction mixture turned a deep red colour on addition of the first 
drop of base, suggesting deprotonation. After leaving the reaction mixture to stir at −60 °C overnight, 
TLC analysis revealed complete consumption of starting material. However, poor mass balance was 
achieved after purification with no major product isolated. Traces of tetrahydroquinoline was observed 
along with a complex mixture of products.  
In summary, as was the case for the benzyl carbamates, benzyl thiocarbamates are not appropriate 
precursors for the ring expansion reaction. Reactivity was only observed on warming of the reaction 
mixture above −78 °C, with the acyl shift product 2-281 dominating when LDA was used as the base. 
Superbases proved unsuccessful, with LICKOR leading to the formation of a complex mixture of 
products. These results further highlight the need for substitution on the heteroatom or steric bulk 





2.2.7 Conclusions & Future Work 
 
A method for the synthesis of benzannulated medium ring nitrogen heterocycles utilising an n to n+3 
ring expansion of benzyl ureas has been developed. The reaction appears to be insensitive to steric and 
electronic factors on the migrating aromatic ring and heteroatoms can be incorporated in the aromatic 
rings or on the tether. The migration is stereospecific when enantioenriched urea precursors are used 
and proceeds with complete diastereoselectivity when substitutents are placed on the tether.  
Changing the nucleophile from benzyl anions to enolates proved challenging with no ring expansion 
being observed in all cases. Allyl anions showed potential as suitable nucleophiles although further 
optimisation is required. Future work should avoid indoline precursors due to additional elimination 
pathways being active.  
Despite the success when using benzyl anions of ureas as nucleophiles, benzyl anions of the related 
carbamates and thiocarbmates were unsuccessful. It can be postulated that the additional steric bulk of 
the methyl group at the nitrogen centre of the urea precursors aided in achieveing the correct 
conformation for ring expansion. Ring expansion was not observed on the carbamate and thiocarbamate 
derivatives which of course lack steric bulk adjacent to the anionic centre. Only in the case were steric 
hindrance was introduced at the anionic centre in carbamates was ring expansion observed, albeit in 
low yield.  
Nitrile groups pose as an attractive alternative to the previously used benzyl group for the ring expansion 
reaction and would allow access to iminohydantoin bicycles 2-290, scheme 2-47. Preliminary studies 
within the group have shown this approach to be viable and future work will explore this further.* 
 





                                                          
* Preliminary nitrile ring expansion experiments carried out by Emily Ellis (MChem) and Dr John Ward.  
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2.3 Dearomatising Anionic Cyclisation of Indoles  
 
N.B. The work described herein (section 2.3) is documented in the first author publication, J. E. Hill*.; 
Q. L. Lefebvre.; L. A. Fraser.; J. Clayden. Org. Lett. 2018, 20, 5770. 
2.3.1 Initial Discovery 
 
Whilst exploring the scope of the ring expansion reaction it was thought that indoles would be an 
interesting substrate class to investigate. Not only are they readily accessible from commercial sources, 
but they also possess both an aryl and a vinyl group, both of which have the potential to migrate under 
the reaction conditions. Both pathways would allow access to desirable medium ring structures, scheme 
2-48.  
 
Scheme 2-48. Possible migratory pathways for indole. 
Surprisingly, treatment of indole urea 2-291 with the optimised ring expansion conditions of LDA (2 
eq.), DMPU (5 eq.) in THF at −78 °C did not follow either of these pathways, and instead polycyclic 
indoline 2-295 was formed in 20% yield as a single diastereomer, through a dearomatising anionic 
cyclisation, scheme 2-49.  
 
Scheme 2-49. Dearomatising anionic cyclisation of indole urea 2-291.* 
Given the generation of structurally interesting heterocyclic 6,5,5 ring systems, we decided to 
investigate this dearomatising cyclisation methodology further.  
                                                          
* Experiment carried out in collaboration with Dr Johnathan Matlock. 
79 
 




Indole dearomatisation is an important strategy for the synthesis of alkaloids which have known positive 
biological properties. Indoline and indolenine have shown promise as therapeutic agents due to their 
biological activity against inflammation, hypertension and cancer.124-129 It therefore comes as no 
surprise that many groups have devoted their research towards the functionalisation of indoles, 
tryptamines and β-carboline building blocks.130 
Functionalisation at the C3 position of indole is most commonly achieved following the reaction of the 
parent indole with suitable electrophiles by enamine type reactivity. Although functionalisation at C2 
is possible, this is typically attained when the C3 position is blocked, scheme 2-50. When 
dearomatisation occurs at the C3 position, the resulting indolenium 2-299 can be attacked by a 
nucleophile at the C2 position resulting in indolenine 2-300 (scheme 2-50, path A). Alternatively, the 
indolenium 2-299 can undergo an intramolecular [1,2]-shift of a C3 substituent to the C2 position, 
followed by trapping of the benzylic carbocation by nucleophilic addition at C3 (scheme 2-50, path B).  
 
Scheme 2-50. Indole reactivity.130 
The dearomatisation reactivity of indole has sparked a vast amount of interest in the field as it enables 
the formation of interesting ring systems, with different substitution patterns obtainable dependent on 
the regioselectivity.  
The usefulness of indole dearomatisation has been demonstrated in the context of natural product 
synthesis and was successfully implemented into the synthesis of the indole alkaloid, Strychnine 2-303. 
Of the many syntheses published, five include an indole dearomatisation strategy at some stage in their 
synthesis. For example, in 1954, Woodward exploited such a dearomative strategy via a ‘Pictet–
Spengler-type’ reaction of an activated tryptamine-derived iminium 2-305 for the construction of the C 




Scheme 2-51. Dearomatising indole as the key steps in the synthesis of strychnine 2-303.131, 132 
Further studies by Magnus showed that a dearomative strategy by a transannular Mannich reaction was 
feasible.132, 133 The use of mercury acetate was reported for the dehydrogenation of tetracyclic indole 2-
307 to produce iminium 2-308 which was subsequently attacked intramolecularly by the nucleophilic 
C3 position to synthesise the pentacyclic indoline scaffold, scheme 2-51. Others have also demonstrated 
dearomative transformations of indole for the synthesis of Strychnine both racemically134 and 
asymmetrically,135 clearly highlighting the importance of this method for accessing useful alkaloid 
structures. 
2.3.2.2 Indole Dearomatisation by Cycloadditions 
 
Cycloadditions are powerful synthetic methods for the construction of complex molecular architectures 
with concomitant control of the resulting stereocentres. Many cycloaddition strategies have been 
exploited as an alternative method to effect dearomatisation of indole to access polycyclic structures, 
such as cyclopropanations, 1-3-dipolar cycloadditions, [2+2] cycloadditions followed by retro-Mannich 
fragmentations and Diels–Alder reactions.130 
2.3.2.2.1 Cyclopropanations 
 
Due to the ability of indole to undergo cyclopropanation, together with the known tendency of 
cyclopropanes to undergo fragmentation, coupling both reactivities has allowed an effective method for 
the synthesis of polycyclic indoline structures. Metals such as rhodium and copper have been reported 
to catalyse these processes by formation of carbenoid species. Jung et al. studied the use of rhodium 
acetate to generate a rhodium carbenoid of 3-substituted indole esters 2-311, followed by 
cyclopropanation yielding 2-312.136 Spontaneous ring opening of the cyclopropane afforded iminium 2-
313, which underwent cyclisation initiated by the ester enolate, yielding 2-315 as the minor product 




Scheme 2-52. Indole dearomatisation via cyclopropanation.136 
Similarly, Qin et al. investigated a dearomatising cyclopropanation procedure in the synthesis of natural 
products (±)-minfiensine and (-)-ardeemin.137, 138 In contrast to the work by Jung, Qin and co-workers 
used copper (II) triflate as the catalyst to aid the reaction. Initially, Qin focused on developing an achiral 
dearomatisation/rearrangement sequence using tryptamine derivative 2-316, scheme 2-53 a. 
 
Scheme 2-53. Copper catalysed cyclopropanation for indole dearomatisation.137, 138 
The cyclopropanation-ring opening generated indolenium 2-318 which was subsequently trapped 
intramolecularly by the pendant amine, scheme 2-53 a. Shortly after, Qin reported a diastereoselective 
dearomatisation of tryptophan derivative 2-320, for the synthesis of (-)-ardeemin 2-323.138 The 
procedure involved a ‘one-pot’ three step cascade reaction including an intermolecular 
cyclopropanation, ring opening and ring closure sequence which proceeded in good yield and 
diastereoselectivity, scheme 2-53 b. An asymmetric cyclopropanation, ring opening sequence was later 
developed by Davies139 exploiting rhodium carbenoids derived from 4-aryl-1-sulfonyl-1,2,3-triazoles. 
The pyrroloindoline products produced using this methodology were accessed in moderate to excellent 
yields and enantioselectivites using methyl protected indoles. Unprotected indoles were also successful 
in the reaction, although the products were isolated with lower enantiomeric excess.  
2.3.2.2.2 1,3-Dipolar Cycloadditions 
 
1,3-Dipolar cycloadditions offer an alternative route to alkaloid frameworks by dearomatisation of 
indoles using two key methods. The first is mediated by Lewis acids, enabling the opening of ring 
systems (cyclopropanes, epoxides), thereby generating 1,3-dipoles that trigger the cycloadditions. The 
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second approach uses metal catalysis for the generation of carbonyl ylides as dipolarophiles for 
cycloadditions.  
Whilst older studies focused on the use of ytterbium triflate for the dearomatisation of 3-methyl 
indoles,140-142 a more recent study by Venkatesh reported a [3+2] cyclopenta[b]annulation for the 
synthesis of polycyclic indoline 2-327, using boron trifluoride as Lewis acid, scheme 2-54 a.143  
 
Scheme 2-54. Lewis acid-mediated [3+2] cycloaddition.143, 144 
Electron-rich arylated cyclopropanes were necessary to promote ring opening on addition of boron 
trifluoride to generate a stable zwitterionic intermediate. This allowed a facile [3+2] cycloaddition 
yielding indoline products 2-327 via an iminium intermediate 2-326, scheme 2-54 a. An array of 
tricyclic indoline products 2-327 were obtained in good to excellent yields. Similarly, Wu et al. 
published the synthesis of oxygenated indoline 2-331, opening an epoxide instead of a cyclopropane, 
scheme 2-54 b.144 Nickel perchlorate was chosen as a suitable catalyst for the transformation along with 
BOX ligand 2-330 to induce enantioselectivity. Although the desired indoline product 2-331 was 
isolated in good yield as a single diastereomer, the enantiomeric excess was poor. 
The most common metal employed for indole dearomatisation using 1,3-dipolar cycloadditions is 
rhodium. In 1995, Padwa et al. reported a rhodium (II)-catalysed cyclisation-cycloaddition sequence in 
the total synthesis of Aspidosperma alkaloids, scheme 2-55.145  
 
Scheme 2-55. Rhodium (II)-catalysed cyclisation and 1-3-dipolar cycloaddition. 
In this strategy the 1,4-diazo imide 2-332 undergoes cyclisation, generating 1,3-carbonyl ylide 2-333 
which encourages the C2-C3 indole double bond to react as a 2π component in the 1,3-dipolar 




2.3.2.2.3 [2+2] Photocycloadditions Followed by Retro-Mannich Fragmentation 
 
[2+2] Photocycloadditions followed by a retro-Mannich fragmentation have also been used for indole 
dearomatisation. Winkler and co-workers investigated this sequence as a key step in the synthesis of 
vindorosine 2-340, scheme 2-56.146 
 
Scheme 2-56. [2+2] Photocycloaddition followed by retro-Mannich fragmentation as a key step in the synthesis 
of vindorosine 2-340.146 
Irradiation of indole 2-335 using a 450 W medium pressure Hg lamp gave cyclobutane 2-337 which 
subsequently underwent a retro-Mannich fragmentation yielding photoadduct 2-338 in excellent yield 
and diastereoselectivity. Treatment of spirocyclic cycloadduct 2-338 with LDA and silyl triflate allowed 
ring closure to the tetracyclic structure 2-339. Using the same method of photocycloaddition followed 
by retro-Mannich fragmentation, White et al. reported the synthesis of many β-carbolines and oxindole 
natural products.147 
2.3.2.2.4 Diels–Alder Cycloadditions 
 
Diels-Alder [4+2] cycloaddition is a powerful synthetic method in an organic chemist’s toolbox for the 
synthesis of ring systems. Not only does it allow access to 6-membered rings, but it simultaneously sets 
stereogenic centres and functional groups.148 Indole substrates can participate in Diels–Alder 
cycloadditions in two ways, either as dienophiles using the C2-C3 double bond, or as dienes when 
substituted at the C2 or C3 positions with a pendent alkene.  
Due to indole’s low tendency to act as a dienophile, normal electron-demand Diels–Alder reactions are 
challenging, often requiring specific substitution on indole and harsh reaction conditions. It is essential 
for the indole to be substituted at nitrogen and the C3 position with electron-withdrawing groups to 
ensure reactivity. Early work by Wenkert showed that indole dearomatisation using a normal demand 
Diels–Alder [4+2] cycloaddition was possible when using high pressures.149 They reported the synthesis 
of tricyclic indoline 2-344 by normal-demand Diels-Alder cycloaddition with Danishefsky’s diene 2-




Scheme 2-57. Diels–Alder [4+2] cycloaddition using high pressure.149 
Pressures as high as 12 kbar at 45 °C for 48 hours were required to access polycyclic indole 2-344 in 
good yield after hydrolysis of the silyl enol ether. The product was isolated as a 3:1 mixture of endo:exo 
products which were separable by column chromatography.  
Inverse electron-demand Diels–Alder cycloadditions for the dearomatisation of indoles are also 
possible, exploiting the indole C2-C3 double bond as a dienophile and reacting it with an electron-poor 
diene. Pioneering work by Snyder showed that indoles can react with 1,2,4,5-tetrazines, 1,2,4-triazines 
and pyridazines in [4+2] cycloadditions to yield the desired polycyclic indoline scaffolds.150-156 An 
example is shown in scheme 2-58.  
 
Scheme 2-58. Inverse electron-demand Diels–Alder cycloaddition for the synthesis of tetracyclic indoline 2-
346.150-156 
Subjecting tryptophan triazine derivative 2-345 to trifluoroacetic anhydride in dioxane led to an 
intramolecular inverse electron-demand Diels–Alder cycloaddition yielding 2-346 as a single 
diastereomer after extrusion of nitrogen and deacylation of the N-trifluoroacetate adduct. The fact that 
no other diastereomer was detected indicates that the chiral centre present in 2-345 imparts excellent 
stereocontrol in the facial approach of the azadiene to the indole dienophile. Tetracyclic indoline 2-346 
is of importance due to being an aza-analog of Aspidosperma alkaloids. 
Hetero-Diels–Alder cycloadditions are predominantly inverse electron-demand reactions and occur 
typically between (aza) quinone methide dipolarophiles and the 2π electrons of the C2-C3 double bond 
of indole. In 2010, Qin et al. reported an intermolecular hetero-Diels–Alder cycloaddition as the key 




Scheme 2-59. Hetero-Diels–Alder cycloaddition as the key step in the synthesis of (+)-perophoramidine.157 
In this work a silver (I) Lewis acid was needed to assist in the formation of a reactive aza-quinone 
methide intermediate 2-349, which underwent an inverse electron-demand [4+2] cycloaddition with 
indole 2-347, generating the complex spirocyclic indoline core 2-350 in 88% yield. Although there is 
potential for multiple isomers, the reaction proceeded with high exo selectivity via an in situ generated 
trans/trans diene, 2-349. 
2.3.2.3 Indole Dearomatisation by Palladium-Catalysed Reactions 
 
Despite their widespread use in synthetic organic chemistry for the formation of new C-C bonds, 
palladium-catalysed cross coupling reactions have not been extensively studied in the context of 
dearomatisation of indoles. As a rare example, in 2012 Wu and co-workers devised a method of 




Scheme 2-60. Palladium-catalysed dearomatisation of indoles.158, 159 
The authors used palladium (II) in conjugation with silver acetate to enable a Heck reaction followed 
by β-hydride elimination to yield structure 2-353 in moderate to excellent yields. In a similar fashion, 
Bedford et al. demonstrated an alternative palladium-catalysed dearomatisation procedure also using 
palladium acetate.159 The catalyst was formed in situ by palladium acetate and N-heterocyclic carbene 
ligand SIPr, and subjected to indole starting material and potassium tert-butoxide in toluene at 100 °C, 
scheme 2-60 b. The desired indoloindole structures 2-355 were generated in moderate to excellent 
yields and could be further modified into oxindoles 2-356 or reduced to tetracyclic indolines 2-357.  
2.3.2.4 Indole Dearomatisation by Radical Cyclisation 
 
Radical cyclisations are an important method for dearomatising indoles and allow access to complex 
polycyclic frameworks. Reissig et al. reported a diastereoselective intramolecular indole 
dearomatisation by addition of a ketyl radical to indole, scheme 2-61.160, 161 The reaction is promoted 
by a samarium diiodide-HMPA complex which transfers an electron to a carbonyl group, therefore 





Scheme 2-61. Indole dearomatisation by radical cyclisation. 
It was hypothesised that the bulky samarium alkoxide prefers an equatorial position in the transition 
state due to steric and electronic reasons, positioning the methyl group in an axial position, 2-360. 
Subsequent protonation of the enolate generates tricyclic indoline 2-362. This methodology was later 
applied to the total synthesis of Strychnine.162 In 2004, Baldwin et al. reported a dearomatising 
spirocyclisation to generate spirolactam structures 2-364a, 2-364b, 2-365, scheme 2-62.163  
 
Scheme 2-62. Indole dearomatisation via spirocyclisation using aryl, vinyl and alkyl radicals.163 
This work demonstrated that aryl, vinyl and alkyl radicals could be used in this ipso-substitution to give 
full dearomatisation of indole. Subjecting each precursor to the same cyclisation conditions of Bu3SnH, 
AIBN in benzene allowed access to the spirocyclic compounds in varying yields. When the high energy 
aryl radicals were used, yields of the desired product were excellent. However, yields were much lower 
for the products isolated using vinyl radicals, despite the fact that no reduced starting material was 
observed. Yields for the spirocycles obtained using alkyl radicals derived from alkyl selenides were 
also moderate, with the remaining mass being reduced starting material.  
Despite the indole dearomatisation methods described above, there is still scope to investigate new 
methods for the synthesis of novel polycyclic indoline structures. A method which utilises commercially 
available indoles and increases the complexity of the molecular architecture using only a few simple 
steps is highly desirable. As a result, employing the simple and transition metal free conditions 
previously developed for the ring expansion of benzyl ureas (see section 2.2) offers an attractive method 
for the synthesis of polycyclic indoline frameworks through indole dearomatisation. 
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2.3.3 Indole Urea Precursor Synthesis 
 
Initial studies focused on developing a general method for precursor synthesis. Indole urea 2-368 was 
synthesised in two steps following a literature procedure, scheme 2-63.164  
 
Scheme 2-63. Synthesis of indole urea precursor 2-368.* 
The method involves the synthesis of indoline carbamic acid and subsequent treatment with oxalyl 
chloride to afford the carbamoyl chloride 2-367. Coupling of 2-367 with N-benzylmethylamine using 
the standard conditions (see section 2.2.2.2) yields the indole benzyl urea 2-368 in 45% yield over all 
steps. 
With the knowledge that treatment of indole urea 2-368 with the standard conditions for ring expansion 
leads to the generation of polycyclic indoline 2-295, it was postulated that blocking the 2-position on 
the indole would favour ring expansion over dearomatising cyclisation. As a result, 2-methyl indole and 
2-phenyl indole were chosen as suitable precursors to test this hypothesis. Despite the fact that indole 
urea 2-368 was synthesised successfully using the CO2 method describe above, this method was not 
applicable to the synthesis of 2-methyl and 2-phenyl indole ureas 2-370. As a result, an alternative, 
general method was investigated for precursor synthesis.  
Firstly, a one-step procedure involving treatment of indole 2-369 with benzyl(methyl)carbamoyl 
chloride 2-15 was attempted, scheme 2-64. 
 
Entry R Solvent Temp, °C Yield 2-370, % 
1 Me THF RT 6 
2 Ph THF RT 33 
3 Me DMF 75 91 
4 Ph DMF 75 43 
Scheme 2-64. Synthesis of 2-substituted indole ureas 2-370.• 
                                                          
* Experiment carried out by Johnathan Matlock. 
• Experiments carried out by Laura Fraser (MChem) 
89 
 
Although this method is simpler from a practical perspective, indoles 2-369 had poor solubility in THF 
and the desired 2-substituted indole ureas 2-370 were isolated in low yields (scheme 2-64 entries 1 and 
2). To circumvent this issue, the solvent was replaced with DMF to aid solubility and allow higher 
reaction temperatures.165 Pleasingly, the 2-substituted indole ureas 2-370 were isolated in improved 
yields (scheme 2-64 entries 3 and 4). As a result, this was chosen as the optimised method for precursor 
synthesis.  
With a method for precursor synthesis in hand our focus turned to synthesising a range of indole benzyl 
ureas. Scheme 2-65 shows the ureas synthesised from commercially available indoles.  
 
Scheme 2-65. Synthesis of indole benzyl ureas from commercial indoles.* 
Using the methodology outlined above, a range of 2- and 3-substituted indoles were converted into their 
benzyl urea counterparts in moderate to excellent yields.  
2.3.4 Dearomatising Anionic Cyclisation of Indole Ureas Derived from Commercial Indoles 
 
As stated previously we were interested in investigating whether substitution at the 2-position of indole 
would block the dearomatising cyclisation, instead favouring the ring expansion. To test this hypothesis, 
indole urea substrates 2-373 and 2-374 were trialled using the conditions previously optimised for ring 
expansion, scheme 2-66.  
                                                          




Scheme 2-66. Dearomatising cyclisation of 2-substituted indole benzyl ureas.•  
Interestingly, despite introducing substitution at the 2-position of indole, the dearomatising cyclisation 
pathway dominated, with no ring expansion products observed. When R=Me the polycyclic indoline 
product 2-380 was isolated in 78% yield as a mixture of separable diastereomers. X-Ray crystallography 
revealed the major diastereomer as having a cis- relationship between the phenyl and methyl groups, 
scheme 2-66. The reaction was repeated in the absence of DMPU to assess its necessity in the reaction. 
TLC analysis of the reaction mixture without DMPU after four hours showed predominantly starting 
material, indicating that DMPU is essential for increasing the rate of reaction, presumably due to 
deaggregation of the LDA solution. The phenyl-substituted substrate 2-374 also gave a polycyclic 
product 2-381, in only 10% yield as an inseparable mixture of diastereomers in a 2:1 ratio.  
3-Substituted indoles were then investigated in the dearomatising cyclisation reaction. The cyclisation 
of 3-substituted indoles would give rise to three stereocentres, hence the possibility for the formation 
of four diastereomers. 3-Methyl indole urea 2-375 was subjected to the cyclisation conditions and 
yielded polycyclic indoline 2-382 as a single diastereomer in 64% yield, scheme 2-67. Nuclear 
Overhauser Effect (NOE) NMR experiments confirmed that the phenyl, the proton and the methyl group 
had a 1,2,3-all-syn-relationship.  
 
Scheme 2-67. Dearomatising cyclisation of 3-substituted indole urea 2-375.  
The reaction was then repeated using s-BuLi in THF in attempt to improve the yield of 2-382. The 
desired product was isolated in a lower yield of 36% as a single diastereomer along with several 
unwanted side products, which suggested alkylation by the nucleophilic s-BuLi. As a result, in all 
subsequent reactions LDA was chosen as the base. 
The remaining indole ureas (see scheme 2-65) were subjected to the optimised conditions for 
dearomatising cyclisation, LDA (2 eq.), DMPU (5 eq.) in THF (0.15 M) at −78 °C and allowed to react 
for 2-4 hours, scheme 2-68.  
                                                          




Scheme 2-68. Dearomatising anionic cyclisation of indole ureas.* 
Methyl ester substrate 2-376 underwent cyclisation successfully in 45% yield with a diastereoselectivity 
of 1.3:1. The diastereomers were separable by flash column chromatography and NOE analysis allowed 
the configuration of the major diastereomer to be assigned as 2-384a. Unfortunately, NOE analysis of 
the minor diastereomer was not enough to unambiguously assign the stereochemistry. Cyano indole 
urea 2-377 cyclised in a higher yield of 64%, however the 3:1.5:1 mixture of diastereomers was 
inseparable by flash column chromatography. As a result, the configuration of the stereocentres was 
difficult to elucidate. Pleasingly, tetrahydrocarbazole derivative 2-378 underwent cyclisation in a 
moderate yield of 47% yielding an inseparable 3:1 mixture of diastereomers. It can be assumed that for 
both observed diastereomers of 2-386 a cis relationship between the indoline scaffold and cyclohexane 
ring will be favoured due to being less strained than the trans analogues.166-167 Unsurprisingly, carbazole 
urea 2-379 failed to cyclise under the reaction conditions. This was a particularly ambitious substrate 
due to the possibility of multiple pathways, dearomatising cyclisation and ring expansion. 
Dearomatising cyclisation would not only dearomatise the indole but also the fused phenyl ring. 
Unfortunately, subjecting this material to the reaction conditions led to a complex mixture of 
unidentified products with no ring expansion or dearomatising cyclisation products observed.  
2.3.5 3-Methyl Indole Urea Precursor Synthesis 
 
With the knowledge that cyclisation of 3-methyl indole urea 2-375 gave the desired polycyclic indoline 
product 2-382 in good yield with excellent diastereoselectivity, our effort turned towards extending the 
scope of 3-substituted indoles. However, in contrast to the simple 3-methyl indole, 3-methyl indoles 
bearing additional substitution on the aromatic ring are not commercially available and therefore needed 
to be synthesised prior to tethering on the benzyl urea.  
A variety of 3-methyl indoles were synthesised from their parent indoles with varying electronic and 
steric properties, scheme 2-69. 
                                                          




Scheme 2-69. 3-Methyl indole urea precursor synthesis. aYields quoted refer to the attaching of the urea step.*  
Indoles were converted into their 3-methyl analogues by a Vilsmeier-Haack reaction.168 This involved 
reaction of the indole with the ‘Vilsmeier reagent’ which is generated in situ after initial treatment of 
DMF with POCl3. After an aqueous work-up the indole aldehyde is isolated, which can then be reduced 
to the desired methyl derivative upon treatment with LiAlH4. The 3-methyl indoles were transformed 
into their benzyl urea counterparts in moderate to excellent yields following the general procedure (see 
section 2.3.3). To investigate the stereospecificity of the cyclisation reaction urea 2-398 was synthesised 
by reaction of 3-methyl indole with (S)-methyl(1-phenylethyl)carbamoyl chloride.  
Alongside 3-methyl indoles, other 3-substituted indoles were studied to investigate the effect the nature 
of the 3-substitutent has on both reactivity and diastereoselectivity, scheme 2-70.  
                                                          




Scheme 2-70. Additional 3-substituted indole urea precursors synthesised.* 
Tryptamine posed as an interesting substrate to explore due to its useful biological properties.169 
Therefore, protected tryptamines 2-401 and 2-402 were synthesised according to literature 
procedures.170, 171 3-Benzyl indole 2-403 was synthesised via a literature procedure exploiting 
‘borrowing hydrogen’ chemistry.172 We were curious to investigate whether the incorporation of a 
benzyl group would affect the reactivity due to potential for competing deprotonation. With a variety 
of 3-substituted indoles synthesised our focus turned towards attempting the dearomatising anionic 
cyclisation. 
2.3.6 Dearomatising Cyclisation Substrate Scope of 3-Substituted Indoles 
 
Treatment of 3-substituted indoles 2-389 under the optimised conditions for dearomatising cyclisation 
allowed a range of polycyclic indoline structures to be synthesised in moderate to excellent yields and 
high diastereoselectivity, scheme 2-71.  
                                                          




Scheme 2-71. Dearomatising cyclisation substrate scope of 3-substituted indole urea precursors.  
 aConfiguration of major diastereomer shown based on stereochemistry of major diastereomer of analogues 3-
methyl indole ring closure product 2-407.* 
Heterocyclic 6,5,5 ring systems 2-405 to 2-416 were accessed following the dearomatising cyclisation 
methodology. Pleasingly, fluorine and chlorine atoms were tolerated at the 5-position, yielding the 
corresponding polycyclic indoline products 2-405 and 2-406 with good diastereoselectivity. A methyl 
group can be introduced at the 5-, 6- and 7-positions to gain access to structure 2-407-2-409 as single 
diastereomers. NOE experiments and an X-ray crystal structure of 2-407 allowed confirmation of an all 
cis relative stereochemistry, figure 2-5. 
 
Figure 2-5. X-Ray crystal structure of 2-407 showing all cis relative stereochemistry. 
A lower yield was obtained for 2-409 suggesting that the presence of a methyl group at the ortho- 
position of the aromatic ring hinders the reaction. The electron-donating methoxy substituent was well 
                                                          
* Experiment carried out by Dr Quenitin Lefebvre 
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tolerated, giving good yields of the corresponding polycyclic structures 2-410 and 2-411 as single 
diastereomers. A higher yield of 74% was obtained when the methoxy group was present at the 6- 
position. This behaviour was tentatively attributed to the increased basicity of the post-addition 
organolithium intermediate, thereby promoting a cleaner reaction by favouring proton transfer from 
diisopropylamine. Unfortunately, indole urea 2-397 bearing a 6-CF3 group failed to undergo the desired 
cyclisation reaction. Instead, a complex mixture of unidentified products and decomposition was 
observed. Tryptamine urea precursors 2-401 and 2-402 cyclised successfully under the reaction 
conditions and delivered 2-414 and 2-415 cleanly as single diastereomers. Despite the potential for 
competing deprotonation at the 3-benzyl position of indole 2-403, efficient dearomatising cyclisation 
occurred delivering the desired polycyclic indoline 2-416 in good yield as a single diastereomer.  
To investigate the stereospecificity of the reaction, urea 2-398 containing an enantioenriched α-methyl 
group was investigated. Treatment of urea 2-398 with LDA (2 eq.), DMPU (5 eq.) in THF at −78 °C 
for four hours yielded the desired cyclised product with no erosion of enantiopurity and as a 4:1 mixture 
of diastereomers, scheme 2-72. 
 
Scheme 2-72. Stereospecific dearomatising cyclisation of urea precursor 2-398. 
The diastereomers were separable by flash column chromatography and NOE NMR experiments were 
used to assign the relative stereochemistry of the stereocentres. Like the analogous 3-methyl indole 
substrates, the major diastereomer has an all cis relative stereochemistry between the methyl, proton 
and phenyl ring 2-413a. Unfortunately, attempts to grow crystals suitable for X-ray diffraction were 
unsuccessful, therefore we were unable to determine the absolute stereochemistry of the 
enantioenriched centre. Nonetheless, it is reasonable to postulate that the reaction proceeds with 
retention of configuration based on the outcomes observed in other rearrangements utilising benzylic 
anions previously reported in the Clayden group.80, 173 
To assess the scalability of the dearomatising cyclisation reaction, indole urea 2-375 was cyclised on a 
gram scale, scheme 2-73.  
 
Scheme 2-73. Gram scale dearomatising cyclisation of indole urea 2-375. 
Pleasingly, the desired product 2-382 was isolated in a higher yield of 79% compared to 64% which 
was achieved on a 0.7 mmol scale. This highlights the potential applications of this methodology in 
industrial research and development.  
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2.3.7 Attempted Stereoselective Deprotonation 
 
Although the cyclised product 2-413 with an enantioenriched centre can be achieved by stereospecific 
reaction from enantiopure precursor 2-398, the possibility of stereoselective deprotonations had not 
been investigated. This would allow access to products with enantioenriched centres from racemic 
starting materials. To determine whether this would be feasible, the deprotonation of 3-methyl indole 
urea 2-375 was attempted with chiral LDA derivative 2-417. LDA derivative 2-417 was chosen as a 
suitable chiral base due to previous work in the group demonstrating its potential for asymmetric 
induction.93 The reaction was attempted in the presence and absence of DMPU, scheme 2-74. 
 
Scheme 2-74. Attempted asymmetric deprotonation of indole benzyl urea 2-375.  
Chiral HPLC analysis showed that the reaction carried out in the presence of DMPU gave slight 
asymmetric induction with an enantiomeric ratio of 54:46 er (see supporting information). In the 
absence of DMPU the desired cyclised product was isolated as a perfect racemate with a 50:50 
enantiomeric ratio. Therefore, although deprotonation with chiral lithium amide 2-417 shows promise 
for asymmetric induction, further work is needed to optimise the reaction to obtain improved 
enantioselectivities.  
2.3.8 Mechanistic Insight 
 
A proposed mechanism for the dearomatising cyclisation reaction is depicted in scheme 2-75.  
 
Scheme 2-75. Potential cyclisation mechanism of indole ureas. 
Deprotonation at the benzylic position generates organolithium 2-419 which subsequently attacks the 
indole at the 2-position. The cyclisation is proposed to proceed via a syn-carbolithiation step where both 
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the carbon and lithium add to the same face of the vinyl group through a 4-membered transition state 
2-420. Polycyclic indoline 2-382 is afforded after protonation of the resulting anion, either in situ from 
diisopropylamine or on quench with aqueous saturated NH4Cl solution.  
Interestingly, when repeating the reaction with methyl iodide as a quenching agent, full methylation 
was not observed, scheme 2-76.  
 
Scheme 2-76. Dearomatising cyclisation of 3-methyl indole with methyl iodide quench.* 
Analysis of the crude reaction mixture by 1H NMR showed a 1.4:1 mixture of non-methylated 2-382 to 
methylated product 2-422. Since LDA gives reversible deprotonation, it is reasonable to suggest that 
reprotonation occurs in situ by diisopropylamine before the reaction is quenched with an external 
source. 
To better understand the origins of the substrate dependent diastereoselectivity, the reaction mechanism 












Scheme 2-77. 3D ReactIR trace monitoring peaks at various wavenumbers over the course of the reaction. Peaks 
are tentatively assigned to the intermediates shown. 
 
                                                          
* Experiment carried out in collaboration with Laura Fraser (MChem). 
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Due to the presence of strong carbonyl stretching frequencies in DMPU, we opted to run the reaction 
in the absence of DMPU to ensure any slight shifts in wavenumber would be observed. Starting material 
2-375 in THF showed a clear carbonyl peak at ν =1682 cm-1. Upon addition of two equivalents of LDA 
at −78 °C, the starting material peak at ν =1682 cm-1 disappeared and a transient species with a carbonyl 
stretch of ν =1633 cm-1 appeared. This most likely corresponds to the lithiated starting material 2-423, 
possibly in a more solvated/aggregated state. This species rapidly disappears and gives rise to three new 
signals at ν =1596 cm-1, 1715 cm-1 and 1720 cm-1 respectively. Over the course of 70 minutes the peak 
at ν =1596 cm-1 slowly decreased in intensity whilst the other two at ν = 1715cm-1 and 1720 cm-1 
increased in intensity. After 70 minutes the reaction was quenched with aq. saturated NH4Cl solution, 
which led to the disappearance of the signals at ν = 1596 cm-1 and 1715 cm-1, tentatively assigned as 
lithiated products 2-424 and 2-425. Simultaneously, the peak at ν =1720 cm-1 increased and was 
identified as product by comparison with the spectrum of an authentic sample. The desired product 2-
382 was isolated in 52% yield after purification. These results support the proposed mechanism of 
benzylic lithiation, syn-carbolithiation followed by partial in situ protonation mediated by 
diisopropylamine. 
2.3.9 Conclusions & Future Work 
 
A method has been developed for the synthesis of heterocyclic 6,5,5 systems exploiting a dearomatising 
anionic cyclisation of lithiated indole benzyl ureas using lithium diisopropylamide. The products of this 
cyclisation reaction are polycyclic indoline structures which have potential to be further functionalised. 
The reaction proceeds with excellent diastereoselectivity when 3-substituted indoles are used, yielding 
products with all cis relative stereochemistry confirmed where possible by NOESY experiments and X-
ray crystal structures. However, the cyclisation was less selective when electron-withdrawing groups 
(CO2Me, CN) were substituted at the 3-position, presumably due to the stabilisation of the resulting 
anion leading to less rapid reprotonation. The structurally interesting tryptamine derivatives cyclised in 
good yields with excellent selectivity and could be later deprotected to access the free amines. 
Substrates with substitution at the 2-position gave varying yields and poor selectivity, highlighting that 
the diastereoselectivity is substrate specific. The reaction is stereospecific when enantioenriched 
starting materials are used, indicating the reaction proceeds through a configurationally stable 
organolithium. Additionally, the reaction can be performed on a gram scale, yielding the desired 
polycyclic indoline scaffold in a higher yield than what was reported on smaller scale, increasing its 
industrial potential. Future work will focus on further derivatisation of the products and investigating 












2.4 Ring Contraction of Medium Ring Nitrogen Heterocycles  
 
N.B. The work described herein (section 2.4) is documented in the first author publication, J. E. 
Hill*.; J. V. Matlock.; Q. Lefebvre.; K. G. Cooper.; J. Clayden. Angew. Chem. Int. Ed. 2018, 57, 
5788. 
 
2.4.1 Initial Discovery 
 
Whilst investigating the substrate scope for the ring expansion of benzyl ureas (see section 2.2.3) it was 
shown that thiophene substrate 2-58 could undergo the ring expansion only in the absence of DMPU, 
scheme 2-78 a.  
 
Scheme 2-78. Discovery of n to n-2 ring contraction of thiophene substrate 2-58.* 
This contrasted with the other substrates which required DMPU to favour the 1,4-aryl migration over 
the 1,2-acyl shift. It was concluded at the time that when using DMPU the product isolated was that of 
the acyl shift, where the anion attacks the urea carbonyl instead of the aromatic ring. However, analysis 
of a crystal by X-ray crystallography allowed the product to be unambiguously assigned as 7-membered 
ring 2-426, where the more heavily substituted benzylic carbon atom had migrated from one urea 
nitrogen to the other, scheme 2-78 b. A possible mechanism for the ring contraction is shown in scheme 
2-79. 
                                                          




Scheme 2-79. Possible mechanism for ring contraction of thiophene substrate. 
The reaction is suspected to begin with the reported n to n+3 ring expansion on addition of two 
equivalents of LDA. When DMPU is in the reaction mixture, this is rapidly followed by a thiophene 
promoted ring opening and a final ring closure to form the 9- or 7-membered ring. Due to the reduced 
strain in the 7-membered ring compared to the 9-, the 7-membered ring was formed preferentially.  
Although this reactivity was only observed with the thiophene substrate, we reasoned that treatment of 
the medium ring precursors with a strong acid might promote a ‘SN1 type’ ring opening, scheme 2-80.  
 
Scheme 2-80. Acid-mediated ring contraction.  
The proposed mechanism starts with protonation of the urea carbonyl 2-429, followed by ring opening 
to form a benzhydryl cation 2-430. This carbocation can then be quenched by intramolecular cyclisation 
to form the 7-membered ring 2-431. 
Initial studies showed that treatment of 9-membered precursor 2-73 with 0.1 equivalents of p-
toluenesulfonic acid monohydrate (p-TsOH.H2O) in dichloromethane resulted in the desired ring 
contracted product 2-431 in 70% yield, scheme 2-81. These tetrahydrobenzazepine structures are 




Scheme 2-81. Ring contraction of 9-membered ring 2-73.  
It was anticipated that this ring contraction methodology could also be applied to 8-membered rings, 
offering access to privileged tetrahydroisoquinoline structures.  
2.4.2 Strategies for the Synthesis of Tetrahydroisoquinolines and Benzazepines 
 
Tetrahydroisoquinolines, benzazepines and related benzo-fused nitrogen heterocycles are privileged 
scaffolds in medicinal chemistry for library design and drug discovery.7, 175-180 There are a multitude of 
isoquinoline alkaloids that display diverse pharmacological and biological properties. The benzazepine 
scaffold forms the key motif for many active pharmaceutical ingredients which specifically target the 




Figure 2-7. Tetrahydroisoquinoline, benzazepine and related motifs in molecules with biological activity.175-180 
 
The most practical methods for the synthesis of tetrahydroisoquinolines are the Pictet-Spengler182-187 
and Bischler-Napieralski reactions.188-190 The Pictet–Spengler reaction involves the condensation of a 






Scheme 2-82. Pictet–Spengler reaction for the synthesis of tetrahydroisoquinolines. 
 
The mechanism begins with protonation of the carbonyl, which is subsequently attacked by amine 2-
433. A sequence of proton transfer steps and the release of a water molecule generates iminium 
intermediate 2-435. This then undergoes a 6-endo-trig cyclisation with loss of aromaticity of the aryl 
ring. The aromaticity is then restored by a final deprotonation step, resulting in tetrahydroisoquinoline 
product 2-436.  
 
The Bischler–Napieralski reaction is an intramolecular electrophilic substitution reaction that allows 
for the cyclisation of β-ethylamides. The reaction requires a dehydrating agent such as phosphorus 
oxychloride (POCl3), phosphorus pentoxide (P2O5) or zinc chloride (ZnCl2) for the synthesis of 3,4-




Scheme 2-83. Bischler–Napieralski reaction for the synthesis of tetrahydroisoquinolines. 
 
The reaction is suspected to proceed by dehydration of the amide to form nitrilium ion 2-439 which is 
then attacked by the electron-rich arene in by an electrophilic substitution reaction. Deprotonation 
regains aromaticity of the aromatic ring giving imine 2-440, scheme 2-83. Imine 2-440 can then be 
reduced yielding tetrahydroisoquinoline derivatives. An alternative mechanism involving a 
dichlorophosphoryl imine-ester intermediate may also be plausible.191 
 
Despite recent advances in the field,192 both reactions are limited by the need for electron-donating 
groups on the aromatic ring and harsh reaction conditions, such as refluxing the substrate in strong acid. 
Additionally, neither reaction works well for the formation of ring sizes other than 6. 
 
The most common synthetic routes to benzodiazepine structures start with an ortho-
aminobenzophenone 2-441, scheme 2-84. This reacts with a haloacetyl halide 2-442, affording the 
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corresponding amide 2-443. The halogen is then displaced with ammonia generating the glycinamine 
2-444 which cyclises to form the imine 2-445.193 
 
Scheme 2-84. Synthesis of benzodiazepine 2-445.193 
Due to the lack of functionalised 2-amino benzophenone structures commercially available, other 
methods have been developed to increase the diversity, usually employing metal catalysis.194  
Photochemistry has also been utilised in the synthesis of benzazepine structures.195 2- and 3-
benzazepines were synthesised via a regioselective intramolecular photoamination of ortho-
(aminoethyl)- and ortho-(aminopropyl)stilbenes, scheme 2-85.  
 
Scheme 2-85. Photochemical synthesis of benzazepines 2-448 and 2-451.195 
Direct irradiation of stilbenes 2-446 and 2-449 using 300 nm light resulted in the formation of 
benzazepines 2-448 and 2-451. Despite the moderate yields achieved, the reaction requires 
deoxygenated solvents and a photochemical reactor, limiting its practicality.  
Therefore, development of a practically simple and inexpensive method for the synthesis of 






2.4.3 Optimisation of Ring Contraction Conditions 
 
With a range of starting materials synthesised via the ring expansion methodology (see section 2.2.3), 
our initial studies focused on screening acids with the aim of improving the yield. 9-Membered nitrogen 
heterocycle 2-73 was chosen as the model substrate for optimisation, with the reactions run in the 
presence of an internal standard, scheme 2-86. 
 
Entry Acid  Yield 2-431, %a 
1 p-TsOH.H2O  98 
2 HCl in Et2O  81 
3 TFA in CDCl3  91 
Scheme 2-86.  Ring contraction of 2-73 with different Brønsted acids. aYields calculated from 1H NMR using 
internal standard.* 
The highest yields were obtained when using p-toluenesulfonic acid to promote the reaction (scheme 
2-86, entry 1). Although still highly yielding, a reduction in yield was observed when using HCl and 
TFA (scheme 2-86, entries 2 and 3). As a result, p-toluenesulfonic acid was chosen as the acid for all 
subsequent ring contraction studies. It was found that loadings as low as 0.1 equivalents were sufficient 
to deliver the desired product in good yield.   
2.4.4 Substrate Scope 
 
With the aim of exploring this consecutive ring expansion and contraction strategy as a general way of 
accessing tetrahydroisoquinolines and related compounds, these conditions were then applied to a series 
of substrates 2-452, each made by ring expansion of the appropriate urea.196 The results are summarised 
in scheme 2-87. 
                                                          




Scheme 2-87. Substrate scope of the ring contraction. aUsing 2.0 eq. of p-TsOH.H2O. bFrom a single 
diastereomer of the starting material. cProduct formed from tetrahydroquinoline benzyl urea 2-45 by a one-pot 
ring expansion-contraction using 10 eq. p-TsOH.H2O. dUsing 2.5 eq. methanesulfonic acid at 0 °C. eFrom 2-82, 
in which R2 = tBu, the tBu is lost in the reaction. 
The reaction was successful when using alternatively substituted 8-membered starting materials (n=1), 
giving the tetrahydroisoquinolines 2-454-2-457 in good yield. Single diastereomers of ring expanded 
starting materials 2-97 and 2-98 produced a diastereoisomeric mixture of products when R3 = Me in 2-
456, but a single diastereomer of phenyl-substituted 2-457. After repeating the ring contraction of 2-97 
at 0 °C in hope of improving the diastereoselectivity, analysis of the 1H NMR spectrum of the crude 
reaction mixture showed a mixture of unreacted starting material and product 2-456 as a single 
diastereomer. Leaving the reaction for longer at 0 °C did not drive the reaction to completion and the 
same ratio of starting material to product was observed. This indicated that although the reaction was 
more selective at lower temperatures, it was less reactive and warmer temperatures were needed for full 
conversion. It was postulated that the reaction is under thermodynamic control and the product can ring 
open and close unselectively, leading to epimerisation which may account for the observed 1:1 
diastereomeric ratio when R3 = Me. These results were particularly pleasing as 1-aryl 
tetrahydroisoquinolines represent a class of biologically relevant compounds which display 
pharmacological activity, indeed 2-454 is a precursor to the drug solifenacin.197 
9-Membered ring expansion starting materials (n=2), which are available196 from tetrahydroquinoline 
benzyl ureas or morpholine (see section 2.2.3) likewise underwent the ring contraction, giving the 
otherwise problematic 1-substituted 2,3,4,5-tetrahydro-1H-benzo-[c]azepines 2-431, 2-458-2-461 and 
the oxa analogue 2-462. 2-461 was formed from precursor 2-82, in which R2 is tBu, which was removed 
under the conditions of the reaction, thereby allowing access to alternatively substituted urea products. 
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The ring contraction reaction was tolerant of variously substituted rings, with electronically diverse 2-
455, 2-459, 2-460 and sterically hindered 2-458 all being formed successfully. 7-Membered ring 
contracted products 2-459 and 2-460 were accessed exploiting a one-pot ring-expansion-contraction 
method using 10 eq. p-toluenesulfonic acid, highlighting the practicality of the method. Unsurprisingly, 
the 8-membered ring contracted product 2-463 was isolated in a lower yield of 38%. This can be 
explained due to the formation of another medium-sized ring, which will have unfavourable 
transannular interactions. 11- and 12-Membered ring expansion products 2-75 and 2-76 were also 
trialled in the ring contraction. Subjecting them to the optimised conditions for the ring contraction p-
toluenesulfonic acid (0.1 eq.), CH2Cl2 (0.1 M) at RT resulted in no conversion. Therefore, both 
substrates heated in the microwave at 100 °C for 15 minutes. Unfortunately, decomposition was 
observed. For the ring contraction of 2-75 and 2-76 to be successful a carbocation would need to form 
and be quenched by an intramolecular cyclisation to give a 9- or 10-membered ring. It can be reasoned 
that the transannular strain present in the products of the 9- and 10-membered rings would be too high 
for the cyclisation to occur. 
Pyridine analogues 2-83 and 2-84 were also attempted in the ring contraction with stoichiometric 
amounts of p-toluenesulfonic acid. Treatment of 2-83 with p-toluenesulfonic acid (2 eq.) in CH2Cl2 at 
room temperature gave trace amounts of ring contracted product 2-464 along with other unidentified 
products. Unlike 2-83, subjecting 2-84 to the ring contraction conditions resulted in a bright yellow 
fluorescent solution. After purification, the major product was identified to be 2-465 in 62% yield, 
where protonation of the pyridine nitrogen had occurred followed by tautomerisation, scheme 2-88.  
 
Scheme 2-88. Attempted ring contraction of pyridine analogues 2-83 and 2-84. 
Presumably, this tautomer is formed preferentially as it minimises transannular interactions across the 
ring.  
Medium ring substrates in which an alternative E1 elimination pathway is available did not undergo 





Scheme 2-89. E1 elimination pathway of substrates with adjacent abstractable protons. 
Compounds 2-89, 2-90, 2-94 and 2-102 underwent elimination on treatment with acid, rather than ring 
contraction, yielding olefinic products, scheme 2-89. The monocyclic compounds 2-89 and 2-90 ring 
opened on elimination to yield the simple 1,1-diarylethylenes 2-468 and 2-469, scheme 2-89. In 
contrast, elimination of bicyclic 2-94 and 2-102 generated 13- and 11- membered cyclic alkenes 2-470 
and 2-471, scheme 2-90. X-Ray crystallography confirmed the Z-alkene geometry of the 11-membered 
ring 2-471. 
 
Scheme 2-90. Elimination pathway leading to generation of larger rings.* 
These results suggest a common mechanism in which protonation of the electron-rich oxygen atom of 
the urea initiates the formation of a carbocation. This carbocation either provides the intermediate for 
E1 elimination when a β-proton is lost, or alternatively is trapped by the remote urea nitrogen in an 
intramolecular SN1 substitution that leads to ring contraction.  
The formation of alkene 2-468 makes an alternative pathway for ring contraction possible where base 
is used, rather than acid. 2-468 is electrophilic towards attack by a nitrogen nucleophile and treatment 
of 2-468 with potassium tert-butoxide promotes intramolecular hydroamination to form 7-membered 
ring 2-472 in 83% yield, scheme 2-91.198 
                                                          




Scheme 2-91. Intramolecular hydroamination to generate 7-membered ring 2-472. 
This method of formation of 7-membered ring 2-472 from diarylalkene 2-468 and hence from the 
indoline benzyl urea precursor 2-59 represents an alternative “n+3−1” ring expansion-recontraction 
strategy for the synthesis of this alternatively substituted class of 1-aryl-2,3,4,5-tetrahydro-1H-
benzo[d]azepines. Unfortunately, similar reactions to form the 8-membered ring from diarylalkene 2-
469 were unsuccessful.  
To assess the scalability and demonstrate the practical utility of the method, a ‘one-pot’ urea formation, 
ring expansion and ring contraction was performed using tetrahydroquinoline carbamoyl chloride 2-




Scheme 2-92. ‘One-pot’ urea formation, ring expansion, ring contraction and subsequent hydrolysis. 
 
Carbamoyl chloride 2-112, which is synthesised in one step from commercially available 
tetrahydroquinoline, was converted into its corresponding benzyl urea counterpart, then ring expanded 
with LDA and DMPU and finally re-contracted to product 2-431 on addition of an excess of p-
TsOH.H2O. The urea tether was then removed by basic hydrolysis under microwave conditions giving 
7-membered ring 2-473 in 72% yield, which can be further functionalised. 
 
2.4.5 Ring Contraction in Flow 
 
Flow chemistry offers many advantages over traditional batch chemistry, especially when considering 
scale-up. As a result, there has been a large amount of research into the development of flow systems, 
both in academia and industry.199, 200 A major advantage with a continuous flow set up is safety. The 
system allows only small amounts of hazardous material to be reacting or generated at any one time 
and the high surface area allows for excellent control of exotherms. Additionally, flow systems can 
result in faster reaction times due to the ease at which they are pressurised. This allows solvents to be 
heated significantly higher than their boiling points, achieving faster rates of reaction. Scaling up from 
small scale to large scale can be a simple procedure due to inherently translatable mixing and heat 
transfer. Higher flow rates and correspondingly larger flow reactors can be used to scale up to 
industrially relevant quantities. Despite these advantages, not all synthetic procedures can be performed 
in flow. For example, reactions which involve suspensions are challenging due to the risk of blockages. 
As a result, they are usually performed under much more dilute conditions compared to batch, making 




Due to the simplicity of the ring contraction methodology, we were interested in investigating if it was 
applicable to flow chemistry. Exploiting a solid-supported acid instead of p-toluenesulfonic acid would 
allow elimination of work-up and purification steps, making the whole procedure more industrially 
relevant. 
 
Amberlyst-15, a polystyrene based ion exchange resin with strongly acidic sulfonic acid groups on the 
surface, was chosen as a suitable alternative to p-toluenesulfonic acid. Initial studies focused on 
replacing p-toluenesulfonic acid with amberlyst resin in batch for the ring contraction of 9-membered 




Scheme 2-93. Acid promoted ring contraction using amberlyst-15 resin. 
 
The reaction was monitored by liquid chromatography mass spectrometry (LCMS) and showed full 
consumption of starting material to the desired product 2-431 after 1 hour and 45 minutes. Before 
transferring to flow, the reaction was first optimised under microwave conditions. Indeed, microwave 
and flow reactions share many similarities. For example, microwave reactions typically have short 
reaction times due to the high temperatures attainable under pressurised conditions. This directly relates 
to short residence times in flow. In addition, the possibility to use flow reactors fitted with backpressure 
regulators allows straightforward replication of the high temperatures and pressures achievable in 
microwave batch experiments.201 The optimal conditions were found to be one weight equivalent of 
amberlyst-15 resin, 60 °C for ten minutes in the microwave. With these conditions in hand our efforts 
turned to transferring the ring contraction to flow.  
 
Flow reactions were performed using a Uniqsis FlowSyn module, figure 2-8. The instrument uses a 
PTFE flow path and the OMNIFIT® glass column, was manually packed with amberlyst-15 resin 
(height 1.3 cm). 
a)                 b)  
 
Figure 2-8. a) Uniqsis FlowSyn module b) OMNIFIT® glass column packed with amberlyst-15 resin. 
The height of packed amberlyst resin was selected to be 1.3 cm as this was the smallest amount of resin 
required to achieve a ten minute residence time using the slowest flow rate of 0.1 mL/min. The starting 
material, as a 1.8 M solution in CH2Cl2, was delivered to the system via tubing from a Schott bottle 
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placed on top of the instrument. A second Schott bottle containing anhydrous dichloromethane was used 
to carry the starting material through the system, ensuring all substrate passes through the column. The 
packed column was connected to the system and secured into the Uniqsis heating block to ensure 
efficient heating. Once the temperature and flow rate were programmed into the system, the run was 
started. After passing through the column, the solvent was collected in a round bottom flask and the 
solvent was removed under reduced pressure.  
The optimised microwave conditions were trialled in the first flow run, 60 °C, 10 minute reaction time, 
0.1 mL/min flow rate, (scheme 2-94, entry 1). 
 
Entry Flow rate, mL/min Column temp, °C Residence time, min 2-73, % 2-431, % 
1 0.1 60 10 - 11 
2 0.2 RT 5 - 51 
3 1.0 RT 1 38 60 
4 0.5 RT 2 11 80 
5 1.0 60 1 - 67 
6 0.4 60 2.5 - 86 
7 5.0 RT 0.2 68 17 
8 0.4 60 2.5 - 92a 
 
Scheme 2-94. Optimisation of ring contraction in flow. aReaction performed on a 4 gram scale. 
Although the desired ring contracted product 2-431 was isolated in 11% yield, mass balance was poor. 
It could be speculated that due to the slow flow rate, high temperature and increased amberlyst resin 
compared to the microwave run, decomposition could occur, and the resulting products could bind to 
the column. To circumvent this issue, the reaction was repeated with a higher flow rate of 0.2 mL/min 
and performed at room temperature (scheme 2-94, entry 2). Pleasingly, the desired product was isolated 
in a higher yield of 51% albeit lower than what was obtained in batch. With the thought that shorter 
residence times were resulting in higher yields of the tetrahydrobenzazepine 2-431, the flow rate was 
increased to 1.0 mL/min (scheme 2-94, entry 3). Unfortunately, the shorter residence time of 1 minute 
meant that full consumption of starting material was not observed, despite 2-431 being present in 60%. 
As a result, the flow rate was reduced to 0.5 mL/min, giving a two minute residence time. Although a 
higher yield of product 2-431 was achieved, starting material 2-73 was present in 11% (scheme 2-94, 
entry 4). With the aim of keeping a quick flow rate and driving the reaction to completion, a flow run 
was conducted with a 1.0 mL/min flow rate at 60 °C (scheme 2-94, entry 5). Product 2-431 was isolated 
in 67% yield with no signs of starting material, indicating that temperature is beneficial for the ring 
contraction in flow. On review of the previous runs the highest yield of 2-431 was obtained when 0.5 
mL/min flow rate was used at room temperature (scheme 2-94, entry 4). However, unreacted starting 
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material remained, and it has been shown that higher temperatures are beneficial to drive the reaction 
to completion. Therefore, with the aim of achieving a high yield of 2-431 without any unreacted starting 
material, 0.4 mL flow rate at 60 °C was trialled (scheme 2-94, entry 6). The desired product was isolated 
cleanly in 86% and required no further purification.  
As a final run to investigate the effect of quicker flow rates at room temperature the reaction was 
repeated with 5.0 mL/min flow rate. As anticipated, starting material remained in 68% along with 17% 
product (scheme 2-94, entry 7). A recycling strategy, where the mixture is passed through the column 
again until starting material is consumed, could be used to allow quicker flow rates.  
To demonstrate the scalability of ring contraction in flow, the reaction was repeated using the optimised 
conditions on a four gram scale, scheme 2-95. 
 
Scheme 2-95. Scale-up of ring contraction in flow. 
7-Membered nitrogen heterocycle 2-431 was isolated in excellent yield of 92% without the need for 
work-up or purification, therefore highlighting the scalability and practicality of the flow method. This 
extremely simple flow method offers an attractive alternative to the batch procedure for the synthesis 
of 1-aryl tetrahydrobenzazepines.  
2.4.5 Conclusions & Future Work 
 
In summary, an acid-mediated n to n−2 ring contraction of medium ring cyclic ureas has been developed 
in batch and in flow. Many acids promote the ring contraction reaction but p-toluenesulfonic acid 
monohydrate was shown to give the highest yields in batch and amberlyst-15 resin was chosen as a 
suitable solid-supported alternative for flow studies. This method, coupled in tandem to the practical 
synthesis of starting materials from readily available heterocycles (see section 2.2.3) allows the rapid 
and scalable synthesis of potentially bioactive 1-aryl tetrahydroisoquinoline and tetrahydrobenzazepine 
derivatives. Alternatively substituted 1-aryl-2,3,4,5-tetrahydro-1H-benzo[d]azepines can be accessed 
via an acid-promoted E1 elimination pathway of appropriate precursors resulting in 1,2-diarylalkenes 
that can undergo intramolecular hydroamination.  
Future work will investigate the potential of chiral Brønsted acids for inducing chirality in the ring 
contraction. Additionally, chiral Lewis acids can be screened to identify if any enantioselectivity is 
obtained in the products.  
Current work within the group is focusing on extending this methodology to linear acyclic systems, 





Scheme 2-96. N→N’ migration in linear acyclic systems.* 
If chirality could be incorporated into the system this would offer an alternative route towards chiral 
amines. Preliminary work has shown that the migration is stereospecific when enantioenriched starting 
materials are used, supporting the presence of a concerted mechanism rather than carbocation 



















                                                          





3.1 General Directions 
 
Reactions requiring anhydrous conditions (where specified) were executed under dry nitrogen or argon 
atmospheres in glassware that was dried using either a combination of vacuum and heat-gun, oven, or 
flame drying. Reaction mixtures were stirred magnetically. Air- and moisture-sensitive liquids and 
solutions were transferred via syringe or cannula into the reaction vessels through rubber septa. All 
reagents were purchased (unless specified) at highest commercial quality and used as received. Non-
anhydrous solvents were purchased (unless specified) at the highest commercial quality and used as 
received. Anhydrous CH2Cl2 and Et2O, THF and MeCN were stored over 3 Å were purchased from 
Acros and used as received. Anhydrous pyridine stored over 3 Å molecular sieves was purchased from 
Acros. DMPU was distilled from CaH2 and stored under nitrogen in a Young’s tube. Triethylamine was 
distilled from CaH2 and stored under nitrogen in a Young’s tube. All temperatures described below −10 
°C were achieved using a Julabo cryostat. 
3.2 Analytical Directions 
 
Rf: TLC was performed on aluminium backed silica plates (0.2 mm, 60 F254) which were developed 
using standard visualising agents: UV fluorescence (254 & 366 nm), phosphomolybdic acid / Δ, vanillin 
/ Δ, potassium permanganate / Δ and Seebach / Δ 
Chromatography: Flash chromatography was performed on an automated Biotage IsoleraTM Spektra 
Four using gradient elution on pre-packed silica gel Biotage® SNAP Ultra columns or by manual means 
using Fluorochem 60 silica (40-60 µm particle size). Solvents for flash chromatography and TLC are 
reported in volume:volume percentages. 
Enantiomeric excess was determined by HPLC on an Agilent Infinity 1260 system with UV detection 
at 254, 230 and 210 nm using either a ChiralPak AD-H or Chiralcel OD-H column and hexane/IPA as 
the eluent for all separations unless otherwise stated.  
 
Mp: Melting points were measured on a Kofler hotstage melting point apparatus and are uncorrected. 
IR: IR spectra were recorded on neat compounds using a Perkin Elmer (Spectrum One) FT-IR 
spectrometer (ATR sampling accessory). Only strong and selected absorbances (νmax expressed in cm−1) 
are reported. 
1H NMR: Spectra were recorded on Jeol ECS (400 MHz), Bruker (400 or 500 MHz) or Varian VNMR 
(400 MHz or 500 MHz) instruments. Chemical shifts (δΗ) are quoted in parts per million (ppm) and 
referenced to the appropriate NMR solvent peak(s). 2D NMR experiments COSY, HSQC and HMBC 
were used where necessary in assigning NMR spectra. Spin-spin coupling constants (J) are reported in 
Hertz (Hz). 
13C NMR: Spectra were recorded on Jeol ECS (100 MHz), Bruker (100 MHz or 125 MHz) or Varian 
VNMR (100 MHz or 125 MHz) instruments. Chemical shifts (δC) are quoted in parts per million (ppm) 
and referenced to the appropriate solvent peak(s). Spin-spin coupling constants (J) are reported in Hertz 
(Hz). 
19F NMR: Spectra were recorded on Jeol ECS (376 MHz) or Varian VNMR (376 MHz) instruments. 
Chemical shifts (δF) are quoted in parts per million (ppm) and referenced to an external standard. Spin-
spin coupling constants (J) are reported in Hertz (Hz). 
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m/z: Low resolution mass spectra (m/z) were recorded on a Bruker Daltronics MicrOTOF 2 mass 
spectrometer (ESI), with only molecular ions ([M]+, [M+H]+, [M+Na]+) and major peaks reported. 
HRMS: High resolution mass spectra were recorded on a Bruker Daltronics MicrOTOF 2 mass 
spectrometer (ESI). 
Optical Rotations: ([𝛼]𝐷
𝑇 ) Optical rotations were measured on a Bellingham and Stanley Ltd. ADP220 
polarimeter where c is given in g/100 mL. 
X-ray Sample Preparation: Crystals suitable for X-ray were grown by dissolving the sample in a dense 
solvent (CH2Cl2) in which it is reasonably soluble and a second chamber placed outside containing a 
less dense solvent (Et2O or n-Pentane). The solvents slowly mixed together, altering the polarity of the 
solution in which the sample is dissolved, leading to crystallisation, figure 3-1.  
 
Figure 3-1. Crystallisation by slow diffusion. 
 
3.3 General Procedures  
 
General Procedure 1 (GP1): Carbamoyl Chloride Synthesis for Cyclic Amines 
 
A flame-dried two-necked round bottom flask cooled to RT under vacuum. Triphosgene (0.46 eq.) was 
added and the flask was subsequently nitrogen/vacuum cycled three times. Anhydrous CH2Cl2 (0.7 M) 
was added and the reaction was cooled to −78 °C. Pyridine (1 eq.) was added dropwise and the reaction 
was stirred for 5 min at −78 °C. Cyclic amine (1 eq.) was added to the reaction mixture dropwise and 
stirred for 5 min. The reaction mixture was warmed to RT until consumption of the cyclic amine was 
observed by TLC. The reaction mixture was quenched with 1 M HCl and extracted three times with 
CH2Cl2. The combined organic phases were washed with sat. NaHCO3, dried over MgSO4, filtered and 
concentrated in vacuo to yield the crude carbamoyl chloride. Purification through a pad of silica eluting 
with 20% EtOAc/petrol gave the desired carbamoyl chloride, which could be used directly in the next 
step or stored in the freezer at −20 °C until required.  
 
General Procedure 2 (GP2): Urea Synthesis using Cyclic Amine Carbamoyl Chlorides 
 
A solution of carbamoyl chloride (1.0 eq.) in anhydrous MeCN was added dropwise under an 
atmosphere of nitrogen to a solution of amine (1.3 eq.) and freshly distilled triethylamine (1.6 eq.) in 
anhydrous MeCN (0.4 M). The reaction was stirred at RT until the consumption of the carbamoyl 
chloride was observed by TLC. The reaction mixture was quenched with sat. NaHCO3 and extracted 
three times with CH2Cl2. The combined organic phases were dried over MgSO4, filtered and 
concentrated in vacuo to give the crude urea. The crude urea was purified using flash column 





General Procedure 3 (GP3): Fresh Preparation of Lithium Diisopropylamide (LDA)  
 
A flame-dried flask was nitrogen/vacuum cycled three times. Freshly distilled diisopropylamine (2 eq.) 
was added to the flask under nitrogen followed by THF (0.6 M). The solution was cooled to 0 °C and 
n-butyllithium (2 eq., 1.6 M in hexanes) was added dropwise. The solution was stirred at 0 °C for 20 
min prior to use.  
 
General Procedure 4 (GP4): Ring Expansion/ N→C Aryl Migration 
 
To a flame-dried Schlenk tube was added urea (1 eq.) followed by THF (0.15 M). DMPU (5 eq.) was 
added to the solution at RT and stirred for 5 min. The Schlenk tube was cooled to −78 °C and a solution 
of freshly prepared LDA (2 eq.)/ commercial LDA solution (2 M in THF/heptane/ethylbenzene) was 
added dropwise to the reaction mixture. The reaction mixture was stirred for 4 h at −78 °C or until 
complete consumption of urea was observed by TLC. The reaction mixture was quenched with sat. 
NH4Cl and warmed to RT. The reaction mixture was then extracted three times with EtOAc and the 
combined organic phases were washed three times with water and once with brine. The combined 
organic phases were dried over MgSO4, filtered and concentrated in vacuo to yield a crude residue. The 
crude ring expansion/aryl migration products were purified by flash column chromatography on silica 
gel to give the desired compounds. 
 
General Procedure 5 (GP5): Synthesis of Amino Acid Esters from Carbamoyl Chlorides 
To a solution of amino acid ester hydrochloride (1.1 eq.) in MeCN (0.4 M) was added freshly distilled 
triethylamine (2.6 eq.) at RT. Carbamoyl chloride (1 eq.) was added over 5 min at RT and the reaction 
mixture was stirred at RT until consumption of the carbamoyl chloride was observed by TLC. CH2Cl2 
was added to the reaction mixture and the organic phase was washed twice with 1 M HCl and once with 
sat. NaHCO3. The combined organic phases were dried over MgSO4, filtered and concentrated in vacuo 
to yield a crude residue. The crude urea was purified by flash column chromatography on silica gel to 
give the desired compound. 
General procedure 6 (GP6): Synthesis of Benzylic Carbamates from Carbamoyl Chlorides 
 
To a suspension of NaH (60% dispersion in mineral oil, 2 eq.) in CH2Cl2 (0.2 M) was added benzyl 
alcohol (2 eq.) at 0 °C. The solution was warmed to RT and carbamoyl chloride (1 eq.) was added 
dropwise. The reaction mixture was stirred until consumption of carbamoyl chloride was observed by 
TLC. The reaction was quenched by slow addition of water, followed by sat. NH4Cl. The organic phase 
was washed with once with water and once with brine. The combined organic phases were then dried 
over MgSO4, filtered and concentrated in vacuo to yield a crude residue. The crude carbamate was 
purified by flash column chromatography on silica gel to give the desired compound.  
 
General procedure 7 (GP7): Synthesis of 3-Methyl Indoles  
By the method of H. G. Cheng et al.,168 to a three-necked flask was added indole (1 eq.) and DMF (5 
eq.). The mixture was cooled to 0 °C, then POCl3 (1.2 eq.) was added dropwise. The solution was heated 
at 40 °C for 2 h. The mixture was cooled to RT and 2 M NaOH solution was added slowly. The resultant 
mixture was heated to 90 °C for a further 1 h. The reaction mixture was cooled to RT and EtOAc was 
added to dissolve the solid. The aqueous phase was extracted three times with EtOAc and the combined 
organics were washed once with brine. The combined organic phases were dried over Na2SO4, filtered 
and concentrated in vacuo. The corresponding 1H-indole-3-carbaldehyde was used in the next step 
without further purification. 
116 
 
To a flame-dried flask was added LiAlH4 (1.5 eq.) followed by THF (4 mL mmol-1 indole) under an 
atmosphere of nitrogen. The solution was cooled to 0 °C before dropwise addition of the above aldehyde 
in THF (4 mL mmol-1 indole). The mixture was stirred overnight at RT. Upon reaction completion, H2O 
(1 mL/ 0.5 g indole) was added dropwise followed by NaOH (1 g/ 0.5 g indole) and H2O (3 mL/ 0.5 g 
indole). The mixture was stirred for 15 min, then the solid was removed by filtration and washed with 
Et2O. The combined organic phases were dried over Na2SO4, filtered and concentrated in vacuo. The 
crude residue was purified by flash column chromatography on silica gel to afford the corresponding 3-
methyl-1H-indole. 
General procedure 8 (GP8): Indole Urea Synthesis using Benzyl(methyl)carbamoyl chloride 
By the method of B. Li et al.165, to a suspension of NaH (60% dispersion in mineral oil, 2 eq.) in DMF 
(0.7 M), a solution of indole (1 eq.) was added dropwise at 0 °C. The reaction mixture was warmed to 
RT and then heated at 75 °C for 3 h. The reaction mixture was cooled to 0 °C and a solution of 
benzyl(methyl)carbamoyl chloride 2-15 (1.5 eq.) was added dropwise. The reaction mixture was then 
heated to 75 °C for 16 h or until TLC showed reaction completion. The reaction mixture was cooled to 
RT, quenched with sat. NH4Cl and extracted three times with EtOAc. The combined organics were 
washed three times with 5% LiCl, dried over MgSO4, filtered and concentrated in vacuo. The crude 
urea was purified by flash column chromatography on silica gel to yield the desired indole urea. 
General Procedure 9 (GP9): Dearomatising Cyclisation of Indole Ureas 
 
To a flame-dried Schlenk tube was added indole urea (1 eq.) followed by THF (0.15 M) under an 
atmosphere of nitrogen. DMPU (5 eq.) was added at RT and the reaction mixture was stirred for 5 min. 
The mixture was cooled to −78 °C and then LDA (2 M in THF/heptane/ethylbenzene, 2 eq.,) was added 
dropwise. The reaction mixture was stirred for 2 h at −78 °C or until TLC showed reaction completion. 
The reaction mixture was quenched with sat. NH4Cl and extracted three times with EtOAc. The 
combined organic phases were washed twice with water and once with brine, before being dried over 
MgSO4, filtered and concentrated in vacuo. The crude residue was purified by flash column 
chromatography on silica gel to afford the desired cyclisation products. 
General procedure 10 (GP10): Ring Contraction of Medium Ring Nitrogen Heterocycles 
 
To a flask containing the corresponding cyclic urea (1 eq.) in CH2Cl2 (0.1 M) in air was added p-
toluenesulfonic acid monohydrate (0.1 - 2 eq.). The reaction mixture was stirred for 1-16 h at RT or 15 
min in the microwave at 100 °C, until complete consumption of starting material was observed by TLC 
(N.B. for some substrates both starting material and product have the same Rf).  Once complete, the 
reaction mixture was quenched with sat. NaHCO3. The aqueous phase was extracted three times with 
CH2Cl2 and the organic phases were washed three times with water. The combined organic phases were 
dried over MgSO4, filtered and concentrated in vacuo to yield a crude residue. The crude product was 













3.4 Characterisation Data 
 
 (E)- 6,7,8,9-Tetrahydro-5H-benzo[7]annulen-5-one oxime (2-10) 
To a stirred solution of 1-benzosuberone (4.0 g, 25 mmol) and hydroxylamine 
hydrochloride (3.5 g, 50 mmol) in EtOH (125 mL) was added pyridine (3.5 mL, 44 
mmol). The reaction mixture was heated to reflux and stirred overnight. The solvent 
was removed in vacuo and the crude product was purified via flash column 
chromatography (10 to 15% EtOAc in petrol) affording 2-10 as a white solid (4.0 g, 
92%).1H NMR (400 MHz, CDCl3) δ: 9.20 (1 H, br s, OH), 7.41 (1 H, dd, J 7.5, 1.5, 
H5), 7.30 (1 H, td, J 7.5, 1.5, H3), 7.23 (1 H, dt, J 7.5, 1.0, H4), 7.13 (1 H, dd, J 7.5, 1.0, H2), 2.77‒
2.71 (4 H, m, H8, H11), 1.78 (2 H, quin, J 6.5, H9/H10), 1.64 (2 H, quin, J 6.5, H9/ H10). 13C NMR 
(100 MHz, CDCl3) δ: 162.9 (C7), 139.6 (C6), 136.2 (C1), 129.4 (C3), 129.0 (C2), 127.5 (C4), 126.7 
(C5), 32.1 (C11), 26.2 (C8), 26.1 (C10), 21.7 (C9). Data in accordance with literature.105 
3,4,5,6-Tetrahydrobenzo[b]azocin-2(1H)-one (2-11) 
Polyphosphoric acid (10 g) was added to a 100 mL RB flask and heated to 115 °C. 
(E)-6,7,8,9-Tetrahydro-5H-benzo[7]annulen-5-one oxime 2-10 (3.5 g, 20 mmol) 
was added in one portion and the reaction mixture was heated to 130 °C and kept at 
this temperature for 10 min. Ice was then added to the reaction mixture and a fine 
white precipitate formed. CH2Cl2 (20 mL) was added and the organic phase was 
separated and washed with sat. NaHCO3. The organic phase was dried over MgSO4, filtered and 
concentrated in vacuo affording 2-11 as a white solid (3.0 g, 86%). 1H NMR (400 MHz, CDCl3) δ: 8.14 
(1 H, br s, NH), 7.28‒7.17 (3 H, m, H2, H3, H4), 7.08 (1 H, dd, J 7.5 1.0, H5), 2.80‒2.60 (2 H, br, H11), 
2.3‒1.5 (6 H, br, H9, H10, H11).  
13C NMR (100 MHz, CDCl3) δ: 177.1 (C7), 140.0 (C1), 136.0 (C6), 131.0 (C3/C4), 127.9 (C3/C4), 
127.1 (C2), 125.3 (C5), 32.7 (C11), 31.3 (C8), 29.7 (C10), 25.0 (C9). Data in accordance with 
literature.105, 202 
1,2,3,4,5,6-Hexahydrobenzo[b]azocine (2-12) 
A solution of 3,4,5,6-tetrahydrobenzo[b]azocin-2(1H)-one 2-11 (1.5 g, 8.6 mmol) 
in THF (20 mL) was added dropwise to a suspension of LiAlH4 (0.98 g, 26 mmol) 
in Et2O (116 mL). The reaction mixture was stirred at reflux for 20 h. Water (1 
mL) was added to quench the reaction, followed by 2 M NaOH (1 mL) and water 
(3 mL). The reaction mixture was stirred for 1 h before the granular salt was filtered 
and washed with Et2O. The solvent was removed in vacuo and the crude material was purified by flash 
column chromatography (50% EtOAc in petrol) yielding 2-12 as a yellow oil (1.1 g, 82%). 
1H NMR (400 MHz, CDCl3) δ: 7.10 (1 H, td, J 7.5, 1.5, H3), 7.06 (1 H, dd, J 7.5, 1.5, H5), 6.92 (1 H, 
dt, J 7.5, 1.0, H4), 6.88 (1 H, dd, J 7.5, 1.0, H2), 3.2‒3.17 (2 H, m, H11), 3.03 (1 H, br s, NH), 2.85‒
2.82 (2 H, m, H7), 1.76‒1.68 (2 H, m, H10/ H8), 1.56‒1.49 (4 H, m, H10/H8, H9);  
13C NMR (100 MHz, CDCl3) δ: 147.7 (C1), 135.1 (C5), 130.5 (C3), 127.4 (C6), 122.9 (C4), 122.8 
(C2), 51.5 (C11), 32.1 (C6), 31.4 (C10), 28.8 (C9), 25.4 (C8).  Data in accordance with literature.203 
Benzyl(methyl)carbamoyl chloride (2-15) 
According to GP1, N-benzylmethylamine (4.7 mL, 37 mmol), triphosgene (5.0 
g, 17 mmol) and pyridine (3.0 mL, 37 mmol) in CH2Cl2 (52 mL) gave the titled 
compound 2-15 as a colourless oil (5.74 g, 93%). N.B. Compound exists as a 
mixture of rotamers in a 1:1.3 ratio. 1H NMR (400 MHz, CDCl3) δ 7.43 – 7.29 
(5 H, m, H1, H2, H3rotA+B), 4.75 (2 H, s, H5rotA), 4.61 (2 H, s, H5rotB) 3.1 (3 H, s, H6rotB), 3.0 (3 H, s, 
H6rotA). 13C NMR (101 MHz, CDCl3) δ 150.6 (C7), 135.6 and 135.3 (C4rotA+B), 129.1 and 129.0 
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(C2/C3rotA+B), 128.3 and 128.2 (C2/C3rotA+B), 127.3 (C1), 56.5 (C5rotA) and 54.6 (C5rotB), 38.0 (C6rotB) 
and 36.5 (C6rotA). Data in accordance with literature.204 
N-(2-Iodophenyl)benzamide, 2-25: 
To a stirred solution of 2-iodoaniline (2.0 g, 9.1 mmol) in THF (20 mL) was added 
benzoyl chloride (1.2 mL, 10 mmol) at RT. The reaction mixture was stirred at RT for 
16 hours or until TLC showed consumption of starting material. The reaction mixture 
was diluted with EtOAc, washed twice with 5% NaHCO3 and once with brine. The 
combined organic phases were dried over MgSO4, filtered and concentrated in vacuo. 
The crude residue was purified by flash column chromatography (10% EtOAc in 
petrol) to yield N-(2-iodophenyl)benzamide 2-25 as a white solid (2.2 g, 74%). 1H 
NMR (400 MHz, CDCl3) δ: 8.47 (1 H, dd, J 8.2, 1.5, H5), 8.30 (1 H, br s, NH), 8.0‒7.97 (2 H, m, H9), 
7.83 (1 H, dd, J 8.0, 1.5, H2), 7.65‒7.51 (3 H, m, H4, H10), 7.44‒7.39 (1H, m, H11), 6.89 (1 H, td, J 7.7, 
1.6, H3); 13C NMR (100 MHz, CDCl3) δ: 165.4 (C7), 139.0 (C6), 138.4 (C2), 134.7 (C8), 132.3 (C11), 
129.6 (C4), 129.1 (C10), 127.3 (C9), 126.2 (C3), 121.9 (C5), 90.3 (C1). Data in accordance with 
literature.205 
Pent-4-en-1-yl 4-methylbenzenesulfonate (2-25a) 
To a solution of 4-penten-1-ol (1.0 g, 12 mmol) and pyridine (1.9 
mL, 23 mmol) in CH2Cl2 (12 mL) was added p-toluenesulfonyl 
chloride (3.3 g, 17 mmol) at 0 °C. The reaction mixture was stirred 
at 0 °C for 3 h then at RT for a further 1 h. H2O (9 mL) was added 
and the mixture was extracted with Et2O (20 mL). The organic phase was subsequently extracted with 
2 M HCl, 5% Na2CO3 and H2O. The combined organic phases were dried over MgSO4, filtered and 
concentrated in vacuo. The crude product was purified by column chromatography (10% Et2O in petrol) 
to yield 2-25a (2.7 g, 96%) as a colourless oil. 1H NMR (400 MHz, CDCl3) δ: 7.79 (2 H, d, J 8.2, H2), 
7.35 (2 H, d, J 8.2, H3), 5.69 (1 H, ddt, J 18.2, 9.6, 6.7,  H9), 4.99‒4.96 (1 H, m, H10), 4.95‒4.93 (1 H, 
m, H10), 4.04 (2 H, t, J 6.4, H6), 2.45 (3 H, s, H5), 2.11‒2.06 (2 H, m, H8), 1.78‒1.71 (2 H, m, H7); 
13C NMR (100 MHz, CDCl3) δ: 144.8 (C1), 136.7 (C4), 133.3 (C9), 129.9 (C3), 128.0 (C2), 115.6 
(C10), 69.9 (C6), 29.5 (C8), 28.1 (C7), 21.8 (C5). Data in accordance with literature.206 
N-(2-Iodophenyl)-N-(pent-en-1-yl)benzamide (2-26) 
To a flame-dried Schlenk tube was added NaH (0.19 g, 60% dispersion 
in mineral oil, 4.6 mmol) and THF (20 mL). The suspension was cooled 
to 0 °C and N-(2-iodophenyl)benzamide 2-25 (1.0 g, 3.1 mmol) was 
added dropwise as a solution in THF (10 mL). The reaction was warmed 
to RT and stirred for 3 h. A solution of pent-4-enyl tosylate 2-25a (0.82 
g, 3.4 mmol) in THF (2 mL) was added to the mixture and stirred at reflux 
for 16 h. The reaction was quenched by the slow addition of H2O (5 mL) 
and diluted with EtOAc. The aqueous phase was extracted three times 
with EtOAc and the organic phases were washed with brine. The combined organic phases were dried 
over MgSO4, filtered through celite and concentrated in vacuo. The crude residue was purified by flash 
column chromatography (5 to 40% EtOAc in petrol) yielding N-(2-iodophenyl)-N-(pent-en-1-
yl)benzamide 2-26 (0.68 g, 56%). Product exists as rotamers in a 1:1 ratio. 1H NMR (400 MHz, 
CDCl3) δ: 7.83 (1 H, d, J 7.9, H2), 7.34‒7.01 (7 H, m, ArH), 6.89 (1 H, t, J 7.8, ArH), 5.87‒5.72 (1H, 
m, H15), 5.04‒4.93 (2 H, m, H16), 4.33‒4.24 (1 H, m, H12 rot ), 3.41‒3.34 (1 H, m, H12 rot), 2.19‒2.06 
(2 H, m, CH2), 1.93‒1.83 (1 H, m, H13 rot), 1.78‒1.66 (1 H, m, H13 rot); 13C NMR (100 MHz, CDCl3) 
δ: 170.5 (C7), 145.3 (C6) 140.5 (C2), 137.9 (C15), 136.2 (C6) 131.6 (C8), 129.7 (C11 rot), 129.6 (C11 
rot), 129.2 (C10 rot), 129.1 (C10 rot), 128.8 (C9 rot), 128.3 (C9 rot), 127.9 (C4 rot), 127.8 (C3), 127.7 (C5), 
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115.3 (C16), 100.2 (C1), 49.4 (C12), 31.4 (C14 rot), 31.3 (C14 rot), 27.0 (C13 rot), 26.5 (C13 rot). Data in 
accordance with literature.207 
 
N-(2-Allylphenyl)-N-pent-4-en-1-yl)benzamide (2-27) 
To a flame-dried Young’s tube was added Pd(OAc)2 (0.02 g, 0.1 mmol, 
4 mol%), PPh3 (0.11 g, 0.41 mmol, 4 eq. with respect to Pd) and LiCl 
(0.12 g, 2.8 mmol). Dimethylacetamide (2 mL) was added and the 
mixture was stirred at RT for 20 min to generate the catalyst. To the 
yellow solution was added N-(2-iodophenyl)-N-(pent-en-1-yl)benzamide 
2-26 (1 g, 2.6 mmol) as a solution in dimethylacetamide (2 mL), followed 
by tributylallyltin (1.2 mL, 3.8 mmol). The Young’s tube was sealed and 
heated to 100 °C for 24 h. The reaction mixture was filtered through celite and washed three times with 
5% LiCl solution and three times with 1 M KF solution. The combined organic phases were filtered 
through celite and washed once with brine. The organic phase was then dried over MgSO4, filtered and 
concentrated in vacuo. The crude product was purified by flash column chromatography (10 to 40% 
EtOAc in petrol) yielding N-(2-allylphenyl)-N-pent-4-en-1-yl)benzamide 2-27 as a yellow oil (0.68 g, 
87%). 1H NMR (400 MHz, CDCl3) δ: 7.28‒7.01 (9 H, m, ArH), 5.84‒5.65 (2 H, m, H15, H18), 5.10‒
4.93 (4 H, m, H16, H19), 4.12 (1 H, ddd, J 13.1, 10.4, 5.6, H12a), 3.49 (1 H, ddd, J 13.1, 10.4, 5.3, 
H12b), 3.34 (1 H, dd, J 15.9, 6.8, H17a), 3.17 (1 H, dd, J 15.9, 6.4, H17b), 2.15‒2.05 (2 H, m, H14), 
1.85‒1.67 (2 H, m, H13); 13C NMR (100 MHz, CDCl3) δ: 170.4 (C7), 141.6 (C6), 137.9 (C15), 137.1 
(C8), 136.3 (C1), 135.9 (C18), 130.6 (CH), 129.9 (CH), 129.6 (CH), 129.2 (CH), 128.5 (CH), 127.9 
(CH), 127.6 (CH), 117.2 (C19), 115.2 (C16), 50.1 (C12), 35.0 (C17), 31.4 (C14), 26.5 (C13). Data in 
accordance with literature.110, 207 
(Z)-Phenyl(2,3,4,7-tetrahydro-1H-benzo[b]azonin-1-yl)methanone (2-28) 
To a flame-dried Young’s tube was added Grubbs I catalyst (0.12 g, 0.14 
mmol, 10 mol%) and N-(2-allylphenyl)-N-pent-4-en-1-yl)benzamide 2-27 
(0.43 g, 1.4 mmol) as a solution in toluene (14 mL, 0.1 M). The solution was 
stirred at RT for 10 min. The Young’s tube was then sealed and heated to 60 
°C for 48 h. The reaction mixture was concentrated in vacuo and purified by 
flash column chromatography (5 to 20% EtOAc in petrol). The product was 
then recrystallised from Et2O to yield 2-28 as colourless prisms (0.21 g, 
54%). 1H NMR (500 MHz, CDCl3) δ: 7.39‒7.38 (2 H, m, ArH), 7.24‒7.22 (2 H, m, ArH), 7.18‒7.11 
(3 H, m, ArH), 6.98 (1 H, td, J 7.6, 1.6, ArH), 6.75 (1 H, dd, J 7.8, 1.3, ArH), 5.75 (1 H, td, J 10.7, 6.0, 
H16), 5.55 (1 H, td, J 10.7, 6.0, H15), 4.30‒4.26 (1 H, m, H17a), 4.19 (1 H, ddd, J 13.2, 4.4, 2.1, H12a), 
3.06‒2.19 (3 H, m, H17b, H12b, H14a), 2.87‒2.79 (1 H, m, H13a), 2.13‒2.06 (1 H, m, H14b), 1.48 (1 H, 
ttd, J 13.7, 4.3, 2.0 H13b); 13C NMR (100 MHz, CDCl3) δ: 172.5 (C7), 145.5 (C6), 137.4 (C8), 136.5 
(C1), 131.1 (ArCH), 129.9 (ArCH), 129.85 (ArCH), 129.1 (C16), 128.8 (C15), 128.11 (ArCH), 128.08 
(ArCH), 127.9 (ArCH), 127.6 (ArCH), 51.6 (C12), 31.5 (C17), 26.1 (C13), 22.6 (C14). Data in 
accordance with literature.110, 207 
 
 (2,3,4,5,6,7-Hexahydro-1H-benzo[b]azonin-1-yl)(phenyl)methanone (2-29) 
To a solution of 2-28 (173 mg, 0.62 mmol), in MeOH (8 mL) was added 
Pd/C (18 mg, 10 wt%). The suspension was stirred at RT under a hydrogen 
atmosphere for 16 h. The reaction mixture was then filtered through celite 
and washed with a mixture of EtOAc and MeOH. The filtrate was 
concentrated in vacuo and the crude product was purified by recrystallisation 
from Et2O giving 2-29 as colourless prisms (142 mg, 82%). 1H NMR (400 
MHz, CDCl3) δ: 7.23‒7.11 (6 H, m, ArH), 7.11‒7.05 (2 H, m, ArH), 6.99‒
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6.96 (1 H, m, ArH), 4.68 (1 H, ddd, J 13.7, 5.9, 4.2, H12a), 3.18 (1 H, ddd, J 13.7, 8.6, 4.2, H12b), 2.76 
(1 H, ddd, J 13.6, 11.6, 4.2, H17a), 2.32‒2.15 (2 H, m, H17a, H13a), 1.78‒1.63 (2 H, m, H13b, H16a), 
1.62‒1.36 (5 H, m, H16b, H14, H15). 13C NMR (100 MHz, CDCl3) δ: 170.4 (C7), 143.9 (C8), 140.2 
(C6), 136.7 (C1), 130.7 (ArCH), 129.2 (ArCH), 128.5 (ArCH), 128.3 (ArCH), 128.1 (ArCH), 127.5 
(ArCH), 127.3 (ArCH), 50.5 (C12), 30.1 (C17), 28.9 (C16), 26.4 (C13), 23.9 (C14), 22.2 (C15). Data 
in accordance with literature.110 
2,3,4,5,6,7-Hexahydro-1H-benzo[b]azonine (2-30)  
 
A solution of (2,3,4,5,6,7-hexahydro-1H-benzo[b]azonin-1-
yl)(phenyl)methanone 2-29 (0.16 g, 0.58 mmol) in dioxane (2 mL) and 6 M HCl 
(2 mL) was stirred in a microwave at 140 °C for 4 h. Once cooled the reaction 
was quenched with 2 M NaOH (2 mL). CH2Cl2 was added and the organic phase 
was separated. The aqueous phase was extracted three times with CH2Cl2 and the 
combined organic phases were dried over MgSO4, filtered and concentrated in vacuo. Purification by 
flash column chromatography eluting with (5% to 20% EtOAc in petrol) gave the title compound 2-30 
as a yellow oil (90 mg, 87%). Rf 0.35 (10% EtOAc/petrol).  νmax /cm-1 (film) 2922, 2800, 1462; 1H 
NMR (500 MHz, CDCl3) δ 7.15 (1 H, td, J 7.6, 1.6, H4), 7.05 (1 H, dd, J 7.6, 1.6, H2), 7.9 (1 H, dd, J 
7.6, 1.2, H5), 6.88 (1 H, td, J 7.6, 1.2, H3), 3.37‒3.35 (2 H, br, H7), 2.79‒2.76 (2 H, m, H12), 1.76‒
1.71 (2 H, br, H11), 1.55‒1.51 (6 H, br, H8, H9, H10); 13C NMR (126 MHz, CDCl3) δ 148.4 (C6), 
133.8 (C1), 130.5 (C2), 127.4 (C4), 121.5 (C3), 121.2 (C5), 50.0 (C7), 31.9 (C12), 28.9 (C11), 27.4 




Benzyl isocyanate (0.54 mL, 3.8 mmol) was added to indoline (0.53 
mL, 4.2 mmol) in CH2Cl2 (4.2 mL) at 0 °C. The reaction mixture was 
stirred at 0 °C for 10 min and then warmed to RT and stirred overnight. 
The reaction was quenched with 1 M HCl (4 mL) and the organic phase 
was washed three times with 1 M HCl. The combined aqueous phases 
were re-extracted with CH2Cl2 and the combined organic phases were dried over MgSO4, filtered and 
concentrated in vacuo to give the crude urea which was used directly in the next step without further 
purification.  
A suspension of sodium hydride (0.15 g, 3.8 mmol, 60% dispersion in mineral oil) was added to a 
suspension of the urea (0.80 g, 3.2 mmol) in THF (21 mL) at 0 °C. Iodomethane (0.30 mL, 4.8 mmol) 
was added dropwise to the resulting solution and stirred for 24 h at RT. H2O (10 mL) and 1 M NaOH 
(10 mL) were added and the aqueous phase was extracted three times with EtOAc. The combined 
organic phases were washed with brine, dried over MgSO4, filtered and concentrated in vacuo to give 
a crude residue. Purification by flash column chromatography eluting with (20% EtOAc in petrol) gave 
the title compound 2-43 as a colourless oil (0.63 g, 75%). Rf 0.21 (20% EtOAc/petrol); νmax /cm-1 (film) 
3029, 2922, 1651; The title compound was obtained as a mixture of rotamers in a 10:1 ratio, only peaks 
corresponding to the major rotamer are reported. 1H NMR (400 MHz; CDCl3) δ 7.39‒7.29 (5 H, m, 
H13, H14, H15), 7.18 (1 H, d, J 7.4, H5), 7.14 (1 H, t, J 7.8, H4), 7.00 (1 H, d, J 8.0, H2), 6.90 (1 H, t, 
J 7.4, H3), 4.53 (2 H, s, H11), 3.95 (2 H, t, J 8.3, H8), 3.05 (2 H, t, J 8.3, H7), 2.85 (3 H, s, H10); 13C 
NMR (101 MHz; CDCl3) δ 160.3 (C9), 144.5 (C1), 137.5 (C12), 131.5 (C6), 128.8 (ArCH), 128.2 
(ArCH), 127.6 (ArCH), 127.2 (C4), 125.0 (C5), 121.6 (C3), 113.6 (C2), 53.9 (C11), 50.7 (C8), 36.2 




Carbamoyl chloride formation: 
According to GP1, 5-chloroindoline (0.50 g, 3.3 mmol), triphosgene 
(0.44 g, 1.5 mmol) and pyridine (0.25 mL, 3.3 mmol) in CH2Cl2 (4.7 
mL) gave the carbamoyl chloride. Rf 0.52 (30% Et2O/n-pentane). 
Urea formation: 
According to GP2, 5-chloroindoline-1-carbamoyl chloride (0.51 g, 
2.3 mmol), N-methylbenzylamine (0.35 mL, 3.0 mmol) and 
triethylamine (0.52 mL, 3.8 mmol) in MeCN (5.9 mL) was stirred at RT for 1 h. Purification by flash 
column chromatography eluting with (10% to 60% Et2O in n-hexane) gave the title compound 2-44 as 
white solid (0.62 g, 64% over 2 steps). Rf 0.17 (30% Et2O/n-pentane); Mp 84‒86 °C (CH2Cl2/n-
pentane); νmax /cm-1 (film) 2918, 1725, 1651; 1H NMR (400 MHz; CDCl3) δ 7.38‒7.26 (5 H, m, H13, 
H14, H15), 7.12 (1 H, d, J 2.1, H5), 7.08 (1 H, dd, J 8.5, 2.1, H3), 6.92 (1 H, d, J 8.5, H2), 4.49 (2 H, 
s, H11), 3.94 (2 H, t, J 8.3, H8), 3.02 (2 H, t, J 8.3, H7), 2.82 (3 H, s, H10); 13C NMR (101 MHz; 
CDCl3) δ 160.2 (C9), 143.4 (C12), 137.3 (C1), 133.4 (C6), 128.8 (C13/C14), 128.1 (C13/C14), 127.7 
(C4), 127.1 (C15), 126.5 (C3), 125.1 (C5), 114.7 (C2), 53.8 (C11), 50.9 (C8), 36.1 (C10), 28.3 (C7); 
HRMS (ESI+) m/z C17H1835ClN2O+ requires: 301.1102; found: 301.1102. C17H1837ClN2O+ requires: 




Carbamoyl chloride formation:  
According to GP1, 1,2,3,4-tetrahydroquinoline (3.7 mL, 29 mmol), 
triphosgene (4.0 g, 14 mmol) and pyridine (2.4 mL, 29 mmol) in CH2Cl2 
(42 mL) gave the carbamoyl chloride. Rf 0.46 (30% Et2O/n-pentane) 
(N.B. The amounts described here were used to prepare a batch stock of 
the carbamoyl chloride, which was subsequently used for the synthesis of 
several urea substrates on smaller scales described below) 
Urea formation: 
According to GP2, 3,4-Tetrahydroquinoline-1(2H)-carbamoyl chloride (0.93 g, 4.8 mmol), N-
methylbenzylamine (0.70 mL, 6.2 mmol) and triethylamine (1.0 mL, 7.6 mmol) in MeCN (12 mL) were 
stirred at RT for 4 h. Purification by flash column chromatography eluting with (3% to 20% EtOAc in 
petrol) gave the title compound 2-45 as a yellow oil (1.3 g, 98%).  Rf 0.23 (20% EtOAc/petrol); νmax 
/cm-1 (film) 3026, 2932, 1643;  1H NMR (400 MHz; CDCl3) δ 7.37‒7.32 (2 H, m, ArH), 7.31‒7.26 (3 
H, m, ArH), 7.10‒7.05 (2 H, m, ArH), 6.95‒6.92 (1 H, m, H2), 6.89 (1 H, td, J 7.4, 1.2, H4), 4.45 (2 H, 
s, H12), 3.62 (2 H, t, J 6.5, H9), 2.74 (2 H, t, J 6.5, H7), 2.70 (3 H, s, H11), 1.95 (2 H, p, J 6.5, H8); 13C 
NMR (101 MHz; CDCl3) δ 161.1 (C10), 140.9 (C13), 137.6 (C1), 129.2 (ArCH), 128.7 (C14/C15), 
128.2 (C14/C15), 127.9 (ArCH), 127.5 (C6), 126.6 (ArCH), 121.9 (ArCH), 119.5 (C2), 53.7 (C12), 





Carbamoyl chloride formation:  
According to GP1, 2,3,4,5-tetrahydro-1H-benzo[b]azepine (0.50 g, 3.4 
mmol), triphosgene (0.46 g, 1.6 mmol) and pyridine (0.26 mL, 3.4 mmol) 
in CH2Cl2 (4.9 mL) gave the carbamoyl chloride. Rf 0.41 (10% 
EtOAc/petrol). 
Urea formation: 
According to GP2, 2,3,4,5-tetrahydro-1H-benzo[b]azepine-1-carbamoyl 
chloride  (0.51 g, 2.4 mmol), N-methylbenzylamine (0.36 mL, 3.2 mmol) and triethylamine (0.54 mL, 
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3.9 mmol) in MeCN (6.0 mL) was stirred at RT for 3 h. Purification by flash column chromatography 
eluting with (10% to 20% EtOAc in petrol) gave the title compound 2-46 as white solid (0.58 g, 58% 
over 2 steps). Rf 0.18 (10% EtOAc/petrol); Mp 105-106 °C (CH2Cl2/n-pentane); νmax /cm-1 (film) 3026, 
2923, 1726, 1644; 1H NMR (400 MHz; CDCl3) δ 7.33‒7.28 (2 H, m, H15), 7.26‒7.23 (1 H, m, H17), 
7.22‒7.16 (3 H, m, H5, H16), 7.12 (1 H, td, J 7.5, 1.6, H3), 7.06 (1 H, td, J 7.5, 1.6, H4), 6.95 (1 H, dd, 
J 7.5, 1.5, H2), 4.31 (2 H, s, H13), 3.72 (2 H, br, H10), 2.76‒2.72 (2 H, m, H7), 2.35 (3 H, s, H12), 
1.80‒1.74 (2 H, m, H9), 1.69‒1.60 (2 H, m, H8); 13C NMR (101 MHz; CDCl3) δ 161.6 (C11), 146.2 
(C14), 138.3 (C1), 138.0 (C6), 130.5 (C5), 128.6 (C15), 128.1 (C16), 127.28 (C17), 127.27 (C3), 125.7 
(C4), 124.8 (C2), 53.8 (C13), 48.8 (C10), 35.8 (C12), 25.3 (C7), 30.9 (C9), 26.0 (C8); HRMS (ESI+) 




Carbamoyl chloride formation:  
According to GP1, 1,2,3,4,5,6-hexahydrobenzo[b]azocine (0.50 g, 3.1 
mmol), triphosgene (0.42 g,  1.4 mmol) and pyridine (0.24 mL, 3.1 mmol) 
in CH2Cl2 (4.4 mL) gave the carbamoyl chloride. Rf 0.58 (10% 
EtOAc/petrol). 
Urea formation: 
3,4,5,6-tetrahydrobenzo[b]azocine-1(2H)-carbamoyl chloride (0.43 g, 1.9 
mmol) and 4-dimethylaminopyridine (20 mg, 0.19 mmol) were added to a 
solution of N-methylbenzylamine (0.22 mL, 1.9 mmol) and triethylamine (0.43 mL, 3.1 mmol) in 
dichloroethane (6.4 mL). The reaction mixture was stirred at reflux for 12 h. After cooling, the mixture 
was quenched with NaHCO3 and extracted with CH2Cl2. The combined organic phases were washed 
with brine, dried over MgSO4, filtered and concentrated in vacuo. Purification by flash column 
chromatography eluting with (20% EtOAc in petrol) gave the title compound 2-47 as a yellow oil (0.45 
g, 52% over 2 steps). Rf 0.21 (20% EtOAc/petrol); νmax /cm-1 (film) 2922, 2852, 1634; 1H NMR (400 
MHz; CDCl3) δ 7.28‒7.18 (6 H, m, ArH), 7.12‒7.09 (2 H, m, H16), 7.04‒7.00 (1 H, m, H4), 4.35 (2 H, 
s, H14), 3.67‒3.58 (2 H, br, H11), 2.76‒2.71 (2 H, m, H7), 2.40 (3 H, s, H13), 1.75‒1.67 (2 H, br, H10), 
1.59‒1.44 (4 H, br, H8, H9); 13C NMR (101 MHz; CDCl3) δ 163.6 (C12), 143.6 (C15), 142.0 (C1), 
138.2 (C6), 130.3 (ArC), 128.4 (C17), 127.8 (C16), 127.69 (ArCH), 127.66 (ArCH), 127.5 (ArCH), 
127.1 (ArCH), 54.6 (C11), 54.0 (C14), 35.8 (C13), 31.9 (C7), 31.8 (C10), 27.1 (C8/C9), 26.3 (C8/C9); 




Carbamoyl chloride formation:  
According to GP1, 2,3,4,5,6,7-hexahydro-1H-benzo[b]azonine (0.13 g, 0.76 
mmol), triphosgene (0.10 g, 0.35 mmol) and pyridine (60 μL, 0.76 mmol) in 
CH2Cl2 (1.1 mL) gave the carbamoyl chloride. Rf 0.58 (10% EtOAc/petrol). 
Urea formation: 
According to GP2, 2,3,4,5,6,7-hexahydro-1H-benzo[b]azonine-1-carbamoyl 
chloride (0.11 g, 0.45 mmol) N-methylbenzylamine (70 μL, 0.59 mmol) and 
triethylamine (0.10 mL, 0.73 mmol) in MeCN (1.2 mL) was stirred at RT for 
16 h. Purification by flash column chromatography eluting with (5% to 20% 
EtOAc in petrol) gave the title compound 2-48 as a colourless oil (0.10 g, 39% over 2 steps). Rf 0.36 
(20% EtOAc/petrol); νmax /cm-1 (film) 2922, 1637, 1450, 1392; 1H NMR (500 MHz, DMSO-d6, 373 
K/100 °C) δ 7.27‒7.23 (2 H, m, ArH), 7.21‒7.13 (4 H, m, ArH), 7.10‒7.08 (2 H, m, ArH), 7.05‒7.02 
(1 H, m, ArH), 4.21 (2 H, s, H15), 3.67‒3.64 (2 H, br m, H12), 2.72 (2 H, t, J 6.0, H7), 2.33 (3 H, s, 
H14), 1.72‒1.67 (2 H, m, H8/H11), 1.65‒1.60 (2 H, m, H8/H11), 1.51‒1.46 (2 H, m, H9/H10), 1.34‒
1.28 (2 H, m, H9/H10); 13C NMR (126 MHz, DMSO-d6, 373 K/100 °C) δ 160.5 (C13), 144.4 (C16), 
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139.7 (C1), 137.8 (C6), 130.2 (ArCH), 127.5 (ArCH), 126.9 (ArCH), 126.8 (ArCH), 126.7 (ArCH), 
126.22 (ArCH), 126.17 (ArCH), 53.0 (C15), 50.8 (C12), 35.1 (C14), 29.0 (C8), 27.4 (C7), 26.4 (C9), 




Carbamoyl chloride formation: 
According to GP1, 8-methyl-1,2,3,4-tetrahydroquinoline (0.50 g, 3.4 
mmol), triphosgene (0.46 g, 1.6 mmol) and pyridine (0.26 mL, 3.4 mmol) 
in CH2Cl2 (4.9 mL) gave the carbamoyl chloride. Rf 0.58 (30% 
EtOAc/petrol). 
Urea formation: 
According to GP2, 8-methyl-3,4-Tetrahydroquinoline-1(2H)-carbamoyl 
chloride (0.58 g, 2.7 mmol), N-methylbenzylamine (0.40 mL, 3.6 mmol) and triethylamine (0.61 mL, 
4.4 mmol) in MeCN (6.9 mL) was stirred at RT for 1 h. Purification by flash column chromatography 
eluting with (15% to 80% Et2O in n-pentane) gave the title compound 2-49 as a white solid (0.64 g, 
58% over 2 steps). Rf 0.11 (30% Et2O/n-pentane); Mp 111-112 °C (CH2Cl2/n-pentane); νmax /cm-1 (film) 
2920, 1724, 1651; 1H NMR (400 MHz; CDCl3) δ 7.34‒7.22 (5 H, m, H14, H15, H16), 7.04‒7.00 (1 H, 
m, H4), 6.98‒6.93 (2 H, m, H3, H5), 4.38 (2 H, br m, H12), 3.65‒3.55 (2 H, br, H9), 2.73‒2.61 (5 H, 
m, H11, H7), 2.12 (3 H, s, H17), 1.98‒1.87 (2 H, br m, H8); 13C NMR (101 MHz; CDCl3) δ 162.0 
(C10), 140.2 (C1), 137.9 (C13), 132.5 (C2), 131.9 (C5), 128.9 (C6), 128.7 (C15), 128.2 (C14), 127.4 
(C3), 126.3 (C16), 124.0 (C4), 53.4 (C12), 46.6 (C9), 35.5 (C11), 27.3 (C7), 24.3 (C8), 18.2 (C17); 




Carbamoyl chloride formation: 
According to GP1, 6-methoxy-1,2,3,4-tetrahydroquinoline (0.50 g, 
3.1 mmol), triphosgene (0.42 g, 1.4 mmol) and pyridine (0.25 mL, 
3.1 mmol) in CH2Cl2 (4.4 mL) gave the carbamoyl chloride. Rf 0.39 
(20% EtOAc/n-pentane). 
Urea formation: 
According to GP2, 6-methoxy-3,4-tetrahydroquinoline-1(2H)-carbamoyl chloride (0.70 g, 3.1  mmol), 
N-methylbenzylamine (0.46 mL, 4.0 mmol) and triethylamine (0.69 mL, 5.0 mmol) in MeCN (8 mL) 
were stirred at RT for 12 h. Purification by flash column chromatography eluting with (10% to 80% 
Et2O in petrol) gave the title compound 2-50 as a yellow oil (0.75 g, 78% over 2 steps). Rf 0.13 (40% 
Et2O/n-pentane); νmax /cm-1 (film) 1636, 1498, 1387, 1198, 701; 1H NMR (500 MHz; CDCl3) δ 7.37‒
7.31 (2 H, m, H14), 7.30‒7.23 (3 H, m, H15, H16), 6.90 (1 H, d, J 8.5, H2), 6.70‒6.61 (2 H, m, H3, 
H5), 4.42 (2 H, s, H12), 3.76 (3 H, s, H17), 3.60 (2 H, t, J 6.6, H9), 2.70 (3 H, t, J 6.6, H7), 2.67 (3 H, 
s, H11), 1.92 (2 H, p, J 6.6, H8); 13C NMR (126 MHz; CDCl3) δ 161.3 (C10), 154.9 (C4), 137.9 (C13), 
134.4 (C6), 129.8 (C1), 128.7 (C15), 128.1 (C14), 127.4 (C16), 121.3 (C2), 113.8 (C3), 112.4 (C5), 
55.5 (C17), 53.8 (C12), 45.7 (C9), 36.1 (C11), 27.3 (C7), 23.7 (C8);  HRMS (ESI+) m/z C19H22N2NaO2+ 













Carbamoyl chloride formation: 
According to GP1, 6-fluoro-1,2,3,4-tetrahydroquinoline (0.25 g, 1.7 
mmol), triphosgene (0.23 g, 0.76 mmol) and pyridine (0.13 mL, 1.7 
mmol) in CH2Cl2 (2.4 mL) gave the carbamoyl chloride. Rf 0.53 (20% 
EtOAc/n-pentane). 
Urea formation:  
According to GP2, 6-fluoro-3,4-tetrahydroquinoline-1(2H)-carbamoyl chloride (0.36 g, 1.7 mmol), N-
methylbenzylamine (0.25 mL, 2.2 mmol) and triethylamine (0.37 mL, 2.7 mmol) in MeCN (4.2 mL) 
was stirred at RT for 12 h. Purification by flash column chromatography eluting with (10% to 80% Et2O 
in petrol) gave the title compound 2-51 as a yellow oil (0.42 g, 85% over 2 steps).  Rf 0.11 (40% Et2O/n-
pentane); νmax /cm-1 (film) 2931, 1642, 1496, 1482, 1390, 1H NMR (400 MHz; CDCl3) δ 7.41‒7.32 (2 
H, m, H14), 7.32‒7.23 (3 H, m, H15, H16), 6.90 (1 H, dd, J 8.6, 5.0, H3), 6.82‒6.74 (2 H, m, H2, H5), 
4.44 (2 H, s, H12), 3.59 (2 H, t, J 6.7, H9), 2.71 (2 H, t, J 6.7, H7), 2.70 (3 H, s, H11), 1.97‒1.88 (2 H, 
m, H8); 13C NMR (101 MHz; CDCl3) δ 161.2 (C10), 158.0 (d, JCF 241, C4), 137.5 (C13), 136.9 (C1), 
129.8 (d, JCF 7, C6), 128.7 (C14), 128.1 (C15/C16), 127.5 (C15/C16), 121.2 (d, JCF 8, C2), 115.3 (d, 
JCF 22, C3/C5), 113.3 (d, JCF 23, C3/C5), 53.7 (C12), 45.8 (C9), 36.0 (C11), 27.1 (C7), 23.2 (C8); 19F 
NMR (376 MHz; CDCl3) δ −121.7 (td, J 8.6, 5.0, F); HRMS (ESI+) m/z C18H19FN2NaO+ requires: 




Carbamoyl chloride formation:  
According to GP1, 1,2,3,4-tetrahydroquinoline (3.7 mL, 29 mmol), 
triphosgene (4.0 g, 14 mmol) and pyridine (2.4 mL, 29 mmol) in CH2Cl2 
(42 mL) gave the carbamoyl chloride. Rf 0.46 (30% Et2O/n-pentane). 
(N.B. The amounts described here were used to prepare a batch stock of 
the carbamoyl chloride). 
Urea formation: 
According to GP2, 3,4-tetrahydroquinoline-1(2H)-carbamoyl chloride (0.30 g, 1.5 mmol), N-methyl-
1-(pyridin-2-yl)methanamine (0.25 mL, 2.0 mmol) and triethylamine (0.34 mL, 2.5 mmol) in MeCN (4 
mL) was stirred at RT for 12 h. Purification by flash column chromatography eluting with (10% to 
100% EtOAc in petrol) gave the title compound 2-57 as a yellow oil (0.42 g, 98%). Rf 0.09 (60% 
EtOAc/n-pentane); νmax /cm-1 (film) 1636, 1491, 1389, 1248, 749; 1H NMR (400 MHz; CDCl3) δ 8.55 
(1 H, ddd, J 4.9, 1.8, 1.0, H14), 7.67 (1 H, td, J 7.8, 1.8, H16), 7.33 (1 H, td, J 7.5. 1.0, H3), 7.21‒7.15 
(1 H, m, H15), 7.10‒7.05 (2 H, m, H5, H17), 7.04‒7.00 (1 H, m, H2), 6.89 (1 H, td, J 7.5, 1.4, H4), 
4.57 (2 H, s, H12), 3.68‒3.56 (2 H, m, H9), 2.79 (3 H, s, H11), 2.73 (2 H, t, J 6.7, H7), 1.99‒1.89 (2 H, 
m, H8); 13C NMR (101 MHz; CDCl3) δ 161.2 (C10), 157.9 (C13), 149.4 (C14), 140.9 (C1), 136.9 
(C16), 129.1 (C5/C17), 128.0 (C6), 126.6 (C5/C17), 122.4 (C15), 122.3 (C3), 122.0 (C4), 119.8 (C2), 
55.5 (C12), 45.8 (C9), 36.9 (C11), 27.1 (C7), 23.6 (C8); HRMS (ESI+) m/z C17H19N3NaO+ requires: 




Carbamoyl chloride formation:  
According to GP1, indoline (0.50 g, 4.2 mmol), triphosgene (0.57 g, 
1.9 mmol) and pyridine (0.33 mL, 4.2 mmol) in CH2Cl2 (6.0 mL) gave 




According to GP2, indoline-1-carbamoyl chloride (0.66 g, 3.6 mmol), (S)-N-methyl-1-phenylethan-1-
amine (0.59 mL, 4.7 mmol) and triethylamine (0.81 mL, 5.8 mmol) in MeCN (9.1 mL) was stirred at 
RT for 3 h. Purification by flash column chromatography eluting with (10% to 20% EtOAc in petrol) 
gave the title compound 2-59 as a yellow oil (0.95 g, 84% over 2 steps). Rf 0.16 (10% EtOAc/petrol); 
νmax /cm-1 (film) 2971, 2901, 1644; 1H NMR (400 MHz; CDCl3) δ 7.45‒7.36 (4 H, m, H14, H15), 7.32‒
7.27 (1 H, m, H16), 7.17 (1 H, dd, J 7.4, 1.3, H5), 7.11 (1 H, td, J 7.7, 1.3, H3), 6.92 (1 H, d, J 7.7, H2), 
6.87 (1 H, td, J 7.4, 1.3, H4), 5.53 (1 H, q, J 7.0, H11), 3.99‒3.88 (2 H, m, H8), 3.04 (2 H, t, J 8.2, H7), 
2.64 (3 H, s, H10), 1.65 (3 H, d, J 7.1, H12); 13C NMR (101 MHz; CDCl3) δ 160.3 (C9), 144.7 (C13), 
141.0 (C1), 131.5 (C6), 128.6 (C14), 127.7 (C15), 127.4 (C16), 127.1 (C3), 124.9 (C5), 121.5 (C4), 
113.6 (C2), 54.0 (C11), 50.8 (C8), 30.9 (C10), 28.4 (C7), 16.1 (C12); HRMS (ESI+) m/z C18H21N2O+ 
requires: 281.1648; found: 281.1643; [𝜶]𝑫
𝟐𝟏 −57 (c. 1.0, CHCl3); HPLC Racemic sample was prepared 
in an analogous manner using (±)-N-methyl-1-phenylethan-1-amine211 which was prepared according 
to literature procedures. 
ChiralPak AD-H column, 1 mL/min, 25 °C, 2% iPrOH/n-hexane; tR: 23.4 min (minor), 30.2 min 




















Peak # Time / min Area Height Width Area / % Symmetry 
1 23.345 271.3 5.1 0.8846 1.107 0.439 





Carbamoyl chloride formation:  
According to GP1, 1,2,3,4-tetrahydroquinoline (3.7 mL, 29 mmol), 
triphosgene (4.0 g, 14 mmol) and pyridine (2.4 mL, 29 mmol) in CH2Cl2 
(42 mL) gave the carbamoyl chloride. Rf 0.46 (30% Et2O/n-pentane). 
(N.B. The amounts described here were used to prepare a batch stock of 
the carbamoyl chloride). 
Urea formation: 
According to GP2, 3,4-tetrahydroquinoline-1(2H)-carbamoyl chloride (0.30 g, 1.5 mmol), (S)-N-
methyl-1-phenylethan-1-amine (0.29 mL, 2.0 mmol) and triethylamine (0.34 mL, 2.5 mmol) in MeCN 
(4 mL) was stirred at RT for 12 h. Purification by flash column chromatography eluting with (7% to 
60% Et2O in petrol) gave the title compound 2-60 as a colourless oil (0.44 g, 99%). Rf 0.20 (30% Et2O/n-
pentane); νmax /cm-1 (film) 2971, 2901, 1637;  1H NMR (400 MHz; CDCl3) δ 7.41−7.32 (4 H, m, H15, 
H16), 7.32‒7.24 (1 H, m, H17), 7.11‒7.02 (2 H, m, H3, H2), 6.93 (1 H, dd, J 8.1, 0.8, H5), 6.88 (1 H, 
td, J 7.4, 1.3, H4) 5.59 (1 H, q, J 7.0, H12), 3.68‒3.54 (2 H, m, H9), 2.76 (2 H, t, J 6.7, H7), 2.44 (3 H, 
s, H11), 2.06‒1.92 (2 H, m, H8), 1.57 (3 H, d, J 7.0, H13); 13C NMR (101 MHz; CDCl3) δ 161.3 (C10), 
141.1 (C14), 141.0 (C1), 129.1 (C5), 128.5 (C16), 128.0 (C6), 127.5 (C15), 127.4 (C4), 126.5 (C17), 
121.8 (C3), 119.5 (C2), 54.1 (C12), 45.9 (C9), 30.7 (C11), 27.1 (C7), 23.6 (C8), 16.0 (C13); HRMS 
m/z (ESI+) m/z C19H23N2O+ requires: 295.1805; found: 295.1791; [𝜶]𝑫
𝟐𝟏 −19 (c. 0.8, CHCl3); HPLC 
Racemic sample was prepared in an analogous manner using (±)-N-methyl-1-phenylethan-1-amine211 
which was prepared according to literature procedures. ChiralPak OD-H column, 1 mL/min, 25 °C, 3% 













Peak # Time / min Area Height Width Area / % Symmetry 
1 10.489 91.7 4.8 0.2964 1.168 0.804 
2 11.419 7759.3 312.5 0.3757 98.832 0.57 
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 (±)-N-Benzyl-N,2-dimethylindoline-1-carboxamide (2-61) 
 
Carbamoyl chloride formation: 
According to GP1, 2-methylindoline (0.15 g, 1.1 mmol), triphosgene 
(0.15 g, 0.52 mmol) and pyridine (90 μL, 1.1 mmol) in CH2Cl2 (1.6 mL) 
gave the carbamoyl chloride. Rf 0.23 (5% EtOAc/petrol). 
Urea formation: 
According to GP2, 2-methylindoline-1-carbamoyl chloride (0.18 g, 
0.92 mmol), N-methylbenzylamine (0.15 mL, 1.2 mmol) and triethylamine (0.21 mL, 1.3 mmol) in 
MeCN (2.3 mL) was stirred at RT for 12 h. Purification by flash column chromatography eluting with 
(10% to 80% Et2O in petrol) gave the title compound 2-61 as a yellow oil (0.22 g, 74% over 2 steps). 
Rf 0.25 (40% Et2O/n-pentane); νmax /cm-1 (film) 2931, 1643, 1491, 1380, 750; 1H NMR (400 MHz; 
CDCl3) δ 7.38‒7.27 (5 H, m, ArH), 7.15‒7.07 (2 H, m, ArH), 6.85 (1 H, td, J 7.6, 1.0, H3), 6.75 (1 H, 
d, J 7.6, H2), 4.71 (1 H, d, J 14.9, H12a), 4.58‒4.49 (1 H, m, H8), 4.37 (1 H, d, J 14.9, H12b), 3.18 (1 
H, dd, J 15.4, 8.6, H7a), 2.86 (3 H, s, H11), 2.67 (1 H, dd, J 15.4, 8.6, H7b), 1.42 (3 H, d, J 6.0, H9); 13C 
NMR (101 MHz; CDCl3) δ 159.6 (C10), 145.0 (C1), 137.5 (C6), 130.3 (C13), 128.8 (ArCH), 128.2 
(ArCH), 127.6 (ArCH), 127.2 (ArCH), 125.1 (ArCH), 121.1 (C3), 111.7 (C2), 58.4 (C12), 53.9 (C8), 





According to GP4 N-benzyl-N-methylindoline-1-carboxamide 2-43 (0.07 g, 0.26 
mmol), DMPU (0.17 mL, 1.3 mmol) LDA (0.27 mL, 0.53 mmol, 2.0 M) in THF 
(1.8 mL) were kept at −78 °C for 4 h. Purification by flash column 
chromatography eluting with (20% to 100% EtOAc in petrol) gave the title 
compound 2-66 as a white solid (49 mg, 70%). Rf 0.22 (80% EtOAc in petrol); 
Mp 180-183 °C (CHCl3);  νmax /cm-1 (film) 3299, 2931, 1645, 1483, 907, 723;  1H 
NMR (500 MHz; CDCl3) δ 7.38‒7.24 (8 H, m, ArH), 7.18 (1 H, dd, J 7.0, 1.9, 
H2), 6.25 (1 H, s, H11), 4.50 (1 H, br, NH), 3.38‒3.33 (1 H, m, H8a), 3.20‒3.09 (2 H, m, H8b, H7a), 
2.93 (3 H, s, H10), 2.80‒2.75 (1H, m, H7a);  13C NMR (126 MHz; CDCl3) δ 165.3 (C9), 140.7 (C1), 
138.9 (C12), 136.7 (C6), 131.2 (ArCH), 130.1 (ArCH), 128.4 (ArCH), 128.3 (ArCH), 127.2 (ArCH), 
127.0 (ArCH), 126.6 (C2), 65.6 (C11), 44.0 (C8), 36.8 (C7), 33.9 (C10); HRMS (ESI+) m/z C17H19N2O+ 




According to GP3, diisopropylamine (0.16 mL, 1.1 mmol), n-butyllithium 
(0.81 mL, 1.1 mmol, 1.4 M in THF) and THF (1.9 mL). 
Acyl shift: 
(N.B. No DMPU was required for this transformation) 
According to GP4, N-benzyl-N-methylindoline-1-carboxamide 2-43 (0.15 
g, 0.56 mmol), and LDA (see above) in THF (3.8 mL) were kept at −78 °C for 3 h. Purification by flash 
column chromatography eluting with (20% to 100% EtOAc in petrol) gave the title compound 2-67 as 
a yellow solid (99 mg, 66%). Rf 0.18 (80% EtOAc/petrol); Mp 151-153 °C (CH2Cl2/n-pentane); νmax 
/cm-1 (film); 2925, 1653, 1598, 1481, 1399; 1H NMR (500 MHz, CDCl3) δ 8.35 (1 H, d, J 7.8, H2), 
7.41‒7.34 (4 H, m, ArH), 7.32‒7.28 (1 H, m, ArH), 7.22 (1 H, t, J 7.8, H3), 7.15 (1 H, d, J 7.8, H5), 
7.03 (1 H, td, J 7.8, 1.1, H4), 4.37 (1 H, s, H10), 4.15 (1 H, td, J 10.3, 6.4, H8a), 3.76 (1 H, td, J 10.3, 
6.4, H8b), 3.17 (1 H, ddd, J 16.5, 10.4, 6.4, H7a), 3.03 (1 H, ddd, J 16.5, 10.4, 6.4, H7b), 2.43 (3 H, s, 
H11). 13C NMR (126 MHz, CDCl3) δ 170.6 (C9), 143.4 (C1), 138.2 (C12), 131.4 (C6), 129.4 (ArC), 
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128.5 (ArC), 128.4 (ArC), 128.0 (C3), 124.9 (C5), 124.4 (C4), 117.7 (C2), 67.6 (C10), 47.6 (C8), 35.1 
(C11), 28.5 (C7); HRMS (ESI+) m/z C17H19N2O+ requires: 267.1491; found: 267.1493; X-ray 
crystallography data: 
 
Bond precision:  C-C = 0.0021 A Wavelength=0.71073 
Cell: a=7.5225(10) b=16.146(3) c=11.6628(17) 
 alpha=90 beta=103.779(10) gamma=90 
Temperature: 100 K   
 Calculated Reported 
Volume 1375.8(4) 1375.8(4) 
Space group P 21/c P 1 21/c 1 
Hall group -P 2ybc -P 2ybc 
Moiety formula C17 H18 N2 O C17 H18 N2 O 
Sum formula C17 H18 N2 O C17 H18 N2 O 
Mr 266.33 266.33 
Dx,g cm-3 1.286 1.286 
Z 4 4 
Mu (mm-1) 0.081 0.081 
F000 568.0 568.0 
F000' 568.21  
h,k,lmax 9,21,15 9,21,15 
Nref 3351 3307 
Tmin,Tmax 0.956,0.976 0.597,0.746 
Tmin' 0.956  
Correction method= # Reported T Limits: Tmin=0.597 Tmax=0.746 AbsCorr = 
MULTI-SCAN 
 
Data completeness= 0.987 Theta(max)= 28.120 


























According to GP3, diisopropylamine (0.09 mL, 0.66 mmol), n-butyllithium 
(0.47 mL, 0.71 mmol, 1.4 M in THF) and THF (1.1 mL). 
Ring Expansion: 
According to GP4, N-benzyl-5-chloro-N-methylindoline-1-carboxamide 2-44 
(0.10 g, 0.33 mmol), DMPU (0.20 mL, 1.7 mmol) and LDA (see above) in 
THF (2.2 mL) were kept at −78 °C for 1 h. Purification by flash column 
chromatography eluting with (0% to 10% MeOH in CH2Cl2) gave the title compound 2-72 as a white 
solid (88 mg, 88%). Rf 0.16 (70% EtOAc/petrol); Mp 219‒220 °C (CH2Cl2/n-pentane); νmax /cm-1 
(film); 3302, 2930, 1646, 1491, 1029. 1H NMR (500 MHz; CDCl3) δ 7.37 (2 H, t, J 7.5, H14), 7.32‒
7.25 (3 H, m, H3, H2, H15), 7.22 (2 H, d, J 8.3, H13), 7.19 (1 H, s, H5), 6.19 (1 H, s, H11), 4.45 (1 H, 
br, NH), 3.38‒3.31 (1 H, m, H8a), 3.20‒3.14 (1 H, m, H8b), 3.10‒3.04 (1 H, m, H7a), 2.91 (3 H, s, H10), 
2.73 (1 H, ddd, J 15.6, 5.7, 3.2, H7b); 13C NMR (126 MHz; CDCl3) δ 165.1 (C9), 142.7 (C1), 138.6 
(C12), 135.4 (C6), 134.0 (C4), 131.6 (C2), 131.3 (C14), 128.7 (C13), 127.3 (C5), 127.1 (C3), 126.8 
(C15), 65.2 (C11), 43.7 (C8), 36.7 (C7), 34.1 (C10); HRMS (ESI+) m/z C17H1735ClN2NaO+ requires: 
323.0922; found: 323.0917. C17H1737ClN2NaO+ requires: 325.0892; found: 325.0890; X-ray 
crystallography data: 
Bond precision: C-C = 0.0017 A Wavelength=0.71073 
Cell: a=6.7936(2) b=28.5203(8) c=7.6673(2) 
 alpha=90 beta=103.0208(16) gamma=90 
Temperature: 100 K   
 Calculated Reported 
Volume 1447.39(7) 1447.38(7) 
Space group P 21/n P 1 21/n 1 
Hall group -P 2yn -P 2yn 
Moiety formula C17 H17 Cl N2 O C17 H17 Cl N2 O 
Sum formula C17 H17 Cl N2 O C17 H17 Cl N2 O 
Mr 300.78 300.77 
Dx,g cm-3 1.380 1.380 
Z 4 4 
Mu (mm-1) 0.264 0.264 
F000 632.0 632.0 
F000' 632.81  
h,k,lmax 8,37,10 8,37,10 
Nref 3464 3462 
Tmin,Tmax 0.874,0.926 0.695,0.746 
Tmin' 0.874  
Correction method= # Reported T Limits: Tmin=0.695 Tmax=0.746 AbsCorr = 
MULTI-SCAN 
 
Data completeness= 0.999 Theta(max)= 27.947 
R(reflections)= 0.0327( 3201) wR2(reflections)= 0.0855( 3462) 








According to GP4 N-benzyl-N-methyl-3,4-dihydroquinoline-1(2H)-carboxamide 
2-45 (0.11 g, 0.39 mmol), DMPU (0.24 mL, 2.0 mmol) and LDA (0.39 mL, 0.78 
mmol, 2.0 M) in THF (2.6 mL) were kept at −78 °C for 1 h. Purification by flash 
column chromatography eluting with (40% to 100% EtOAc in petrol) gave the 
title compound 2-73 as a white solid (91 mg, 83%). Rf 0.11 (90% Et2O/n-
pentane); Mp 151‒152 °C (CH2Cl2/n-pentane); νmax /cm-1 (film) 3297, 2927, 
1656; 1H NMR (400 MHz; CDCl3) δ 7.43‒7.40 (1 H, m, ArH), 7.37‒7.33 (2 H, m, ArH), 7.33‒7.30 (2 
H, m, ArH), 7.29‒7.23 (2 H, m, ArH), 7.12 (2 H, d, J 7.5, H14), 6.84 (1 H, s, H12), 4.03 (1 H, t, J 8.2, 
NH), 3.32‒3.24 (1 H, m, H9a), 3.22‒3.13 (1 H, m, H9b), 2.91‒2.85 (1 H, m, H7a), 2.83 (3 H, s, H11), 
2.76‒2.71 (1 H, m, H7b), 2.04-1.96 (1 H, m, H8a), 1.60-1.49 (1 H, m, H8b); 13C NMR (101 MHz; 
CDCl3) δ 168.6 (C10), 139.8 (C1), 138.7 (C13), 138.7 (C6), 130.5 (ArCH), 128.7 (C14), 128.5 (ArCH), 
128.5 (ArCH), 128.4 (ArCH), 127.2 (ArCH), 127.0 (ArCH), 61.5 (C12), 43.5 (C9), 31.7 (C8), 31.5 
(C11), 29.6 (C7); HRMS (ESI+) m/z C18H21N2O+ requires: 281.1648; found: 281.1649; X-ray 
crystallography data: 
Bond precision: C-C = 0.0019 A Wavelength=0.71073 
Cell: a=8.2085(6) b=8.9895(6) c=11.0786(7) 
 alpha=87.681(5) beta=83.866(5) gamma=67.212(5) 
Temperature: 100 K   
 Calculated Reported 
Volume 749.37(9) 749.37(9) 
Space group P -1 P -1 
Hall group -P 1 -P 1 
Moiety formula C18 H20 N2 O C18 H20 N2 O 
Sum formula C18 H20 N2 O C18 H20 N2 O 
Mr 280.36 280.36 
Dx,g cm-3 1.242 1.243 
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Z 2 2 
Mu (mm-1) 0.078 0.078 
F000 300.0 300.0 
F000' 300.11  
h,k,lmax 10,11,14 10,11,14 
Nref 3642 3599 
Tmin,Tmax 0.975,0.981 0.675,0.746 
Tmin' 0.975  
Correction method= # Reported T Limits: Tmin=0.675 Tmax=0.746 AbsCorr = 
MULTI-SCAN 
 
Data completeness= 0.988 Theta(max)= 28.081 
R(reflections)= 0.0440( 2727) wR2(reflections)= 0.1214( 3599) 






According to GP3, diisopropylamine (0.10 mL, 0.68 mmol), n-butyllithium 
(0.49 mL, 0.68 mmol, 1.4 M in THF) and THF (1.1 mL). 
Ring Expansion: 
According to GP4, N-benzyl-N-methyl-2,3,4,5-tetrahydro-1H-
benzo[b]azepine-1-carboxamide 2-46 (0.10 g, 0.34 mmol), DMPU (0.21 mL, 
1.7 mmol) and LDA (see above) in THF (2.3 mL) were kept at −78 °C for 1 h. 
Purification by flash column chromatography eluting with (50% EtOAc in 
petrol) gave the title compound 2-74 as a white solid (77 mg, 77%). Rf 0.41 (80% EtOAc/petrol); Mp 
229‒230 °C (CH2Cl2/n-pentane); νmax /cm-1 (film) 3352, 2925, 1611; 1H NMR (400 MHz; DMSO-d6) 
δ 7.36‒7.33 (2 H, t, J 7.5, ArH), 7.29‒7.22 (3 H, m, ArH), 7.17‒7.12 (3 H, m, H2, H15), 6.95 (1 H, d, 
J 7.8, H5), 6.71 (1 H, s, H13), 3.63‒3.54 (1 H, br, H10a), 3.17‒3.09 (1 H, br, H7a), 2.83‒2.75 (1 H, br, 
H10b), 2.74‒2.64 (1 H, br, H7b), 2.38 (3 H, s, H12), 1.92‒1.80 (1 H, br, H9a), 1.44‒1.33 (1 H, br, H9b), 
1.29‒1.20 (2 H, br, H8); 13C NMR (101 MHz; DMSO-d6) δ 161.1 (C11), 141.6 (C1), 140.4 (C14), 
135.7 (C6), 129.8 (C5), 129.6 (ArCH), 128.1 (ArCH), 127.6 (C14), 127.5 (ArCH), 126.5 (ArCH), 124.9 
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(C2), 60.0 (C13), 40.9 (C10), 31.1 (C7), 29.7 (C12), 28.3 (C9), 25.8 (C8); HRMS (ESI+) m/z 
C19H23N2O+ requires: 295.1805; found: 295.1801; X-ray crystallography data: 
Bond precision: C-C = 0.0030 A Wavelength=0.71073 
Cell: a=18.2387(5) b=36.1019(11) c=9.4070(3) 
 alpha=90 beta=90 gamma=90 
Temperature: 100 K   
 Calculated Reported 
Volume 6194.1(3) 6194.0(3) 
Space group F d d 2 F d d 2 
Hall group F 2 -2d F 2 -2d 
Moiety formula C19 H22 N2 O C19 H22 N2 O 
Sum formula C19 H22 N2 O C19 H22 N2 O 
Mr 294.39 294.38 
Dx,g cm-3 1.263 1.263 
Z 16 16 
Mu (mm-1) 0.079 0.079 
F000 2528.0 2528.0 
F000' 2528.92  
h,k,lmax 24,47,12 24,47,12 
Nref 3719[ 1971] 3697 
Tmin,Tmax 0.970,0.982 0.679,0.746 
Tmin' 0.970  
Correction method= # Reported T Limits: Tmin=0.679 Tmax=0.746 AbsCorr = 
MULTI-SCAN 
 
Data completeness= 1.88/0.99 Theta(max)= 27.919 
R(reflections)= 0.0340( 3467) wR2(reflections)= 0.0824( 3697) 











According to GP3, diisopropylamine (0.91 mL, 0.65 mmol), n-butyllithium 
(0.47 mL, 0.65 mmol, 1.4 M in THF) and THF (1.1 mL). 
Ring Expansion: 
According to GP4, N-benzyl-N-methyl-3,4,5,6-tetrahydrobenzo[b]azocine-
1(2H)carboxamide 2-47 (0.10 g, 0.32 mmol), DMPU (0.21 mL, 1.6 mmol) and 
LDA (see above) in THF (2.2 mL) were kept at −78 °C for 1 h. Purification by 
flash column chromatography eluting with (50% to 100% EtOAc in petrol) 
gave the title compound 2-75 as a white solid (81 mg, 81%). Rf 0.30 (60% EtOAc/petrol); Mp 230‒231 
°C (CH2Cl2/n-pentane); νmax /cm-1 (film) 3675, 3335, 2922, 1727, 1621; 1H NMR (500 MHz, DMSO-
d6, 373 K/100 °C) δ 7.36 (2 H, t, J 7.7, H17), 7.29‒7.25 (2 H, m, H2/H18), 7.21 (1 H, td, J 7.5, 1.5, 
H3), 7.17‒7.14 (2 H, d, J 7.1, H16), 7.09 (1 H, td, J 7.5, 1.5, H4), 6.86 (1 H, d, J 7.5, H5), 6.82 (1 H, s, 
H14), 6.68 (1 H, br, NH), 3.53‒3.47 (1 H, m, H11a), 3.24‒3.19 (1 H, m, H7a), 3.12‒3.09 (1 H, br, H11b), 
2.48 (3 H, s, H13), 2.43 (1 H, td, J 12.7, 6.1, H7b), 1.90‒1.81 (1 H, br, H9a), 1.69‒1.56 (3 H, br, H8a, 
H10), 1.54‒1.46 (1 H, br, H9b), 1.29‒1.21 (1 H, br, H8b); 13C NMR (126 MHz, DMSO-d6, 373 K/100 
°C) δ 158.8 (C12), 143.0 (C1), 140.6 (C15), 136.8 (C6) 129.9 (C5), 129.8 (C18), 127.5 (C17), 126.90 
(C16), 126.88 (C3), 125.8 (C2), 124.3 (C4), 58.9 (C14), 40.6 (C11), 31.1 (C13), 30.2 (C7), 29.2 (C8), 






According to GP4, N-benzyl-N-methyl-2,3,4,5,6,7-hexahydro-1H-
benzo[b]azonine-1-carboxamide 2-48 (50 mg, 0.16 mmol), DMPU (0.10 mL, 
0.78 mmol) and LDA (0.16 mL, 0.32 mmol, 2.0 M) in THF (1.0 mL) were 
kept at −78 °C for 1 h. Purification by flash column chromatography eluting 
with (10% to 100% EtOAc in petrol) gave the title compound 2-76 as a white 
solid (42 mg, 84%). Rf 0.36 (50% EtOAc/petrol); Mp 205‒206 °C (CH2Cl2/n-
pentane); νmax /cm-1 (film) 3300, 2925, 1621, 1539; 1H NMR (500 MHz, 
DMSO-d6, 373 K/100 °C) δ 7.34 (2 H, t, J 7.5, H18), 7.29‒7.24 (2 H, m, H2, H19), 7.20 (1 H, t, J 7.4, 
H3), 7.12 (2 H, d, J 7.5, H17), 7.06 (1 H, t, J 7.4, H4), 6.81‒6.77 (2 H, m, H5, H15), 6.50 (1 H, br s, 
NH), 3.30‒3.23 (1 H, br, H12a), 3.09 (1 H, td, J 12.5, 4.4, H7a), 2.93‒2.90 (1 H, br, H12b), 2.53 (3 H, s, 
H14), 2.37 (1 H, td, J 12.5, 5.1, H7b), 1.69‒1.46 (5 H, br, H8a, H9a, H11a, H10), 1.42‒1.29 (3 H, br, 
H8b, H9b, H11b); 
13C NMR (100 MHz, DMSO-d6, 373 K/100 °C) δ 157.7 (C13), 142.6 (C1), 140.7 (C16), 137.3 (C6), 
130.0 (C18), 129.7 (C5), 127.5 (C18), 126.9 (C3), 126.7 (C17), 125.8 (C2), 124.4 (C4), 57.8 (C15), 
40.1 (C12), 31.3 (C7), 29.4 (C14), 28.9 (C8/C9/C11), 28.4 (C8/C9/C11), 27.7 (C8/C9/C11), 21.6 (C10); 
















According to GP3, diisopropylamine (0.10 mL, 0.68 mmol), n-butyllithium (0.49 
mL, 0.68 mmol, 1.4 M in THF) and THF (1.1 mL). 
Ring Expansion: 
According to GP4, N-benzyl-N,8-dimethyl-3,4-dihydroquinoline-1(2H)-
carboxamide 2-49 (0.10 g, 0.34 mmol), DMPU (0.21 mL, 1.7 mmol) and LDA 
(see above) in THF (2.3 mL) were kept at −78 °C for 1 h. Purification by flash 
column chromatography eluting with (15% to 100% EtOAc in petrol) gave the 
title compound 2-79 as a white solid (68 mg, 68%). Rf 0.37 (70% EtOAc/petrol); Mp 134‒135 °C 
(CH2Cl2/n-pentane); νmax /cm-1 (film) 3310, 2920, 1658, 1448, 781; 1H NMR (500 MHz; DMSO-d6, 
373 K/100 °C) δ 7.34 (2 H, t, J 7.5, H15), 7.28‒7.22 (3 H, m, H14, H16), 7.12 (1 H, t, J 7.4, H4), 7.04 
(1 H, d, J 7.4, H3), 6.98 (1 H, d, J 7.4, H5), 6.02 (1 H, br, NH), 5.92 (1 H, s, H12), 3.53‒3.43 (1 H, m, 
H9a), 3.01‒2.95 (1 H, m, H9b), 2.83 (1 H, ddd, J 13.3, 9.9, 2.8, H7a), 2.71‒2.69 (3 H, m, H11), 2.61‒
2.55 (1 H, m, H7b), 2.33 (3 H, s, H17), 1.74‒1.67 (1 H, m, H8a), 1.64‒1.55 (1 H, m, H8b); 13C NMR 
(126 MHz; DMSO-d6, 373 K/ 100 °C) δ 165.3 (C10), 142.6 (C1), 140.1 (C13), 136.9 (C6), 136.7 (C2), 
129.0 (C5), 128.2 (C3), 127.8 (C4, ArCH), 127.1 (C14), 126.0 (C16), 64.5 (C12), 42.4 (C9), 36.6 (C11), 
32.6 (C7), 31.5 (C8), 21.0 (C17); 1 × aromatic (C) signal is not observed due to overlapping peaks, a 





According to GP4 N-benzyl-6-methoxy-N-methyl-3,4-dihydroquinoline-
1(2H)-carboxamide 2-50 (0.10 g, 0.32 mmol), DMPU (0.19 mL, 1.6 mmol) 
LDA (0.32 mL, 0.64 mmol,  2.0 M) in THF (2.2 mL) were kept at −78 °C 
for 1 h. Purification by flash column chromatography eluting with (20% to 
100% EtOAc in petrol) gave the title compound 2-80 as a white solid (90 
mg, 90%).  
Rf 0.20 (70% EtOAc/petrol); Mp 195‒196 °C (CH2Cl2/n-pentane); νmax /cm-1 (film) 3321, 2923, 1646, 
1607, 1447; 1H NMR (500 MHz, DMSO-d6, 373 K/100 °C)  δ 7.31 (2 H, t, J 7.0, H15), 7.22 (1 H, t, J 
7.0, H16), 7.01‒6.98 (3 H, m, ArH), 6.78 (1 H, d, J 2.6, H5), 6.74‒6.69 (1 H, m, ArH), 6.51 (1 H, s, 
H12), 6.16 (1 H, br, NH), 3.82‒3.77 (1 H, m, H9a), 3.76‒3.75 (3 H, br, H17), 3.02‒2.95 (1 H, m, H9b), 
2.72‒2.64 (2 H, br, H7), 2.63‒2.61 (3 H, br, H11), 1.71‒1.62 (1 H, br, H8a), 1.62‒1.55 (1 H, br, H8b); 
13C NMR (100 MHz, CDCl3) δ 159.0 (C10), 158.8 (C4), 142.8 (C1), 141.4 (C13), 132.0 (C6), 128.7 
(C15), 127.9 (C14), 127.0 (C16), 116.8 (C5), 111.3 (C3), 62.5 (C12), 55.6 (C17), 43.5 (C9), 34.6 (C7), 





According to GP4, N-benzyl-6-fluoro-N-methyl-3,4-dihydroquinoline-1(2H)-
carboxamide 2-51 (0.10 g, 0.34 mmol), DMPU (0.21 mL, 1.7 mmol) LDA (0.34 
mL, 0.67 mmol,  2.0 M) in THF (2.2 mL) were kept at −78 °C for 1 h. 
Purification by flash column chromatography eluting with (17% to 100% 
EtOAc in petrol) gave the title compound 2-81 as a white solid (77 mg, 77%). 
Rf 0.32 (30% EtOAc/petrol); Mp 160-161 °C (CH2Cl2/n-pentane); νmax /cm-1 
(film) 3305, 2950, 1650, 1493, 1394, 729. 1H NMR (500 MHz, CDCl3) δ 7.37 
(1 H, dd, J 8.6, 5.8, H2), 7.34‒7.30 (2 H, m, H15), 7.28‒7.22 (1 H, m, H16), 7.13‒7.06 (2 H, m, H14), 
7.03 (1 H, td, J 8.4, 2.8, H5), 6.95 (1 H, dd, J 9.6, 2.8, H3), 6.78 (1 H, s, H12), 4.16 (1 H, t, J 8.0, NH), 
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3.32‒3.13 (2 H, m, H7a, H9a), 2.89‒2.80 (1 H, m, H9b), 2.79 (3 H, s, H11), 2.70 (1 H, ddd, J 14.1, 6.2, 
2.5, H7b), 2.09‒1.92 (1 H, m, H8a), 1.62‒1.49 (1 H, m, H8b); 13C NMR (126 MHz, CDCl3) δ 168.4 
(C10), 162.5 (d, JCF 248, C4), 142.4 (d, JCF 7, C6), 138.5 (C13), 134.6 (d, JCF 3.2, C1), 130.0 (d, JCF 
6.9, C2), 128.6 (C15/C16), 128.5 (C15/C16), 127.3 (C14), 116.8 (d, JCF 20, C3), 114.0 (d, JCF 21, C5), 
61.0 (C12), 43.4 (C9), 31.5 (C8), 31.3 (C11), 29.8 (C7); 19F NMR (376 MHz, CDCl3) −113.8 (m, CF3); 





According to GP4, N-benzyl-N-methyl-3,4-dihydro-1,8-naphthyridine-1(2H)-
carboxamide 2-55 (0.10 g, 0.36 mmol), DMPU (0.21 mL, 1.8 mmol) and LDA 
(0.36 mL, 0.71 mmol, 2.0 M) in THF (2.4 mL) were kept at −60 °C for 16 h. 
Purification by flash column chromatography eluting with (0% to 3% MeOH in 
CH2Cl2) gave the title compound 2-83 as an colourless oil (50 mg, 50%). Rf 0.39 
(5% MeOH/CH2Cl2); νmax /cm-1 (film) 1646, 1427, 1393, 726, 698; 1H NMR (500 
MHz; CDCl3) δ 8.64 (1 H, br, H2), 7.51 (1 H, d, J 7.7, H4), 7.38‒7.14 (6 H, m, 
ArH), 6.88 (1 H, s, H11), 4.07 (1 H, t, J 8.2, NH), 3.34 (1 H, td, J 13.9, 5.6, H6a), 3.26‒3.11 (1 H, m, 
H8a), 2.90 (3 H, s, H10), 2.80‒2.65 (2 H, m, H8b, H6b), 2.06 (1 H, t, J 14.9, H7a), 1.51 (1 H, t, J 14.9, 
H7b); 13C NMR (126 MHz; CDCl3) δ 168.4 (C9), 158.8 (C1), 148.2 (C2), 137.9 (C4), 137.7 (C12), 
134.5 (C6), 129.2 (ArCH), 128.4 (ArCH), 127.3 (ArCH), 123.3 (ArCH), 60.9 (C11), 43.3 (C8), 31.7 





According to a modified procedure of GP4, N-Methyl-N-(pyridin-2-ylmethyl)-
3,4-dihydroquinoline-1(2H)-carboxamide 2-57 (0.10 g, 0.36 mmol), DMPU 
(0.20 mL, 1.6 mmol) and LDA (0.34 mL, 0.68 mmol, 2.0 M) in THF (2.3 mL) 
were kept at −78 °C for 30 min, before warming to −30 °C for 16 h. Purification 
by flash column chromatography eluting with (0% to 4% MeOH in CH2Cl2) gave 
the title compound 2-84 as a yellow solid (59 mg, 59%). Rf 0.37 (70% 
EtOAc/petrol); Mp 175‒176 °C (CH2Cl2/n-pentane);  νmax /cm-1 (film) 3243, 
2935, 1659, 1428, 1392; 1H NMR (500 MHz; CDCl3) δ 8.64 (1 H, ddd, J 4.9, 1.9, 1.0, H14), 7.63 (1 
H, td, J 7.5, 1.9, H16), 7.53‒7.47 (1 H, m, H17), 7.35‒7.29 (2 H, m, ArH), 7.25‒7.19 (2 H, m, ArH), 
7.19‒7.16 (1 H, m, ArH), 6.80 (1 H, br s, H12), 4.11 (1 H, s, NH), 3.35‒3.22 (1 H, m, H7a), 3.22‒3.16 
(1 H, m, H9a), 2.97‒2.85 (1 H, m, H9b), 2.81 (3 H, s, H11), 2.78‒2.68 (1 H, m, H7b), 2.08‒1.96 (1 H, 
m, H8a), 1.58 (1 H, ddddd, J 14.5, 12.5, 6.2, 4.3, 2.3, H8b); 13C NMR (126 MHz; CDCl3) δ 168.3 (C10), 
158.3 (C13), 149.6 (C14), 139.9 (C1), 138.2 (C6), 136.5 (C16), 130.5 (ArCH), 129.2 (ArCH), 128.5 
(ArCH), 126.8 (ArCH), 123.7 (ArCH), 122.1 (ArCH), 63.6 (C12), 43.4 (C9), 32.1 (C11), 31.9 (C8), 
















According to GP3, diisopropylamine (0.10 mL, 0.71 mmol), n-butyllithium (0.51 
mL, 0.71 mmol, 1.4 M in THF) and THF (1.2 mL). 
Ring Expansion: 
According to GP4, (S)-N-methyl-N-(1-phenylethyl)indoline-1-carboxamide 2-59 
(0.10 g, 0.36 mmol), DMPU (0.22 mL, 1.8 mmol) and LDA (see above) in THF 
(1.2 mL) were kept at −78 °C for 4 h. Purification by flash column 
chromatography eluting with (20% to 100% EtOAc in petrol) gave the title 
compound 2-89 as a colourless oil (89 mg, 89%). Rf 0.11 (30% EtOAc/petrol); νmax /cm-1 (film) 3331, 
2972, 1623, 1522, 1244; 1H NMR (400 MHz; CDCl3) δ 7.25‒7.22 (4 H, m, ArH), 7.20‒7.15 (4 H, m, 
ArH), 4.66 (1 H, br, NH), 3.18‒3.02 (2 H, m, H8), 2.99‒2.90 (1 H, m, H7a), 2.76 (3 H, s, H10), 2.74‒
2.68 (1 H, m, H7b), 1.96 (3 H, s, H12); 13C NMR (101 MHz; CDCl3) δ. 164.4 (C9), 147.0 (C13), 142.7 
(C1), 139.2 (C6), 131.8 (ArCH), 129.2 (ArCH), 127.6 (ArCH), 126.9 (ArCH), 126.7 (ArCH), 126.3 
(ArCH), 68.8 (C11), 43.5 (C8), 35.6 (C7), 33.5 (C10), 32.7 (C12); HRMS (ESI+) m/z 
C18H21N2O+requires: 281.1648; found: 281.1644; [𝜶]𝑫
𝟐𝟏 +41 (c. 0.27, CHCl3); HPLC Racemic sample 
was prepared in an analogous manner using (±)-N-methyl-N-(1-phenylethyl)indoline-1-carboxamide 
(±)-8. 
ChiralPak OD-H column, 1 mL/min, 25 °C, 230 nm, 5% iPrOH/n-hexane; tR: 17.0 min (minor), 20.1 










Peak # Time / min Area Height Width Area / % Symmetry 
1 17.042 181.7 3 0.85 2.103 0.672 






According to GP4, (−)-(S)-N-Methyl-N-(1-phenylethyl)-3,4-dihydroquinoline-
1(2H)-carboxamide 2-60 (0.10 g, 0.34 mmol), DMPU (0.21 mL, 1.7 mmol) and 
LDA (0.34 mL, 0.68 mmol, 2.0 M) in THF (1.2 mL) were kept at −78 °C for 16 
h. Purification by flash column chromatography eluting with (12% to 100% 
EtOAc in petrol) gave the title compound 2-90 as a white solid (77 mg, 77%). Rf 
0.21 (50% EtOAc/petrol); Mp 125‒127 °C (CH2Cl2/n-pentane); νmax /cm-1 (film) 
1681, 1643, 1082, 1067, 1034; 1H NMR (500 MHz; DMSO-d6, 373 K/100 °C) δ 7.41‒7.34 (3 H, m, 
H16, H17), 7.33‒7.28 (2 H, m, H15) 7.24‒7.10 (2 H, m, ArH), 7.10‒7.00 (2 H, m, ArH), 6.09 (1 H, br, 
NH), 3.67‒3.29 (1 H, br, H9a), 3.10‒2.93 (2 H, m, H9b, H7a), 2.82 (3 H, s, H11), 2.51‒2.34 (1 H, br, 
H7b), 2.02 (3 H, s, H13), 1.90‒1.67 (2 H, m, H8);  
13C NMR (126 MHz; DMSO-d6, 373 K/100 °C) δ 165.1 (C10), 145.8 (C14), 143.1 (C1), 142.4 (C6), 
131.6 (ArCH), 127.3 (ArCH), 127.0 (ArCH), 126.9 (ArCH), 126.5 (ArCH), 125.2 (ArCH), 124.2 
(ArCH), 66.3 (C12), 42.8 (C9), 34.0 (C7), 33.9 (C11), 31.8 (C8), 25.9 (C13); HRMS (ESI+) m/z 
C18H20N2NaO+ requires: 303.1468; found: 303.1466; [𝜶]𝑫
𝟐𝟏 +41 (c. 0.27, CHCl3); HPLC Racemic 
sample was prepared in an analogous manner using (±)-N-methyl-N-(1-phenylethyl)-3,4-
dihydroquinoline-1(2H)-carboxamide (±)-9. ChiralPak OD-H column, 1 mL/min, 25 °C, 230 nm, 5% 











Peak # Time / min Area Height Width Area / % Symmetry 
1 11.658 2861.7 111.1 0.4294 6.613 0.579 





According to GP4, N-benzyl-N,2-dimethylindoline-1-carboxamide 2-61 (0.06 g, 
0.22 mmol), DMPU (0.14 mL, 1.1 mmol) and LDA (0.22 mL, 0.44 mmol, 2.0 M) 
in THF (1.5 mL) were kept at −78 °C for 2 h. Purification by flash column 
chromatography eluting with (40% to 100% EtOAc in petrol) gave the title 
compound 2-97 as a white solid (43 mg, 71%). Rf 0.28 (70% EtOAc/petrol); Mp 
184‒186 °C (CH2Cl2/n-pentane); νmax /cm-1 (film) 3210, 3070, 2893, 1648, 1481; 
1H NMR (400 MHz; CDCl3) δ 7.36‒7.24 (6 H, m, ArH), 7.21 (2 H, d, J 7.6, 
ArH), 7.13‒7.11 (1 H, m, ArH), 6.03 (1 H, s, H12), 3.99 (1 H, br, NH), 3.51‒3.43 (1 H, br, H8), 2.99 
(3 H, s, H11), 2.82‒2.72 (1 H, br, H7a), 2.63 (1 H, dd, J 15.5, 4.3, H7b), 1.20 (3 H, d, J 6.5, H9). 13C 
NMR (101 MHz; CDCl3) δ 163.9 (C10), 140.2 (C1), 139.8 (C13), 136.3 (C6), 131.5 (ArCH), 131.3 
(ArCH), 128.6 (ArCH), 128.5 (ArCH), 127.0 (ArCH), 126.9 (ArCH), 126.6 (ArCH), 67.6 (C12), 49.5 
(C8), 44.6 (C7), 35.0 (C11), 24.6 (C9); HRMS (ESI+) m/z C18H21N2O+ requires: 281.1648; found: 
281.1647; X-ray crystallography data: 
Bond precision: C-C = 0.0041 A Wavelength=0.71073 
Cell: a=18.6703(10) b=9.6103(5) c=18.5204(11) 
 alpha=90 beta=112.274(3) gamma=90 
Temperature: 100 K   
 Calculated Reported 
Volume 3075.1(3) 3075.1(3) 
Space group P 21/c P 1 21/c 1 
Hall group -P 2ybc -P 2ybc 
Moiety formula C18 H20 N2 O C18 H20 N2 O 
Sum formula C18 H20 N2 O C18 H20 N2 O 
Mr 280.36 280.36 
Dx,g cm-3 1.211 1.211 
Z 8 8 
Mu (mm-1) 0.076 0.076 
F000 1200.0 1200.0 
F000' 1200.44  
h,k,lmax 24,12,24 24,12,24 
Nref 7344 7202 
Tmin,Tmax 0.957,0.985 0.621,0.746 
Tmin' 0.957  
Correction method= # Reported T Limits: Tmin=0.621 Tmax=0.746 AbsCorr = 
MULTI-SCAN 
 
Data completeness= 0.981 Theta(max)= 27.868 
R(reflections)= 0.0620( 4758) wR2(reflections)= 0.1240( 7202) 




tert-Butyl N-(indoline-1-carbonyl)-N-methylglycinate (2-224) 
 
According to GP5, sarcosine tert-butyl ester hydrochloride (0.55 g, 3.0 
mmol) was dissolved in MeCN (6.9 mL) and triethylamine (1.0 mL, 
7.2 mmol) was added dropwise. Indoline-1-carbamoyl chloride 2-41 
(0.5 g, 2.8 mmol) was dissolved in a small amount of MeCN and added 
dropwise to the reaction mixture at RT. The mixture was stirred at 
reflux for 2 h. Purification by flash column chromatography eluting 
with (10 to 40% EtOAc in petrol) gave the title compound 2-224 as a 
colourless oil (0.58 g, 73%). Rf 0.48 (40% EtOAC/petrol); νmax /cm-1 
(film) 2974, 1739, 1654, 1482; 1H NMR (400 MHz, CDCl3) δ 7.19‒7.10 (3 H, m, ArH), 6.91‒6.85 (1 
H, m, ArH), 3.98 (2 H, s, H11), 3.91 (2 H, t, J 8.2, H8), 3.04‒3.00 (2 H, m, H7), 2.99 (3 H, s, H10), 
1.49 (9 H, s, H14); 13C NMR (101 MHz, CDCl3) δ 168.9 (C12), 159.8 (C9), 144.1 (C1), 131.4 (C6), 
127.1 (ArCH), 124.8 (ArCH), 121.5 (ArCH), 113.6 (ArCH), 81.8 (C13), 52.0 (C11), 50.4 (C8), 37.7 














Ethyl N-methyl-N-(1,2,3,4-tetrahydroquinoline-1-carbonyl)glycinate (2-228) 
 
According to GP5, sarcosine ethyl ester hydrochloride (0.26 g, 1.7 mmol) was 
dissolved in MeCN (3.8 mL) and triethylamine (0.56 mL, 4.0 mmol) was added 
dropwise. 3,4-Tetrahydroquinoline-1(2H)-carbamoyl chloride 2-112 (0.3 g, 1.5 
mmol) was dissolved in a small amount of MeCN and added dropwise to the 
reaction mixture at RT. The mixture was stirred at RT for 16 h. Purification by 
flash column chromatography eluting with (10 to 40% EtOAc in petrol) gave 
the title compound 2-228 as a colourless oil (0.34 g, 80%). Rf 0.16 (20% EtOAc/ 
petrol); νmax /cm-1 (film) 2935, 1744, 1649, 1493; 1H NMR (400 MHz, CDCl3) 
δ 7.20 (1 H, d, J 8.1, H2), 7.13‒7.08 (2 H, m, H3, H5), 6.91 (1 H, td, J 7.4, 1.3, 
H4), 4.21 (2 H, q, J 7.1, H14), 4.05 (2 H, s, H12), 3.60 (2 H, t, J 6.5, H9), 2.79 
(3 H, s, H11), 2.75 (2 H, t, J 6.5, H7), 1.97 (2 H, p, J 6.5, H8), 1.29 (3 H, t, J 7.1, H15); 13C NMR (101 
MHz, CDCl3) δ 169.9 (C13), 160.7 (C10), 140.5 (C1), 128.9 (C5), 128.2 (C9), 126.6 (C3), 122.1 (C4), 
120.2 (C2), 61.1 (C14), 51.3 (C12), 45.5 (C9), 37.9 (C7), 26.9 (C11), 23.6 (C8), 14.2 (C15); HRMS 
(ESI+) m/z C15H21N2O3+ requires: 277.1547; found: 277.1559. 
 
Ethyl (1,2,3,4-tetrahydroquinoline-1-carbonyl)-L-alaninate (2-223d) 
 
According to GP5, L-alanine ethyl ester hydrochloride (0.86 g, 5.6 mmol) was 
dissolved in MeCN (13 mL) and triethylamine (1.9 mL, 13 mmol) was added 
dropwise. 3,4-Tetrahydroquinoline-1(2H)-carbamoyl chloride 2-112 (1.0 g, 5.1 
mmol) was dissolved in a small amount of MeCN and added dropwise to the 
reaction mixture at RT. The mixture was stirred to reflux for 2 h. Purification 
by flash column chromatography eluting with (10 to 50% EtOAc in petrol) gave 
the title compound 2-223d as a colourless oil (1.1 g, 78%). Rf 0.19 (30% EtOAc/ 
petrol); νmax /cm-1 (film) 2937, 1737, 1659, 1492, 1197; 1H NMR (400 MHz, 
CDCl3) δ 7.41 (1 H, d, J 8.0, H2), 7.23‒7.14 (2 H, m, H3, H5), 7.07‒7.01 (1 H, 
m H4), 5.66 (1 H, d, J 7.5, NH), 4.54 (1 H, p, J 7.2, H11), 4.20‒4.15 (2 H, m, 
H14), 3.80 (1 H, dt, J 12.5, 6.2, H9a), 3.66 (1 H, dt, J 12.5, 6.2, H9b), 2.74 (2 H, t, J 6.5, H7), 1.97‒1.86 
(2 H, m, H8), 1.37 (3 H, d, J 7.2, H12), 1.27 (3 H, t, J 7.1, H15); 13C NMR (101 MHz, CDCl3) δ 173.8 
(C13), 155.8 (C10), 139.0 (C1), 132.2 (C6), 129.5 (C3/C5), 126.6 (C3/C5), 124.3 (C4), 123.1 (C2), 
61.3 (C14), 49.5 (C11), 43.4 (C9), 27.0 (C7), 23.9 (C8), 18.7 (C12), 14.1 (C15); HRMS (ESI+) m/z 
C15H21N2O3+ requires: 277.1546; found: 277.1542; [𝜶]𝑫
𝟐𝟏 +83 (c. 0.21, CHCl3). 
 
Ethyl N-methyl-N-(1,2,3,4-tetrahydroquinoline-1-carbonyl)-L-alaninate (2-223) 
 
To a solution of ethyl (1,2,3,4-tetrahydroquinoline-1-carbonyl)-L-alaninate, 
(1.1 g, 3.8 mmol) in THF (19 mL) was added NaH (0.30 g, 7.6 mmol, 60% 
dispersion in mineral oil) at 0 °C. Methyl iodide (0.71 mL, 11 mmol) was added 
dropwise and the reaction was stirred at RT for 16 h. The reaction was quenched 
with water (5 mL) followed by 1 M NaOH (5 mL). The aqueous phase was 
extracted three times with EtOAc and the combined organic phases were dried 
over MgSO4 and filtered and concentrated in vacuo. The crude product was 
purified by flash column chromatography, eluting with (10 to 40% EtOAc in 
petrol) to give the title compound 2-223 as a yellow oil (0.64 g, 58%). Rf 0.25 
(30% EtOAc/petrol) νmax /cm-1 (film) 2987, 1738, 1646, 1375, 1066; Product 
exists as rotamers in a 2:1 ratio. Rotamers will be assigned as major and minor 
(maj+min) 1H NMR (400 MHz, CDCl3) δ 7.44 (1 H, dd, J 8.3, 1.2, H2min), 7.14‒7.06 (3 H, m, H2maj, 
H3, H5), 6.90 (1 H, ddd, J 8.2, 6.7, 2.0, H4), 4.73 (1 H, q, J 7.2, H11maj), 4.24‒4.16 (3 H, m, H11min, 
H15), 3.62‒3.55 (2 H, m, H9), 2.79‒2.72 (2 H, m, H7), 2.67 (3 H, s, H11maj), 2.62 (3 H, s, H11min), 
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2.01‒1.94 (2 H, m, H8), 1.44 (3 H, d, J 7.3, H13), 1.30 (3 H, t, J 7.1, H16maj), 1.27 (3 H, t, J 7.2, H16min); 
13C NMR (101 MHz, CDCl3) δ 174.6 (C14min), 172.1 (C14maj), 160.8 (C10maj), 160.4 (C10min), 140.7 
(C1min), 140.6 (C1maj), 128.9 (ArCHmaj), 128.8 (ArCHmin), 128.1 (C6min), 128.0 (C6maj), 126.6 (ArCHmin), 
126.4 (ArCHmaj), 122.0 (C4maj), 121.9(C4min), 120.2 (C2min), 119.9 (C2maj), 61.2 (H11min), 61.1 (H15maj), 
61.0 (H15min), 55.0 (H11maj), 45.5 (H9maj), 45.0 (H9min), 32.8 (H11maj), 32.5 (H11min), 27.0 (H9min), 27.95 
(H9maj), 26.7 (H7min), 23.6 (H7maj), 23.1 (H13maj), 14.5 (H13min), 14.2 (H16maj), 14.2 (H16min); HRMS 
(ESI+) m/z C16H23N2O3+ requires: 291.1703; found: 291.1701. 
 
Methyl N-methyl-N-(1,2,3,4-tetrahydroquinoline-1-carbonyl)-L-alaninate (2-223e) 
 
According to GP5, methyl N-methyl-L-alaninate hydrochloride (0.6 g, 3.9 
mmol) was dissolved in MeCN (9 mL) and triethylamine (1.3 mL, 9.3 mmol) 
was added dropwise. 3,4-Tetrahydroquinoline-1(2H)-carbamoyl chloride 2-112 
(0.7 g, 3.6 mmol) was dissolved in a small amount of MeCN and added 
dropwise to the reaction mixture at RT. The mixture was stirred at RT for 16 h. 
Purification by flash column chromatography eluting with (10 to 50% EtOAc 
in petrol) gave the title compound 2-223e as a colourless oil (0.66 g, 67%). Rf 
0.17 (30% EtOAc/petrol); νmax /cm-1 (film) 2987, 1647, 1393, 1066; 1H NMR 
(400 MHz, CDCl3) δ 7.12‒7.05 (3 H, m, H2, H3, H5), 6.90 (1 H, ddd, J 7.4, 
5.7, 2.6, H4), 4.72 (1 H, q, J 7.2, H12), 3.74 (3 H, s, H15), 3.64‒3.53 (2 H, m, H9), 2.76 (2 H, t, J 6.7, 
H7), 2.67 (3 H, s, H11), 2.01‒1.93 (2 H, m, H8), 1.45 (3 H, d, J 7.2, H13); 13C NMR (101 MHz, CDCl3) 
δ 172.7 (C14), 160.8 (C16), 140.5 (C1), 128.9 (C5), 128.2 (C6), 126.5 (C3), 122.1 (C4), 119.9 (C2), 
54.9 (C12), 52.2 (C15), 45.5 (C9), 33.0 (C11), 26.9 (C7), 23.6 (C8), 14.6 (C13); HRMS (ESI+) m/z 
C15H21N2O3+ requires: 277.1547; found: 277.1557; [𝜶]𝑫




To a solution of tert-butyl N-(indoline-1-carbonyl)-N-methylglycinate 2-224 
(0.43 g, 1.5 mmol) in CH2Cl2 (2.5 mL) was added TFA (2.5 mL) at 0 °C. The 
reaction mixture warmed to RT and stirred for 2 h. The reaction mixture was 
diluted with CH2Cl2 (8 mL) and washed three times with water. The combined 
organic phases were dried over MgSO4, filtered and concentrated in vacuo. 
The crude product was purified by flash column chromatography eluting with 
(10 to 100% EtOAc in petrol) yielding the title compound 2-234 as an orange 
oil (0.33 g, 99%). Rf 0.09 (5% MeOH/CH2Cl2); νmax /cm-1 (film) 2925, 1650, 1484, 1390; 1H NMR 
(400 MHz, CDCl3) δ 7.92 (1 H, br s, OH), 7.19‒7.10 (3 H, m, H2, H3, H5), 6.93 (1 H, td, J 7.3, 1.3, 
H4), 4.07 (2 H, s, H11), 3.96 (2 H, t, J 8.2, H8), 3.06 (2 H, t, J 8.2, H7), 3.02 (3 H, s, H10); 13C NMR 
(101 MHz, CDCl3) δ 172.9 (C12), 160.7 (C9), 143.2 (C1), 131.7 (C6), 127.2 (C5), 125.0 (C3), 122.4 
(C4), 114.2 (C2), 51.9 (C11), 50.6 (C8), 38.1 (C10), 28.2 (C7); HRMS (ESI+) m/z C12H14N2NaO3+ 




According to GP5, sarcosine tert-butyl ester hydrochloride (0.51 g, 2.8 mmol) 
was dissolved in MeCN (6.4 mL) and triethylamine (0.93 mL, 6.6 mmol) was 
added dropwise. 3,4-Tetrahydroquinoline-1(2H)-carbamoyl chloride 2-112 (0.5 
g, 2.6 mmol) was dissolved in a small amount of MeCN and added dropwise to 
the reaction mixture at RT. The mixture was stirred at reflux for 3 h. Purification 
by flash column chromatography eluting with (10 to 40% EtOAc in petrol) gave 
the tert-butyl ester as a colourless oil.  
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To a solution of the tert-butyl ester (0.6 g, 2.0 mmol) in CH2Cl2 (3.3 mL) was added TFA (3.3 mL) at 
0 °C. The reaction mixture warmed to RT and stirred for 3 h. The reaction mixture was diluted with 
CH2Cl2 (9 mL) and washed three times with water. The combined organic phases were dried over 
MgSO4, filtered and concentrated in vacuo. The crude product was purified by flash column 
chromatography eluting with (10 to 100% EtOAc in petrol) yielding the title compound 2-235 as an off-
white sticky oil (0.35 g, 71%). Rf  0.13 (5% MeOH/CH2Cl2); νmax /cm-1 (film) 2933, 1738, 1601, 1492, 
1397; 1H NMR (400 MHz, CDCl3) δ 7.16‒7.07 (3 H, m, H2, H3, H5), 6.97 (1 H, td, J 7.3, 1.4, H4), 
6.74 (1 H, br, OH), 4.02 (2H, s, H12), 3.65 (2 H, t, J 6.6, H9), 2.76 (2 H, t, J 6.6, H7), 2.73 (3 H, s, 
H11), 1.99 (2 H, p, J 6.6, H8); 13C NMR (101 MHz, CDCl3) δ 172.3 (C13), 161.9 (C10), 139.5 (C1), 
129.1 (C6), 129.0 (C5), 126.7 (C3), 123.2 (C4), 120.5 (C2), 52.4 (C12), 45.6 (C9), 38.2 (C11), 26.8 




Following literature procedure,115 ethanolic MeNH2 (57 mL, 460 mmol) was added 
to L-alanine ethyl ester hydrochloride (10 g, 65 mmol) and the reaction mixture was 
stirred at RT for 16 h. The solvent was removed in vacuo and the crude product was 
dissolved in CHCl3 and washed with aq. 3.8 M K2CO3 solution. The aqueous phase 
was extracted three times with chloroform and the combined organic phases were dried over MgSO4 
and filtered. The solvent was removed in vacuo yielding the title compound 2-244 as pale yellow oil 
(3.8 g, 58%). 1H NMR (400 MHz, CDCl3) δ 7.33 (1 H, br s, NH), 3.30 (1 H, q, J 7.0, H1), 2.62 (3 H, 
d, J 5.0, H4), 1.43 (2 H, br s, NH2), 1.14 (3 H, d, J 7.0, H2); 13C NMR (101 MHz, CDCl3) δ 176.5 (C3), 
50.6 (C1), 25.6 (C4), 21.6 (C2). Data in accordance with literature.208 
 
(5S)-2-(tert-Butyl)-3,5-dimethyl-4-oxoimidazolidine-1-carbamoyl chloride (2-246) 
 
To a solution of (S)-2-amino-N-methylpropanamide 2-244 (2.0 g, 20 mmol) in 
anhydrous toluene (30 mL) was added molecular sieves (3 Å), pivalaldehyde (2.3 
mL, 22 mmol) and p-toluenesulfonic acid monohydrate (0.56 g, 2.9 mmol). The 
reaction mixture was stirred at reflux overnight. The reaction mixture was filtered 
and quenched by slow addition of sat. NaHCO3 until pH >9. The organic phase was 
separated, and the aqueous phase was extracted three times with CH2Cl2. The 
combined organic phases were dried over MgSO4, filtered and concentrated in vacuo. The crude product 
was dissolved in anhydrous CH2Cl2 (3.3 mL) and added dropwise to a solution of triphosgene (1.8 g, 
6.0 mmol) and 2,6-lutidine (1.9 mL, 16 mmol) in anhydrous CH2Cl2 (6.7 mL) at −78 °C. After 15 min, 
the reaction mixture was warmed to RT and stirred for 3 h. The reaction was quenched by addition of 
1 M HCl. The organic phase was separated, and the aqueous phase was extracted three times with 
CH2Cl2. The combined organic phases were dried over MgSO4, filtered and concentrated in vacuo. 
Purification by flash column chromatography (eluting with 1% Acetone in CH2Cl2) gave isolated 
diastereomers: cis- 2-246 (0.78 g, 15%) as a yellow oil; Rf 0.24 (1% Acetone/CH2Cl2); νmax /cm-1 (film) 
2976, 2880, 1747, 1710; 1H NMR (400 MHz, CDCl3) δ 5.10 (1 H, s, H6), 4.39 (1 H, q, J 7.0, H2), 3.01 
(3 H, s, H5), 1.61 (3 H, d, J 7.0, H3), 1.04 (9 H, s, H8); 13C NMR (101 MHz, CDCl3) δ 170.2 (C4), 
150.3 (C1), 83. 8 (C6), 58.5 (C2), 38.0 (C7), 31.6 (C5), 26.6 (C8), 17.5 (C3); HRMS m/z (ESI+) 
C10H18ClO2N2+ requires: 233.1051; found: 233.1049. trans- 2-246 (3.6 g, 69%) as a white solid; Rf 0.42 
(1% Acetone/ CH2Cl2); νmax /cm-1 (film); 2972, 2875, 1746, 1713; Product exists as rotamers in a 55:45 
ratio. Rotamers will be assigned as major and minor (maj+min) 1H NMR (400 MHz, CDCl3) δ 5.17 (1 
H, br s, H6min), 5.13 (1 H, br s, H6maj), 4.14 (1 H, br, H2), 3.05 (3 H, s, H5), 1.75 (3 H, br, H3min), 1.61 
(3 H, br, H3maj), 1.06 (9 H, s, H8maj), 1.01 (9 H, s, H8min); 13C NMR (101 MHz, CDCl3) δ 171.1 (C4), 
148.7 (C1), 83.7 (C6maj), 82.6 (C6min), 58.4 (C2maj/min), 57.3 (C2maj/min), 41.1 (C7), 32.2 (C5), 26.7 






Cis- 2-246 (0.2 g, 0.86 mmol), indoline (0.48 mL, 4.3 mmol), 2,6-lutidine 
(0.2 mL, 1.7 mmol) and KI (0.16 mg, 0.95 mmol) were reacted in 
CH2Cl2/toluene (2.5 mL, 4:1 v/v) at 60 °C for 3 h. The reaction was quenched 
with 1 M HCl and the aqueous phase was extracted three times with CH2Cl2. 
The combined organic phases were dried over MgSO4, filtered and 
concentrated in vacuo. The crude product was purified by flash column 
chromatography, eluting with (30 to 100% EtOAc in petrol) to give the title 
compound 2-248 as an off-white solid (0.22 g, 79%); Rf 0.23 (40% 
EtOAc/petrol); Mp 134‒135 °C (CH2Cl2/n-pentane); νmax /cm-1 (film) 2917, 2901, 1704, 1658, 1381; 
1H NMR (400 MHz, CDCl3) δ 7.44 (1 H, d, J 8.0, H2), 7.21‒7.15 (2 H, m, H3, H5), 6.97 (1 H, t, J 7.4, 
H4), 5.68 (1 H, s, H14), 4.09‒4.03 (3 H, m, H10, H8), 3.30‒3.20 (1 H, m, H7a), 3.11‒3.04 (1 H, m, 
H7b), 3.05 (3 H, s, H15), 1.68 (3 H, d, J 6.8, H11), 1.03 (9 H, s, H16); 13C NMR (101 MHz, CDCl3) δ 
172.7 (C12), 161.4 (C9), 144.0 (C1), 131.2 (C6), 127.2 (C3/C5), 124.7 (C3/C5), 123.1 (C4), 116.7 (C2), 
82.2 (C14), 58.4 (C10), 51.3 (C8), 36.3 (C15), 31.6 (C13), 29.1 (C7), 26.6 (C16), 20.2 (C11); HRMS 




Trans- 2-246 (0.3 g, 1.3 mmol), indoline (0.29 mL, 2.1 mmol) and 
triethylamine (0.29 mL, 2.1 mmol) were reacted in MeCN (3.2 mL) at 60 °C 
for 16 h. The reaction was quenched with sat. NaHCO3 and the aqueous 
phase was extracted three times with CH2Cl2. The combined organic phases 
were dried over MgSO4, filtered and concentrated in vacuo. The crude 
product was purified by flash column chromatography, eluting with (10 to 
100% EtOAc in petrol) to give the title compound 2-249 as a white solid 
(0.34 g, 83%). Rf 0.18 (40% EtOAC/petrol); Mp 195‒196 °C (CH2Cl2/n-
pentane); νmax /cm-1 (film) 2917, 2901, 1704, 1658, 1381; Product exists as rotamers in a 58:42 ratio. 
Rotamers will be assigned as major and minor (maj+min); 1H NMR (400 MHz, CDCl3) δ 7.68‒7.64 
(1 H, br, H2maj), 7.26‒7.17 (2 H, m, H3, H5), 7.06 (1 H, d, J 7.8, H2min), 7.00‒6.96 (1 H, m, H4), 5.58 
(1 H, s, H14min), 5.44 (1 H, s, H14maj), 4.08‒3.90 (3 H, m, H16, H8), 3.34‒2.95 (5 H, m, H7, H13), 1.39 
(3 H, d, J 6.7, H11maj), 1.14 (3 H, d, J 6.7, H11min), 1.04 (9 H, s, H16min), 0.96 (9 H, s, H9maj); 13C NMR 
(101 MHz, CDCl3) δ 172.4 (C12), 159.9 (C9), 142.8 (C1), 132.4 (C6), 127.6 (C3maj/C5maj), 127.5 
(C3maj/C5maj), 125.7(C3min/C5min), 124.7 (C3min/C5min), 123.1 (C4maj), 122.5 (C4min), 116.2 (C2maj), 112.5 
(C2min), 81.1 (C14min), 80.6 (C14maj), 56.0 (C10), 49.8 (C8maj), 48.6 (C8min), 39.5 (C15) 31.9 (C13maj), 
31.7 (C13min), 28.5 (C7maj), 27.3 (C7min), 26.1 (C16min), 25.7 (C16maj), 17.3 (C11maj), 16.7 (C11min); 





To a solution of cis- 2-246 (0.05 g, 0.16 mmol) in THF (1.6 mL) was added 
KHMDS (0.24 mL, 0.24 mmol, 1 M in THF) dropwise at 0 °C. The reaction 
mixture was stirred at 0 °C for 15 min before being warmed to RT and 
stirred for 4 h. The reaction was quenched with NH4Cl and stirred for 15 
min. The aqueous phase was extracted three times with EtOAc, dried over 
MgSO4, filtered and concentrated in vacuo. The crude product was purified 
by flash column chromatography, eluting with (30 to 80% EtOAc in petrol) 
to give the title compound 2-252 as white solid (0.45 g, 90%). Rf 0.26 (40% 
EtOAc/petrol) Mp 167‒168 °C (CH2Cl2/n-pentane); νmax /cm-1 (film) 2924, 
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2867, 1729, 1663, 1461. 1H NMR (400 MHz, CDCl3) δ 8.24 (1 H, d, J 8.0, H2), 7.72 (1 H, br, NH), 
7.53 (1 H, s, H14), 7.17 (1 H, t, J 7.5, H3), 7.11 (1 H, d, J 7.5, H5), 6.99 (1 H, t, J 7.5, H4), 3.77‒3.61 
(2 H, m, H8), 3.0‒2.89 (5 H, m, H7, H13), 1.53 (3 H, s, H11), 1.03 (9 H, s, H16); 13C NMR (101 MHz, 
CDCl3) δ 172.9 (C14), 172.7 (C12), 167.7 (C9), 143.3 (C1), 131.2 (C6), 127.4 (C3), 124.3 (C5), 124.1 
(C4), 117.8 (C2), 73.5 (C10), 46.8 (C8), 37.0 (C15), 28.4 (C7), 26.6 (C11), 26.3 (C16), 26.1 (C13). 
HRMS (ESI+) m/z C18H26N3O2+ requires: 316.2020; found: 316.2025; X-ray crystallography data: 
Bond precision: C-C = 0.0033 A Wavelength=0.71073 
Cell: a=10.4437(4) b=12.4907(4) c=13.5222(4) 
 alpha=90 beta=90 gamma=90 
Temperature: 100 K   
 Calculated Reported 
Volume 1763.96(10) 1763.96(10) 
Space group P 21 21 21 P 21 21 21 
Hall group P 2ac 2ab P 2ac 2ab 
Moiety formula C18 H25 N3 O2 C18 H25 N3 O2 
Sum formula C18 H25 N3 O2 C18 H25 N3 O2 
Mr 315.41 315.41 
Dx,g cm-3 1.188 1.188 
Z 4 4 
Mu (mm-1) 0.079 0.079 
F000 680.0 680.0 
F000' 680.26  
h,k,lmax 13,16,17 13,16,17 
Nref 4250[ 2414] 3205 
Tmin,Tmax 0.958,0.982 0.597,0.746 
Tmin' 0.954  
Correction method= # Reported T Limits: Tmin=0.597 Tmax=0.746 AbsCorr = 
MULTI-SCAN 
 
Data completeness= 1.33/0.75 Theta(max)= 27.987 
R(reflections)= 0.0392( 2951) wR2(reflections)= 0.0950( 3205) 







Carbamoyl chloride formation:  
According to GP1, 1,2,3,4-tetrahydroquinoline (3.7 mL, 29 mmol), triphosgene 
(4.0 g, 14 mmol, 0.46) and pyridine (2.4 mL, 29 mmol) in CH2Cl2 (42 mL) gave 
the carbamoyl chloride. Rf 0.46 (30% Et2O/n-pentane).  
Urea formation: 
According to a modified GP2, 3,4-Tetrahydroquinoline-1(2H)-carbamoyl 
chloride 2-112 (0.50 g, 2.56 mmol), N-Allylmethylamine (0.18 mL, 3.3 mmol) 
and triethylamine (0.57 mL, 4.1 mmol) in MeCN (6.4 mL) as stirred at RT for 16 
h. Purification by flash column chromatography eluting with (10% to 80% Et2O in n-Pentane) gave the 
title compound 2-256 as a yellow oil (0.43 g, 73%). Rf 0.20 (30% Et2O/n-pentane); νmax /cm-1 (film) 
2925, 1645, 1492, 1387, 752. 1H NMR (400 MHz; CDCl3) δ 7.11‒7.06 (2 H, m, ArH), 6.95‒6.86 (2 H, 
m, ArH), 5.82 (1 H, ddt, J 16.8, 10.8, 6.1, H13), 5.21‒5.19 (1 H, m, H14a), 5.18‒5.14 (1 H, m, H14b), 
3.86‒3.83 (2 H, m, H12), 3.60‒3.56 (2 H, m, H9), 2.76 (2 H, t, J 6.7, H7), 2.72 (3 H, s, H11), 2.00‒1.93 
(2 H, m, H7); 13C NMR (101 MHz; CDCl3) δ 161.0 (C10), 141.0 (C1), 133.7 (C13), 129.2 (ArCH), 
127.9 (C6), 126.6 (ArCH), 121.9 (ArCH), 119.7 (ArCH), 117.9 (C14), 52.7 (C12), 45.7 (C9), 35.6 




According to a modified GP2, indoline-1-carbamoyl chloride 2-41 (0.40 g, 
2.2 mmol), diallylamine (0.22 mL, 2.9 mmol) and triethylamine (0.49 mL, 
3.5 mmol) in MeCN (5.5 mL) was stirred at RT for 12 h. Purification by 
flash column chromatography eluting with (10% to 100% EtOAc in petrol) 
gave the title compound as a yellow oil (0.43 g, 80%). Rf 0.51 (10% 
EtOAc/petrol); νmax /cm-1 (film) 2921, 1650, 1481, 1396, 1242; 1H NMR 
(400 MHz; CDCl3) δ 7.20‒7.14 (2 H, m, H5, H3), 7.10 (1 H, dd, J 7.5, 1.0, 
H2), 6.91 (1 H, td, J 7.5, 1.1, H4), 5.87 (2 H, ddt, J 17.9, 9.7, 6.0, H11), 5.27‒5.20 (4 H, m, H12), 3.95‒
3.90 (6 H, H8, H10), 3.06 (2 H, t, J 8.3, H7); 13C NMR (101 MHz; CDCl3) δ 160.0 (C9), 144.5 (C1), 
134.0 (C11), 131.6 (C6), 127.2 (C3/C5), 125.0 (C5/C3), 121.8 (C4), 118.0 (C12), 113.8 (C2), 50.7 




To a flame-dried Schlenk tube was added N,N-diallylindoline-1-carboxamide 
(0.40 g, 1.7 mmol), Grubbs’ 1st generation catalyst (0.07 g, 0.08 mmol) and 
CH2Cl2 (33 mL). The reaction mixture was stirred at RT for 16 h. The solvent 
was removed in vacuo leaving the crude residue. Purification by flash column 
chromatography eluting with (10% to 100% EtOAc in petrol) gave the title 
compound 2-261 as a yellow oil (0.28 g, 78%). Rf 0.24 (20% EtOAc/petrol); 
νmax /cm-1 (film) 2857, 1647, 1623, 1482, 1385; 1H NMR (400 MHz; CDCl3) δ 7.20‒7.15 (3 H, m, H2, 
H3, H5), 6.94‒6.89 (1 H, m, H4), 5.87‒5.84 (2 H, m, H11), 4.35‒4.33 (4 H, m, H10), 3.98 (2 H, t, J 
8.3, H8), 3.11 (2 H, t, J 8.3, H7); 13C NMR (101 MHz; CDCl3) δ 158.5 (C9), 144.3 (C1), 131.4 (C6), 
127.1 (C3/C5), 125.7 (C11), 124.8 (C3/C5), 121.7 (C4), 114.9 (C2), 54.7 (C10), 50.3 (C8), 28.8 (C7). 











According to GP3, diisopropylamine (0.13 mL, 0.93 mmol), n-butyllithium 
(0.58 mL, 0.93 mmol, 1.6 M in THF) and THF (1.5 mL). 
Attempted ring Expansion: 
According to GP4, (2,5-dihydro-1H-pyrrol-1-yl)(indolin-1-yl)methanone 2-
261 (0.10 g, 0.47 mmol), DMPU (0.20 mL, 2.4 mmol) and LDA (see above) 
in THF (3.1 mL) were kept at −78 °C for 4 h. Purification by flash column 
chromatography eluting with (10% to 100% EtOAc in petrol) gave the title 
compound 2-263 as a colourless oil (32 mg, 22%). Rf 0.14 (90% 
EtOAc/petrol); νmax /cm-1 (film) 2861, 1643, 1620, 1482, 1389; 1H NMR (400 MHz; CDCl3) δ 7.27‒
7.24 (1 H, m, H2), 7.11‒7.06 (2 H, m, H3, H5), 6.82 (1 H, td, J 7.4, 1.1, H4) 5.96‒5.92 (1 H, m, 
H11/H12), 5.80‒5.66 (4 H, m, H11/H12, H13, H16, H17), 4.58‒4.50 (2 H, m, H15a, H10a), 4.32‒4.20 
(2 H, m, H15b, H16a) 4.15‒4.06 (2 H, m, H16b, H10b), 3.95‒3.88 (2 H, m, H8), 3.11‒3.02 (1 H, m, H7a), 
2.95‒2.88 (1 H, m, H7b); 13C NMR (101 MHz; CDCl3) δ 168.5 (C14), 157.7 (C9), 144.0 (C1), 131.5 
(C6), 128.6 (C11/C12), 127.3 (C3/C5), 126.0 (C11/C12/C16/C17), 125.0 (C16/C17), 124.7 (C16/C17), 
124.5 (C3/C5), 121.9 (C4), 115.1 (C2), 66.1 (C13), 55.6 (C10), 53.6 (C16), 53.1 (C15), 50.3 (C8), 28.7 




3-bromocyclohexene (1.4 g, 8.7 mmol) was added to a 50 mL RBF and cooled 
to 0 °C. Methylamine (10.8 mL, 87 mmol, 10 wt %) was added slowly and the 
reaction mixture was warmed to RT and stirred for 16 h. The reaction was 
quenched with 2 M NaOH and the aqueous phase was extracted three times 
with CH2Cl2. The combined organic phases were washed with brine, dried 
over MgSO4, filtered and concentrated in vacuo yielding N-methylcyclohex-
2-en-1-amine which was used in the next step without further purification. 
According to a modified GP2, indoline-1-carbamoyl chloride 2-41 (0.20 g, 
1.1 mmol), N-methylcyclohex-2-en-1-amine (0.16 mg, 1.4 mmol) and triethylamine (0.25 mL, 1.8 
mmol) in MeCN (2.8 mL) were stirred at RT for 4 h. Purification by flash column chromatography 
eluting with (10% to 100% EtOAc in petrol) gave the title compound 2-264 as a yellow oil (0.15 g, 
38%). Rf 0.20 (10% EtOAc/petrol); νmax /cm-1 (film) 3021, 2928, 1644, 1603, 1480; 1H NMR (400 
MHz; CDCl3) δ 7.20‒7.12 (2 H, m, H3, H5), 6.99‒6.96 (1 H, m, H2), 6.89 (1 H, td, J 7.4, 1.1, H4), 
5.99‒5.94 (1 H, m, H12/H13), 5.66‒5.62 (1 H, m, H12/H13), 4.70‒4.64 (1 H, m, H11), 3.98‒3.87 (2 
H, m, H8), 3.07‒3.03 (2 H, m, H7), 2.81 (3 H, s, H10), 2.09‒2.02 (2 H, m, H14), 2.01‒1.95 (1 H, m, 
H16a), 1.90‒1.83 (1 H, m, H15a), 1.76‒1.64 (2 H, m, H15b, H16b); 13C NMR (101 MHz; CDCl3) δ 
160.4 (C9), 144.7 (C1), 131.7 (C12/C13), 131.6 (C6), 128.9 (C12/C13), 127.1 (C3/C5), 124.9 (C3/C5), 
121.4 (C4), 113.4 (C2), 53.9 (C11), 50.7 (C8), 31.4 (C10), 28.3 (C7), 26.5 (C16), 24.8 (C14), 21.7 














According to GP4, N-(cyclohex-2-en-1-yl)-N-methylindoline-1-carboxamide 
2-264 (35 mg, 0.14 mmol), DMPU (0.08 mL, 0.68 mmol) and LDA (0.15 mL, 
0.3 mmol, 2.0 M) in THF (1.0 mL) were kept at −78 °C for 16 h. Purification 
by flash column chromatography eluting with (10% to 100% EtOAc in petrol) 
gave the title compound 2-266 as a colourless oil (12 mg, 34%). Rf 0.46 (20% 
EtOAc/petrol); νmax /cm-1 (film) 3021, 2930, 1632, 1513, 1479; 1H NMR (400 
MHz; CDCl3) δ 7.82 (1 H, d, J 8.1, H2), 7.36 (1 H, dd, J 7.7, 1.6, H5), 7.27‒
7.23 (1 H, m, H3), 7.05 (1 H, t, J 7.5, H4), 6.80 (1 H, dd, J 17.4, 11.1, H7), 
6.45 (1 H, br s, NH), 5.99‒5.93 (1 H, m, H12/H13), 5.65 (1 H, dd, J 17.4, 1.4, H8a), 5.60‒5.55 (1 H, m, 
H12/H13), 5.39 (1 H, dd, J 11.1, 1.4, H8b), 4.84‒4.76 (1 H, m, H11), 2.90 (3 H, s, H10), 2.07‒2.01 (2 
H, m, H14), 1.98‒1.91 (1 H, m, H16a), 1.87‒1.80 (1 H, m, H15a), 1.73‒1.54 (2 H, m, H15b, H16b); 13C 
NMR (101 MHz; CDCl3) δ; 155.6 (C9), 136.3 (C1), 132.9 (C7), 132.1 (C12/C13), 129.8 (C6), 128.9 
(C12/C13), 128.6 (C3), 127.0 (C5), 123.8 (C4), 122.9 (C2), 117.8 (C8), 52.8 (C11), 30.7 (C10), 27.0 
(C16), 24.7 (C14), 21.6 (C15); HRMS (ESI+) m/z C16H21N2O+ requires: 257.1648; found: 257.1660. 
 
Benzyl 3,4-tetrahydroquinoline-1-(2H)-carboxylate (2-269) 
 
Carbamoyl chloride formation:  
According to GP1, 1,2,3,4-tetrahydroquinoline (3.7 mL, 29 mmol), 
triphosgene (4.0 g, 14 mmol) and pyridine (2.4 mL, 29 mmol) in CH2Cl2 
(42 mL) gave the carbamoyl chloride. Rf 0.46 (30% Et2O/n-pentane) 
(N.B. The amounts described here were used to prepare a batch stock of 
the carbamoyl chloride). 
Carbamate formation 
According to GP6, to a suspension of NaH (0.41 g, 10 mmol) in CH2Cl2 (26 mL) was added benzyl 
alcohol (1.1 mL, 10 mmol) at 0 °C. 3,4-Tetrahydroquinoline-1(2H)-carbamoyl chloride 2-112 (1.0 g, 
5.1 mmol) was added at RT and the mixture was stirred at RT for 16 h. Purification by flash column 
chromatography eluting with (0 to 10% EtOAc in petrol) gave the title compound 2-269 (1.1 g, 81%). 
Rf 0.20 (5% EtOAc/petrol); νmax /cm-1 (film) 2945, 1702, 1492, 1392; 1H NMR (400 MHz, CDCl3) δ 
7.74 (1 H, d, J 8.3, H2), 7.43‒7.32 (5 H, m, ArH), 7.17 (1 H, td, J 7.8, 1.2, H3), 7.10 (1 H, dd, J 7.3, 
1.2, H5), 7.02 (1 H, td, J 7.3, 1.2, H4), 5.26 (2 H, s, H11), 3.83‒3.80 (2 H, m, H9), 2.79 (2 H, t, J 6.5, 
H7), 1.96 (2 H, p, J 6.5, H8); 13C NMR (101 MHz, CDCl3) δ 154.8 (C10), 138.2 (C12), 136.6 (C1), 
130.1 (C6), 128.7 (C5), 128.6 (ArCH), 128.2 (ArCH), 128.1 (ArCH), 126.1 (C3), 124.0 (C2), 123.8 
(C4), 67.6 (C11), 45.0 (C9), 27.4 (C7), 23.6 (C8); HRMS (ESI+) m/z C17H17NNaO2+ requires: 




Carbamoyl chloride formation:  
According to GP1, indoline (0.50 g, 4.2 mmol), triphosgene (0.57 g, 
1.9 mmol) and pyridine (0.33 mL, 4.2 mmol) in CH2Cl2 (6.0 mL) gave 
the carbamoyl chloride. Rf 0.42 (10% EtOAc/Petrol). 
Carbamate formation 
According to GP6, to a suspension of NaH (0.13 g, 3.3 mmol) in CH2Cl2 (8.3 mL) was added benzyl 
alcohol (0.37 mL, 10.2 mmol) at 0 °C. Indoline-1-carbamoyl chloride (0.3 g, 1.6 mmol) was added at 
RT and the mixture was stirred at RT for 16 h. Purification by flash column chromatography eluting 
with (0 to 10% EtOAc in petrol) gave the title compound (0.3 g, 72%). Rf 0.17 (5% EtOAc/petrol); νmax 
/cm-1 (film) 2919, 1704, 1602, 1487, 1408; 1H NMR (500 MHz, DMSO-d6, 373 K/100 °C) δ 7.66 (1 
H, d, J 7.9, H2), 7.46‒7.42 (2 H, m, H12), 7.42‒7.37 (2 H, m, H13), 7.36‒7.31 (1 H, m, H14), 7.20 (1 
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H, d, J 7.4, H5), 7.14 (1 H, t, J 7.9, H3), 6.96‒6.93 (1 H, m, H4), 5.26 (2 H, s, H10), 4.01 (2 H, t, J 8.7, 
H8), 3.11 (2 H, t, J 8.7, H7); 13C NMR (126 MHz, DMSO-d6, 373 K/100 °C) δ 152.0 (C9), 141.6 (C11), 
136.2 (C1), 130.9 (C6), 127.8 (C13), 127.3 (C14), 127.1 (C12), 126.5 (C3), 124.3 (C5), 121.9 (C4), 






According to GP4, benzyl 3,4-dihydroquinoline-1-(2H)-carboxylate 2-269 
(0.10 g, 0.37 mmol), DMPU (0.22 mL, 1.9 mmol), LDA (0.37 mL, 0.75 
mmol, 2.0 M) in THF (2.5 mL) were kept at −78 °C for 5 h. Purification by 
flash column chromatography eluting with (10 to 40% EtOAc in petrol) 
gave the title compound 2-273 as a colourless oil (46 mg, 29%). Rf 0.40 
(20% EtOAc/petrol); νmax /cm-1 (film) 2923, 1671, 1492, 1391.1H NMR 
(500 MHz; DMSO-d6, 373 K/100 °C) δ 7.81 (1 H, d, J 8.2, H2), 7.56 (1 H, 
d, J 7.5, H18), 7.34‒7.09 (10 H, m, ArH), 6.98 (1 H, td, J 7.4, 1.2, ArH), 
6.54 (1 H, s, H11), 3.97 (1 H, dt, J 12.9, 6.5, H25a), 3.90 (1 H, ddd, J 12.4, 
7.1, 4.9, H9a), 3.54 (1 H, ddd, J 12.4, 7.8, 4.5, H9b), 3.36‒3.30 (1 H, m, 
H25b), 2.77‒2.66 (2 H, m, H7), 2.55 (1 H, dt, J 15.8, 6.2, H23a), 2.25‒2.11 (1 H, br, H23b), 1.95‒1.88 
(1 H, m, H8a), 1.87‒1.81 (1 H, m, H8b), 1.78‒1.73 (1 H, m, H24a), 1.59 (1 H, dp, J 13.4, 6.5, H24b); 13C 
NMR (126 MHz; DMSO-d6, 373 K/ 100 °C) δ 168.5 (C16), 154.1 (C10), 139.0 (ArC), 138.4 (ArC), 
134.8 (ArC), 133.8 (ArC), 130.5 (ArC), 129.2 (ArCH), 128.9 (ArCH), 128.85 (ArCH), 128.84 (ArCH), 
128.2 (ArCH), 126.4 (ArCH), 126.0 (ArCH), 124.85 (ArCH), 124.84 (C18), 123.99 (ArCH), 123.98 
(C2), 75.0 (C11), 45.2 (C9), 43.9 (C25), 27.1 (C7), 26.0 (C23), 23.6 (C24), 23.4 (C8); HRMS (ESI+) 
m/z C27H27N2O3+ requires: 427.2016; found: 427.2018. 
 
(S)-1-Phenylethyl 3,4-tetrahydroquinoline-2(2H)-carboxylate (2-274) 
 
According to GP6, to a suspension of NaH (0.16 g, 4.1 mmol) in CH2Cl2 
(10 mL) was added (S)-(-)-1-phenylethanol (0.5 mL, 4.1 mmol) at 0 °C. 
3,4-Tetrahydroquinoline-1(2H)-carbamoyl chloride 2-112 (0.4 g, 2.0 
mmol) was added at RT and the mixture was stirred at RT for 16 h. 
Purification by flash column chromatography eluting with (0 to 10% 
EtOAc in petrol) gave the title compound 2-274 (0.47 g, 82%). Rf 0.20 
(5% EtOAc/petrol); νmax /cm-1 (film) 2930, 1700, 1492, 1383; 1H NMR 
(400 MHz, CDCl3) δ 7.71 (1 H, d, J 8.3, H2) 7.38‒7.27 (5 H, m, ArH), 7.17‒7.13 (1 H, m, H3), 7.09 (1 
H, d, J 7.4, H5), 7.01 (1 H, t, J 7.4, H4), 5.94 (1 H, q, J 6.6, H11), 3.83‒3.77 (2 H, m, H9), 2.77 (2 H, 
t, J 6.5, H7), 1.94 (2 H, p, J 6.5, H8), 1.61 (3 H, d, J 6.6, H12); 13C NMR (101 MHz, CDCl3) δ 154.3 
(C10), 142.3 (C13), 138.3 (C1), 130.2 (C6), 128.7 (C5), 128.6 (C14/C15), 127.9 (C16), 126.1 
(C14/C15), 126.0 (C3), 124.2 (C2), 123.7 (C4), 74.2 (C11), 45.0 (C9), 27.5 (C7), 23.6 (C8), 23.0 (C12); 











According to a modified GP4, to a solution of (S)-1-phenylethyl 3,4-
dihydroquinoline-2(2H)-carboxylate 2-274 (0.1 g, 0.36 mmol), in THF (4.1 mL) 
and DMPU (1.02 mL, 1:4 DMPU:THF) was added  LDA (0.45 mL, 0.89 mmol, 
2.0 M) dropwise at −78 °C. The reaction mixture was stirred for 2 h. Purification 
by flash column chromatography, eluting with (10 to 60% EtOAc in petrol) gave 
the title compound 2-275 as a white solid (35 mg, 35%). Rf 0.24 (30% 
EtOAc/petrol); Mp 130-131 °C (CH2Cl2/n-pentane); νmax /cm-1 (film) 2936, 1717, 
1447, 1391, 1057; 1H NMR (400 MHz, CDCl3) δ 7.63 (1 H, dd, J 7.6, 1.6, H2), 
7.34‒7.22 (7 H, m, H3, H4, H14, H15, H16), 7.19 (1 H, dd, J 7.4, 1.7, H5), 4.88 (1 H, t, J 6.9, NH), 
3.61 (1 H, dddd, J 14.5, 12.4, 7.5, 1.7, H9a), 2.90 (1 H, dddd, J 14.5, 6.2, 4.1, 2.6, H9b), 2.46 (1 H, ddd, 
J 13.8, 11.0, 1.6, H7a), 2.40‒2.34 (1 H, m, H7b), 2.30 (3 H, s, H12), 1.91 (1 H, dddt, J 13.8, 7.5, 3.5, 
1.7, H8a), 1.73‒1.62 (1 H, m, H8b); 13C NMR (101 MHz, CDCl3) δ 157.7 (C10), 148.1 (C13), 143.1 
(C1), 140.1 (C6), 132.8 (C5), 128.7 (C2), 128.3 (ArCH), 128.1 (ArCH), 126.7 (ArCH), 125.5 (ArCH), 
124.9 (ArCH), 85.5 (C11), 43.8 (C9), 35.6 (C8), 33.2 (C7), 32.0 (C12); HRMS (ESI+) m/z C18H20NO2+ 
requires: 282.1488; found: 282.1493; X-ray crystallography data: 
Bond precision: C-C = 0.0030 A Wavelength=0.71073 
Cell: a=18.0471(4) b=13.5717(3) c=12.2289(3) 
 alpha=90 beta=90 gamma=90 
Temperature: 100 K   
 Calculated Reported 
Volume 2995.22(12) 2995.22(12) 
Space group P c a 21 P c a 21 
Hall group P 2c -2ac P 2c -2ac 
Moiety formula C18 H19 N O2 C18 H19 N O2 
Sum formula C18 H19 N O2 C18 H19 N O2 
Mr 281.34 281.34 
Dx,g cm-3 1.248 1.248 
Z 8 8 
Mu (mm-1) 0.081 0.081 
F000 1200.0 1200.0 
F000' 1200.52  
h,k,lmax 23,17,16 23,17,16 
Nref 7204[ 3772] 7146 
Tmin,Tmax 0.961,0.973 0.643,0.746 
Tmin' 0.961  
Correction method= # Reported T Limits: Tmin=0.643 Tmax=0.746 AbsCorr = 
MULTI-SCAN 
 
Data completeness= 1.89/0.99 Theta(max)= 28.000 
R(reflections)= 0.0345( 6407) wR2(reflections)= 0.0800( 7146) 

















2-Methylbenzyl 3,4-tetrahydroquinoline-1(2H)-carboxylate (2-277) 
 
According to GP6, to a suspension of NaH (0.16 g, 4.1 mmol) in CH2Cl2 
(10 mL) was added 2-methylbenzyl alcohol (0.5 g, 4.1 mmol) at 0 °C. 
3,4-Tetrahydroquinoline-1(2H)-carbamoyl chloride 2-112 (0.4 g, 2.0 
mmol) was added at RT and the mixture was stirred at RT for 16 h. 
Purification by flash column chromatography eluting with (0 to 10% 
EtOAc in petrol) gave the title compound 2-277 (0.45 g, 78%). Rf 0.17 
(5% EtOAc/petrol); νmax /cm-1 (film) 2987, 2901, 1699, 1393, 1065; 1H 
NMR (400 MHz, CDCl3) δ 7.72 (1 H, d, J 8.3, H2), 7.39‒7.36 (1 H, m, H14), 7.27‒7.19 (3 H, m, H15, 
H16, H17), 7.17‒7.13 (1 H, m, H3), 7.09 (1 H, d, J 7.5, H5), 7.01 (1 H, td, J 7.5, 1.2, H4), 5.26 (2 H, s, 
H11), 3.81‒3.77 (2 H, m, H9), 2.78 (2 H, t, J 6.5, H7), 2.38 (3 H, s, H18), 1.95 (2 H, p, J 6.5, H8); 13C 
NMR (101 MHz, CDCl3) δ 154.8 (C10), 138.3 (C12), 136.9 (C1), 134.5 (C6), 130.4 (ArC), 130.1 
(C13), 129.1 (C14), 128.7 (C5), 128.5 (ArC), 126.1 (ArC), 126.1 (C3), 124.0 (C2), 123.8 (C4), 66.0 
(C11), 45.1 (C9), 27.5 (C7), 23.6 (C8), 19.1 (C18); HRMS (ESI+) m/z C18H19NNaO2+ requires: 




According to a modified GP4, to a solution of 2-methylbenzyl 3,4-
Tetrahydroquinoline-1(2H)-carboxylate 2-277 (0.1 g, 0.36 mmol) in THF (5 
mL) and DMPU (1.25 mL, 1:4 DMPU:THF) was added LDA (0.36 mL, 0.71 
mmol, 2.0 M) dropwise at −78 °C. The reaction stirred for 2 h at −78 °C. 
Purification by flash column chromatography, eluting with (10 to 60% EtOAc 
in petrol) gave the title compound 2-278 as a colourless oil (45 mg, 45%). Rf 
0.48 (30% EtOAc/petrol); νmax /cm-1 (film) 3399, 1652, 1023, 998; 1H NMR 
(400 MHz, CDCl3) δ 7.57 (1 H, d, J 8.0, H2), 7.29‒7.27 (1 H, m, ArH), 7.19‒
7.07 (6 H, m, ArH), 5.67 (1 H, d, J 6.7, H11), 5.39 (1 H, d, J 6.7, OH), 3.85 (1 
H, dt, J 12.7, 6.4, H9a), 3.32 (1 H, dt, J 12.7, 6.4, H9b), 2.62 (1 H, dt, J 15.9, 6.4, H7a), 2.48‒2.41 (1 H, 
m, H7b), 2.12 (3 H, s, H18), 1.87 (1 H, dp, J 13.0, 6.4, H8a), 1.63 (1 H, dp, J 13.0, 6.4, H8b). 13C NMR 
(101 MHz, CDCl3) δ 177.0 (C10), 143.6 (C1), 143.58 (C13), 140.7 (C12), 135.3 (ArCH), 133.7 (ArCH), 
132.8 (ArCH), 132.1 (ArCH), 131.0 (ArCH), 130.9 (ArCH), 130.2 (ArCH), 129.2 (C2), 73.8 (C11), 








S-Benzyl 3,4-tetrahydroquinoline-1(2H)-carbothioate (2-279) 
 
To a solution of benzyl thiol (0.58 mL, 4.9 mmol) in CH2Cl2 (10 mL) was 
added triethylamine (0.68 mL, 4.9 mmol). 3,4-hydroquinoline-1(2H)-
carbamoyl chloride 2-112 (0.8 g, 4.1 mmol) was added and the reaction 
mixture was stirred at reflux for 16 h. The mixture was washed twice with 
aq. 1 M HCl, dried over MgSO4, filtered and the solvent was removed in 
vacuo. The crude product was purified by flash column chromatography, 
eluting with (5% EtOAc in petrol) to give the title compound 2-279 as colourless oil (1.0 g, 93%). Rf 
0.48 (5% EtOAc/petrol); νmax /cm-1 (film) 2929, 1654, 1489, 1296. 1H NMR (400 MHz, CDCl3) δ 7.73 
(1 H, d, J 8.1, H2), 7.39‒7.36 (2 H, m, H13), 7.33‒7.29 (2 H, m, H14), 7.26‒7.22 (1 H, m, H15), 7.18 
(1 H, td, J 7.5, 1.9, H3), 7.15‒7.07 (2 H, m, H4, H5), 4.20 (2 H, s, H11), 3.82‒3.78 (2 H, m, H9), 2.76 
(2 H, t, J 6.6, H7), 1.99 (2 H, p, J 6.6, H8); 13C NMR (101 MHz, CDCl3) δ 168.2 (C10), 138.0 (C12), 
137.9 (C1), 131.8 (C6), 129.2 (C13), 128.8 (C4/C5), 128.7 (C14), 127.3 (C15), 126.1 (C3), 125.3 
(C4/C5), 124.9 (C2), 45.3 (C9), 35.4 (C11), 27.0 (C7), 23.8 (C8); HRMS (ESI+) m/z C17H17NNaOS+ 




To a solution of S-benzyl 3,4-dihydroquinoline-1(2H)-carbothioate 2-279 (0.1 g, 
0.35 mmol) in THF (2.35 mL) and DMPU (0.22 mL, 1.8 mmol) was added LDA 
(0.36 mL, 0.71 mmol, 2.0 M) dropwise at −78 °C. The mixture was warmed to −60 
°C and left to stir for 2 h. The reaction was quenched with propionic acid (0.08 
mL, 1.1 mmol), followed by sat. NH4Cl and warmed to RT. The aqueous phase 
was extracted three times with Et2O and the combined organic phases were washed 
three times with water and once with brine. The organic phase was dried over 
MgSO4, filtered and concentrated in vacuo. The crude product was purified by 
flash column chromatography, eluting with (0 to 20% EtOAc in petrol) to give the 
title compound 2-281 as a colourless oil (41 mg, 41%). Rf 0.19 (5% EtOAc/petrol); νmax /cm-1 (film) 
2926, 2561, 1650, 1490, 1380; 1H NMR (500 MHz; DMSO-d6, 373 K/100 °C) δ 7.40 (1 H, d, J 8.0, 
H2), 7.32‒7.12 (8 H, m, ArH), 5.41 (1 H, d, J 7.7, H11), 3.85‒3.80 (1 H, m, H9a), 3.61 (1 H, dt, J 15.5, 
6.6, H9b), 3.20 (1 H, d, J 7.7, SH), 2.66‒2.60 (1 H, m, H7a), 2.49‒2.44 (1 H, m, H7b), 1.89‒1.82 (1 H, 
m H8a), 1.81‒1.74 (1 H, m, H8b); 13C NMR (126 MHz; DMSO-d6, 373 K/ 100 °C) δ 170.3 (C10), 140.7 
(C1), 139.4 (C12), 133.6 (C6), 128.9 (ArCH), 128.7 (ArCH), 128.0 (ArCH), 127.7 (ArCH), 126.4 
(ArCH), 125.9 (ArCH), 124.8 (C2), 44.3 (C11), 44.3 (C9), 26.2 (C7), 23.8 (C8); HRMS (ESI+) m/z 
C17H18NOS+ requires: 284.1103; found: 284.1104. 
 
N-Benzyl-N,3-dimethyl-1H-indole-1-carboxamide (2-375) 
According to GP8, 3-methylindole (0.25 g, 1.9 mmol) in DMF (1 ml) was added to 
a suspension of NaH (0.15 g, 3.8 mmol) in DMF (1.0 mL) at 0 °C and stirred at 75 
°C for 3 h. Addition of benzyl(methyl)carbamoyl chloride (0.53 g, 2.9 mmol) in DMF 
(0.7 mL) and purification by flash column chromatography eluting with (5 to 20% 
EtOAc in petrol) gave the title compound 2-375 as a pale yellow solid (0.35 g, 66%). 
Rf 0.26 (10% EtOAc/petrol); Mp 80-81 °C (CH2Cl2/n-pentane); νmax /cm-1 (film) 
2917, 1673, 1451, 1394, 1336; 1H NMR (400 MHz, CDCl3) δ 7.71 (1 H, br d, J 8.2, 
H2), 7.54 (1H, d, J 7.6, H5), 7.41‒7.21 (6 H, m, H3, H14, H15, H16), 7.22 (1 H, td, 
J 7.6, 1.5, H4), 7.12 (1 H, br, H9), 4.67 (2 H, s, H12), 2.98 (3 H, s, H11), 2.29 (3 H, 
s, H8). 13C NMR (101 MHz, CDCl3) δ 155.6 (C10), 136.6 (C13), 136.2 (C1), 130.4 
(C6), 129.0 (C15), 128.1 (C14), 128.0 (C16), 123.8 (C3), 123.4 (C9), 121.6 (C4), 119.2 (C5), 115.3 
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(C7), 113.8 (C2), 54.3 (C12), 35.5 (C11), 9.8 (C8); HRMS (ESI+) m/z C18H19N2O+ requires: 279.1492; 
found: 279.1479.  
2,9-Dimethyl-1-phenyl-1,2,9,9a-tetrahydro-3H-imidazo[1,5-a]indol-3-one (2-382) 
According to general procedure GP9, N-benzyl-N,3-dimethyl-1H-indole-
1-carboxamide 2-375 (0.2 g, 0.72 mmol), DMPU (0.43 mL, 3.6 mmol) and 
LDA (0.72 mL, 1.4 mmol, 2.0 M) in THF (4.8 mL) were kept at −78 °C 
for 2 h. Purification by flash column chromatography eluting with (3 to 
30% EtOAc in petrol) afforded the title compound 2-382 as a white solid 
as a single diastereomer (0.13 g, 64%) d.r. >20:1. Rf 0.24 (20% 
EtOAc/petrol); Mp 132 °C (CH2Cl2/n-pentane); νmax /cm-1 (film) 2959, 
1709, 1478, 1390, 758; 1H NMR (400 MHz, CDCl3) δ 7.50 (1 H, br d, J 7.8, H2), 7.47‒7.43 (2 H, m, 
H13), 7.40–7.36 (3 H, m, H12, H14), 7.27‒7.23 (1 H, m, J 7.4, H3), 7.13 (1 H, br d, J 7.5, H5), 7.05 (1 
H, td J 7.2, 1.0, H4), 4.42 (1 H, d, J 6.3, H10), 3.89 (1 H, dd, J 8.7, 6.3, H9), 3.48 (1 H, p, J 7.0, H7), 
2.69 (3 H, s, H15), 1.31 (3 H, d, J 7.0, H8); 13C NMR (101 MHz, CDCl3) δ 159.6 (C16), 142.6 (C1), 
139.8 (C11), 136.7 (C6), 129.4 (C13), 128.7 (C14), 128.1 (C3), 126.9 (C12), 123.9 (C4), 123.5 (C5), 
115.9 (C2), 73.6 (C9), 69.5 (C10), 44.2 (C7), 29.2 (C15), 18.0 (C8); HRMS (ESI+) m/z C18H19N2O+, 
requires: 279.1492; found: 279.1497. 
Following GP9 on a 3.6 mmol scale, the title compound 2-382 was obtained as a white solid (0.79 g, 
79%). Spectroscopic data of 2-382 matches that previously stated for 2-382. 
Attempted asymmetric deprotonation with chiral LDA derivative 2-417:  
To a flame-dried flask was added (S)-(-)-N-Isopropyl-1-phenylethylamine hydrochloride (0.09 g, 0.43 
mmol) and THF (0.72 mL). The solution was cooled to 0 °C and n-BuLi (0.54 mL, 0.86 mmol, 1.6 M 
in hexanes) was added dropwise and stirred at 0 °C for 20 mins before immediate use. According to 
general procedure GP9, N-Benzyl-N,3-dimethyl-1H-indole-1-carboxamide 2-375 (0.06 g, 0.22 mmol), 
DMPU (0.13 mL, 1.1 mmol) and chiral LDA derivative 2-417 (as above) in THF (1.43 mL) were kept 
at −78 °C for 2 h. Purification by flash column chromatography (eluting with 3% to 30% EtOAc in 
petrol) afforded the title compound 2-382 as a white solid (0.46 g, 76%).  Spectroscopic data of 2-382 
matches that previously stated for 2-382. HPLC Racemic sample was prepared according to GP9. 








Peak # Time / min Area Height Width Area / % 
1 9.241 12261 623.55 0.299 50.6 
2 17.276 11989 278.32 0.648 49.4 
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According to GP7, 5-fluoroindole (0.5 g, 3.7 mmol), DMF (1.4 mL, 19 mmol) and 
POCl3 (0.42 mL, 4.4 mmol) were stirred at 40 °C for 2 h. 2 M NaOH solution (20 
mL) was added and the solution was stirred at 90 °C for 1 h. The crude aldehyde was 
used in the next step without purification.  
To a solution of LiAlH4 (0.21 g, 5.6 mmol) in THF (13.5 mL) was added the above 
crude aldehyde in THF (13.5 mL) dropwise at 0 °C. The reaction mixture was stirred at RT overnight. 
Purification by flash column chromatography eluting with (5 to 20% EtOAc in petrol) gave the title 
compound 2-388 (0.37 g, 66% over two steps).1H NMR (400 MHz, CDCl3) δ 7.88 (1 H, br s, NH), 
7.29‒7.23 (2 H, m, H2, H5), 7.05‒7.02 (1 H, m, H9), 6.96 (1 H, td, J 9.0, 2.5, H3), 2.33 (3 H, d, J 1.1, 
H8); 13C NMR (101 MHz, CDCl3) δ 157.9 (d, JCF 234, C4) 132.9 (C1), 128.8 (d, JCF 9.5, C6), 123.5 
(C9), 112.1 (d, JCF 4.8, C7), 111.6 (C3), 110.3 (C3), 103.9 (C5), 9.76 (C8); 19F NMR (376 MHz; CDCl3) 
δ −125.2 (td, J 9.4, 4.3, F). Data in accordance with literature.168 
5-Chloro-3-methyl-1H-indole (2-388) 
According to GP7, 5-chloroindole (1.0 g, 6.6 mmol), DMF (2.6 mL, 33 mmol) and 
POCl3 (0.74 mL, 8.0 mmol) were stirred at 40 °C for 2 h. 2 M NaOH solution (40 
mL) was added and the solution was stirred at 90 °C for 1 h. The crude aldehyde 
was used in the next step without purification.  
To a solution of LiAlH4 (0.38 g, 9.9 mmol) in THF (27 mL) was added the above 
crude aldehyde in THF (27 mL) dropwise at 0 °C. The reaction mixture was stirred at RT overnight. 
Purification by flash column chromatography eluting with (5 to 20% EtOAc in petrol) gave the title 
compound 2-388 (0.56 g, 51% over two steps). 1H NMR (400 MHz, CDCl3) δ 7.91 (1 H, br s, NH), 
7.58 (1 H, d, J 2.0, H5), 7.28 (1 H, d, J 8.5, H2), 7.17 (1 H, dd, J 8.5, 2.0, H3), 7.03‒7.0 (1 H, m, H9), 
2.33 (3 H, d, J 1.1, H8); 13C NMR (101 MHz, CDCl3) δ 134.7 (C1), 129.6 (C6), 125.0 (C4), 123.1 
(C9), 122.3 (C3), 118.5 (C5), 112.0 (C2), 111.7 (C7), 9.67 (C8). Data in accordance with literature.168 
3,5-Dimethyl-1H-indole (2-388) 
According to GP7, 5-methylindole (0.5 g, 3.8 mmol), DMF (1.5 mL, 19 mmol) 
and POCl3 (0.3 mL, 4.6 mmol) were stirred at 40 °C for 2 h. 2 M NaOH solution 
(20 mL) was added and the solution stirred at 90 °C for 1 h. The crude aldehyde 
was used in the next step without purification.  
To a solution of LiAlH4 (0.22 g, 5.7 mmol) in THF (13.5 mL) was added the above 
Peak # Time / min Area Height Width Area / % 
1 9.3 10461 494.55 0.3188 53.8 
2 17.4 8971.4 207.05 0.6495 46.2 
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crude aldehyde in THF (13.5 mL) dropwise at 0 °C. The reaction mixture was stirred at RT overnight. 
Purification by flash column chromatography eluting with (5 to 20% EtOAc in petrol) gave the title 
compound 2-388 (0.28 g, 51% over two steps). 1H NMR (400 MHz, CDCl3) δ 7.76 (1 H, br s, NH), 
7.42‒7.41 (1 H, m, H5), 7.28‒7.25 (1 H, m, H2), 7.06 (1 H, dd, J 8.2, 1.6, H3), 6.97‒6.95 (1 H, m, H9), 
2.52 (3 H, s, H10), 2.36 (3 H, d, J 1.1, H8);13C NMR (101 MHz, CDCl3) δ 134.7 (C1), 128.7 (C4), 
128.5 (C6), 123.6 (C3), 121.9 (C9), 118.6 (C5), 111.4 (C4), 110.7 (C2), 21.6 (C10), 9.79 (C8). Data in 
accordance with literature.168 
3,6-Dimethyl-1H-indole (2-388) 
According to GP7, 5-methylindole (0.5 g, 3.8 mmol), DMF (1.5 mL, 19 mmol) 
and POCl3 (0.43 mL, 4.6 mmol) were stirred at 40 °C for 2 h. 2 M NaOH solution 
(20 mL) was added and the solution stirred at 90 °C for 1 h. The crude aldehyde 
was used in the next step without purification.  
To a solution of LiAlH4 (0.21 g, 5.7 mmol) in THF (13.5 mL) was added the above 
crude aldehyde in THF (13.5 mL) dropwise at 0 °C. The reaction mixture was stirred at RT overnight. 
Purification by flash column chromatography eluting with (5 to 20% EtOAc in petrol) gave the title 
compound 2-388 (0.23 g, 41% over two steps). 1H NMR (400 MHz, CDCl3) δ 7.71 (1 H, br s, NH), 
7.47 (1 H, d, J 8.0, H5), 7.15‒7.13 (1 H, m, H2), 6.99‒6.96 (1 H, m, H4), 6.90‒6.88 (1 H, m, H9), 2.48 
(3 H, s, H10), 2.33 (3 H, d, J 0.8, H8); 13C NMR (101 MHz, CDCl3) δ 136.9 (C1), 131.8 (C3), 126.3 
(C6), 121.0 (C4, C9), 118.6 (C5), 111.7 (C7), 111.0 (C2), 21.9 (C10), 9.86 (C8). Data in accordance 
with literature.168 
3,7-Dimethyl-1H-indole (2-388) 
According to GP7, 5-methylindole (0.5 g, 3.3 mmol), DMF (1.5 mL, 19 mmol) and 
POCl3 (0.43 mL, 4.6 mmol) were stirred at 40 °C for 2 h. 2 M NaOH solution (20 mL) 
was added and the solution stirred at 90 °C for 1 h. The crude aldehyde was used in 
the next step without purification.  
To a solution of LiAlH4 (0.22 g, 5.7 mmol) in THF (13.5 mL) was added the above 
crude aldehyde in THF (13.5 mL) dropwise at 0 °C. The reaction mixture was stirred 
at RT overnight. Purification by flash column chromatography eluting with (5 to 20% EtOAc in petrol) 
gave the title compound 2-388 (0.12 g, 22% over two steps).1H NMR (400 MHz, CDCl3) δ 7.68 (1 H, 
br s, NH), 7.38‒7.36 (1 H, m, H5), 6.97 (1 H, t, J 7.4, H4), 6.93‒6.90 (1 H, m, H3), 6.89‒6.87 (1 H, m, 
H9), 2.39 (3 H, s, H10), 2.26 (3 H, d, J 1.1, H8); 13C NMR (101 MHz, CDCl3) δ 136.0 (C1), 128.0 
(C6), 122.5 (C3), 121.4 (C9), 120.2 (C2), 119.5 (C4), 116.7 (C5), 112.4 (C7), 16.7 (C10), 9.94 (C8). 
Data in accordance with literature.209 
6-Methoxy-3-methyl-1H-indole (2-388) 
According to GP7, 6-methoxyindole (0.5 g, 3.4 mmol), DMF (1.3 mL, 17 
mmol) and POCl3 (0.38 mL, 4.1 mmol) were stirred at 40 °C for 2 h. 2 M NaOH 
solution (20 mL) was added and the solution was stirred at 90 °C for 1 h. The 
crude aldehyde was used in the next step without purification.  
To a solution of LiAlH4 (0.19 g, 5.1 mmol) in THF (13.5 mL) was added the 
above crude aldehyde in THF (13.5 mL) dropwise at 0 °C. The reaction mixture was stirred at RT 
overnight. Purification by flash column chromatography eluting with (5 to 20% EtOAc in petrol) gave 
the title compound 2-388 (0.30 g, 55% over two steps). 1H NMR (400 MHz, CDCl3) δ 7.76 (1 H, br s, 
NH), 7.49‒7.46 (1 H, m, H5), 6.89‒6.82 (3 H, m, H2, H4, H9), 3.88 (3 H, s, H10), 2.34 (3 H, d, J 1.2, 
H8); 13C NMR (101 MHz, CDCl3) δ 156.6 (C3), 137.7 (C1), 123.0 (C6), 120.4 (C9), 119.5 (C5), 111.8 




According to GP7, 6-(trifluoromethyl)-1H-indole (0.5 g, 2.7 mmol), DMF (1.1 
mL, 14 mmol) and POCl3 (0.30 mL, 3.2 mmol) were stirred at 40 °C for 2 h. 2 M 
NaOH solution (20 mL) was added and the solution was stirred at 90 °C for 1 h. 
The crude aldehyde was used in the next step without purification. To a solution 
of LiAlH4 (0.15 g, 4.1 mmol) in THF (13.5 mL) was added the above crude 
aldehyde in THF (13.5 mL) dropwise at 0 °C. The reaction mixture was stirred at RT overnight. 
Purification by flash column chromatography eluting with (5 to 20% EtOAc in petrol) gave the title 
compound 2-388 (0.19 g, 35% over two steps). 1H NMR (400 MHz, CDCl3) δ 8.08 (1 H, br s, NH), 
7.67‒7.63 (2 H, m, H4, H5), 7.38‒7.34 (1 H, m, H2), 7.13‒7.11 (1 H, m, H9), 2.36 (3 H, d, J 1.1, H8); 
13C NMR (101 MHz, CDCl3) δ 135.2 (C1), 130.7 (C6), 125.5 (q, JCF 271, C10) 124.4 (C9), 124.1 (q, 
JCF 31.6, C3) 119.4 (C5), 116.0 (q, JCF 3.6, C2), 112.3 (C7), 108.6 (q, JCF 4.4, C4), 9.68 (C8); 19F NMR 
(376 MHz; CDCl3) δ −60.5 (s, CF3). Data in accordance with literature.
3 
N-Benzyl-5-fluoro-N,3-dimethyl-1H-indole-1-carboxamide (2-390) 
According to GP8, 5-fluoro-3-methyl-1H-indole (0.25 g, 1.7 mmol) in DMF (1 
mL) was added to a suspension of NaH (0.13 g, 3.4 mmol) in DMF (1.0 mL) at 0 
°C and stirred at 75 °C for 3 h. Addition of benzyl(methyl)carbamoyl chloride 2-
15 (0.46 g, 2.5 mmol) in DMF (0.3 mL) and purification by flash column 
chromatography eluting with (10 to 60% EtOAc in petrol) gave the title compound 
2-390 as a white solid (0.33 g, 67%). Rf 0.28 (20% EtOAc/petrol); Mp 116-117 °C 
(CH2Cl2/n-pentane); νmax /cm-1 (film) 2918, 2855, 1674, 1446, 1394; 1H NMR (400 
MHz, CDCl3) δ 7.67 (1 H, dd, J 8.9, 4.5, H2), 7.42‒7.32 (5 H, m, H14, H15, H16), 
7.17 (1 H, dd, J 9.0, 2.6, H5), 7.14‒7.13 (1 H, br, H9), 7.03 (1 H, td, J 9.0, 2.6, H3), 
4.66 (2 H, s, H12), 2.98 (3 H, s, H11), 2.24 (3 H, d, J 1.2, H8); 13C NMR (101 
MHz, CDCl3) δ 158.9 (d, JCF 238, C4), 155.3 (C10), 136.4 (C13), 132.7 (C1), 131.2 (d, JCF 9.5, C6), 
129.1 (C14/C15), 128.03 (C14/C15), 128.02 (C16), 124.8 (C9), 115.2 (d, JCF 4.3, H7), 114.8 (d JCF 9.3, 
C2), 111.8 (d JCF 26, C3), 104.5 (d JCF 24, C5), 54.3 (C12), 36.5 (C11), 9.7 (C8); 19F NMR (376 MHz; 
CDCl3) δ −122.1 (1 H, td, J 9.1, 4.5, F); HRMS (ESI+) m/z C18H18FN2O+, requires: 297.1398; found 
297.1400. 
N-Benzyl-5-chloro-N,3-dimethyl-1H-indole-1-carboxamide (2-391) 
According to GP8, 5-chloro-3-methyl-1H-indole (0.25 g, 1.5 mmol) in DMF (1 
mL) was added to a suspension of NaH (0.12 g, 3.0 mmol) in DMF (1.0 mL) at 0 
°C and stirred at 75 °C for 3 h. Addition of benzyl(methyl)carbamoyl chloride 2-
15 (0.45 g, 2.3 mmol) in DMF (0.2 mL) and purification by flash column 
chromatography eluting with (10 to 60% EtOAc in petrol) gave the title compound 
2-391 as an orange oil (0.36 g, 77%). Rf 0.59 (30% EtOAc/petrol); νmax /cm-1 
(film) 2921, 2852, 1683, 1449, 1396; 1H NMR (400 MHz, CDCl3) δ 7.64 (1 H, 
dd, J 8.8, 0.6, H2), 7.49 (1 H, dd, J 2.2, 0.6, H5), 7.41‒7.30 (5 H, m, H14, H15, 
H16), 7.25 (1 H, dd, J 8.8, 2.2, H3), 7.12 (1 H, br q, J 1.2, H9), 4.65 (2 H, s, H12), 
2.97 (3 H, s, H11), 2.24 (3 H, d, J 1.2, H8); 13C NMR (101 MHz, CDCl3) δ 155.1 
(C10), 136.3 (C13), 134.7 (C1), 131.6 (C6), 129.1 (C14/C15), 128.1 (C16), 128.0 (C14/C15), 127.4 
(C4), 124.5 (C9), 124.1 (C3), 118.9 (C5), 114.89 (C7), 114.86 (C2), 54.3 (C12), 36.5 (C11), 9.7 (C8); 







According to GP8, 3-(2-(2,5-dimethyl-1H-pyrrol-1-yl)ethyl)-1H-indole (0.17 
g, 0.71 mmol) in DMF (0.5 mL) was added to a suspension of NaH (0.057 g, 
1.4 mmol) in DMF (0.4 mL) at 0 °C and stirred at 75 °C for 3 h. Addition of 
benzyl(methyl)carbamoyl chloride 2-15 (0.196 g, 1.07 mmol) in DMF (0.2 mL) 
and purification by flash column chromatography eluting with (10 to 60% 
EtOAc in petrol) gave the title compound 2-402 as a colourless oil (0.13 g, 
49%). Rf 0.38 (20% EtOAc/petrol); νmax /cm-1 (film) 2919, 1676, 1452, 1394, 
1079; 1H NMR (400 MHz, CDCl3) δ 7.71 (1 H, d, J 8.2, H2), 7.52 (1 H, d, J 
7.8, H5), 7.42‒7.30 (6 H, m, H3, H14, H15, H16), 7.26‒7.21 (1 H, m H4), 6.99 
(1 H, s, H9), 5.74 (2 H, s, H20), 4.63 (2 H, s, H12), 4.01 (2 H, t, J 7.6, H17), 
3.00 (2 H, t, J 7.6, H8), 2.94 (3 H, s, H11), 2.13 (6 H, s, H19); 13C NMR (101 
MHz, CDCl3) δ 155.2 (C10), 136.4 (C1), 136.1 (C13), 129.3 (C16), 129.0 
(C14/C15), 128.1 (C14/C15), 128.0 (C18), 127.5 (C6), 124.1 (C3), 123.9 (C9), 
121.9 (C4), 118.8 (C5), 115.9 (C7), 113.9 (C2), 105.5 (C20), 54.3 (C12), 43.7 (C17), 36.4 (C11), 26.7 
(C8), 12.6 (C19); HRMS (ESI+) m/z C25H28N3O+, requires; 386.2227 found 386.2233. 
7-Fluoro-2,9-dimethyl-1-phenyl-1,2,9,9a-tetrahydro-3H-imidazo[1,5-a]indol-3-one (2-405) 
According to GP9, N-benzyl-5-chloro-N,3-dimethyl-1H-indole-1-
carboxamide 2-390 (0.15 g, 0.51 mmol), DMPU (0.31 mL, 2.6 mmol) 
and LDA (0.51 mL, 1.0 mmol, 2.0 M) in THF (3.4 mL) were kept at −78 
°C for 2 h. Purification by flash column chromatography eluting with 
(10 to 50% EtOAc in petrol) afforded the title compound 2-405 as an 
inseparable mixture of diastereomers (89 mg, 60%) d.r. 10:1. Rf 0.19 
(20% EtOAc/petrol); νmax /cm-1 (film) 2965, 2906, 1710, 1483, 1392; 
Diastereomers are assigned as major diastereomer and minor diastereomer (Diamaj/Diamin) 1H NMR 
(400 MHz, CDCl3) δ 7.47‒7.35 (6 H, m, H2, H12, H13, H14), 6.95‒6.90 (1 H, m, H3), 6.83 (1 H, ddd, 
J 8.3, 2.6, 1.2, H5), 4.60 (0.09 H, d, J 6.2, H10 Diamin), 4.53 (0.09 H, dd, J 8.8, 6.2, H9 Diamin), 4.42 
(0.91 H, d, J 5.7, H10 Diamaj), 3.91 (0.91 H, dd, J 8.9, 5.7, H9 Diamaj), 3.47 (0.91 H, p, J 7.4, H7 Diamaj), 
3.36 (0.09 H, p, J 7.7, H7 Diamin), 2.69 (2.7 H, s, H15 Diamaj), 2.67 (0.27 H, s, H15 Diamin), 1.31 (3 H, 
d, J 6.9, H8 Diamaj+min); Signals reported are for the major diastereomer only. 13C NMR (101 MHz, 
CDCl3) δ 160.1 (d, JCF 241, C4), 159.6 (C16), 139.6 (C11), 138.68 (d, JCF 2.0, C1), 138.62 (d, JCF 8.0, 
C6), 128.7 (C14) 126.7 (C12/C13) 116.8 (d, JCF 8.6, C2) 114.4 (d, JCF 24, C3) 110.8 (d, JCF 24, C5) 
73.9 (C9), 68.8 (C10), 44.4 (C7), 29.0 (C15), 17.5 (C8); 19F NMR (376 MHz; CDCl3) δ −119.3 (1 H, 
td, J 8.5, 4.5, F); HRMS (ESI+) m/z C18H18FN2O+ requires: 297.1398; found: 297.1419. 
7-Chloro-2,9-dimethyl-1-phenyl-1,2,9,9a-tetrahydro-3H-imidazo[1,5-a]indol-3-one (2-406) 
According to GP9, N-benzyl-5-chloro-N,3-dimethyl-1H-indole-1-
carboxamide 2-391 (0.15 g, 0.48 mmol), DMPU (0.29 mL, 2.4 mmol) 
and LDA (0.48 mL, 0.96 mmol, 2.0 M) in THF (3.2 mL) were kept at 
−78 °C for 2 h. Purification by flash column chromatography eluting 
with (10 to 60% EtOAc in petrol) afforded the title compound 2-406 as 
a white solid as an inseparable mixture of diastereomers (65 mg, 43%) 
d.r. 10:1. Rf 0.19 (20% EtOAc/petrol); Mp 136-137 °C (CH2Cl2/n-
pentane); νmax /cm-1 (film) 2961, 2910, 1711, 1476, 1390; Diastereomers are assigned as major 
diastereomer and minor diastereomer (Diamaj/Diamin). 1H NMR (400 MHz, CDCl3) δ 7.46‒7.36 (6 H, 
m, H2, H12, H13, H14), 7.20 (1 H, dd, J 8.4, 2.1, H3), 7.12‒7.11 (0.09 H, br, H5 Diamin), 7.11‒7.08 
(0.91, br, H5 Diamaj), 4.61 (0.09 H, d, J 6.8, H10 Diamin), 4.52 (0.09 H, dd, J 8.9, 6.7, H9 Diamin), 4.42 
(0.91 H, d, J 6.1, H10 Diamaj), 3.90 (0.91 H, dd, J 8.8, 6.1, H9 Diamaj), 3.46 (0.91 H, p, J 7.0, H7 Diamaj), 
3.36 (0.09 H, p, J 7.8, H7 Diamin), 2.68 (2.73 H, s, H15 Diamaj), 2.67 (0.27 H, s, H15 Diamin), 1.30 (3 H, 
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d, J 7.0, H8 Diamin+Diamaj). Signals reported are for the major diastereomer only. 13C NMR (101 MHz, 
CDCl3) δ 159.3 (C16), 141.4 (C11), 139.5 (C1), 138.7 (C6), 129.5 (C12/C13), 129.1 (C4), 128.9 (C14), 
128.1 (C3), 126.8 (C12/C13), 123.9 (C5), 116.8 (C2), 73.7 (C9), 69.3 (C10), 44.3 (C7), 29.2 (C15), 
17.8 (C8); HRMS (ESI+) m/z C18H18ClN2O+ requires: 313.1102; found: 313.1108. 
2,7,9-Trimethyl-1-phenyl-1,2,9,9a-tetrahydro-3H-imidazo[1,5-a]indol-3-one (2-407) 
According to GP9, N-benzyl-N,3,5-trimethyl-1H-indole-1-
carboxamide 2-392 (0.15 g, 0.51 mmol), DMPU (0.31 mL, 2.6 mmol) 
and LDA (0.52 mL, 1.0 mmol, 2.0 M) in THF (3.4 mL) were kept at 
−78 °C for 2 h. Purification by flash column chromatography eluting 
with (5 to 50% EtOAc in petrol) afforded the title compound 2-407 as 
a white solid as a single diastereomer (80 mg, 53%) d.r. >20:1. Rf 0.19 
(20% EtOAc/petrol); Mp 112‒113 °C (CH2Cl2/n-pentane); νmax /cm-1 
(film) 2924, 1708, 1612, 1489, 1390; 1H NMR (400 MHz, CDCl3) δ 7.46‒7.37 (6 H, m, H2, H12, H13, 
H14), 7.05 (1 H, d, J 8.0, H3), 6.95 (1 H, s, H5), 4.42 (1 H, d, J 6.0, H10), 3.87 (1 H, dd, J 8.8, 6.0, H9), 
3.44 (1 H, p, J 7.0, H7), 2.68 (3 H, s, H15), 2.32 (3 H, s, H17), 1.30 (3 H, d, J 7.0, H8); 13C NMR (101 
MHz, CDCl3) δ 159.8 (C16), 140.3 (C11), 139.9 (C1), 136.8 (C4), 133.5 (C6), 129.4 (C12/C13), 128.7 
(C14), 128.5 (C3), 126.8 (C12/C13), 124.1 (C5), 115.6 (C2), 73.8 (C9), 69.2 (C10), 44.3 (C7), 29.1 
(C15), 21.3 (C17), 17.8 (C8); HRMS (ESI+) m/z C19H21N2O+ requires: 293.1648; found: 293.1647; X-
ray crystallography data: 
Bond precision: C-C = 0.0040 A Wavelength=0.71073 
Cell: a=12.3834(11) b=9.0000(9) c=14.3130(13) 
 alpha=90 beta=102.337(6) gamma=90 
Temperature: 100 K   
 Calculated Reported 
Volume 1558.4(3) 1558.4(3) 
Space group P 21/n P 1 21/n 1 
Hall group -P 2yn -P 2yn 
Moiety formula C19 H20 N2 O C19 H20 N2 O 
Sum formula C19 H20 N2 O C19 H20 N2 O 
Mr 292.37 292.37 
Dx,g cm-3 1.246 1.246 
Z 4 4 
Mu (mm-1) 0.078 0.078 
F000 624.0 624.0 
F000' 624.23  
h,k,lmax 14,10,17 14,10,17 
Nref 2852 2853 
Tmin,Tmax 0.975,0.986 0.557,0.745 
Tmin' 0.975  
Correction method= # Reported T Limits: Tmin=0.557 Tmax=0.745 AbsCorr = 
MULTI-SCAN 
 
Data completeness= 1.000 Theta(max)= 25.349 
R(reflections)= 0.0529( 1913) wR2(reflections)= 0.1200( 2853) 







According to GP9, N-benzyl-N,3,7-trimethyl-1H-indole-1-carboxamide 
2-394, (85 mg, 0.29 mmol), DMPU (0.18 mL, 1.5 mmol) and LDA (0.29 
mL, 0.58 mmol, 2.0 M) in THF (1.9 mL) were kept at −78 °C for 2 h. 
Purification by flash column chromatography eluting with (10 to 40% 
EtOAc in petrol) afforded the title compound 2-409 as a colourless oil as a 
single diastereomer (15 mg, 18%) d.r. >20:1. Rf 0.23 (20% EtOAc/petrol); 
νmax /cm-1 (film) 3029, 2957, 2921, 1708, 1391; 1H NMR (400 MHz, 
CDCl3) δ 7.48‒7.39 (5 H, m, H12, H13, H14), 7.11‒7.09 (1 H, br m, H5), 7.05 (1 H, t, J 7.4, H4), 6.97 
(1 H, d, J 7.4, H3), 4.45 (1 H, d, J 3.2, H10), 3.84 (1 H, dd, J 9.9, 3.2, H9), 3.52‒3.44 (1 H, m, H7), 
2.76 (3 H, s, H15), 2.63 (3 H, s, H17), 1.36 (3 H, d, J 6.8, H8); 13C NMR (101 MHz, CDCl3) δ 160.5 
(C16), 142.4 (C11), 140.7 (C1), 138.0 (C6), 130.1 (C5), 129.4 (C12/C13), 129.3 (C2), 128.6 (C14), 
126.7 (C12/C13), 125.3 (C4), 120.2 (C3), 75.0 (C9), 66.0 (C10), 44.5 (C7), 29.2 (C15), 19.0 (C17), 
16.4 (C8); HRMS (ESI+) m/z C19H20N2NaO+ requires: 315.1468; found: 315.1476. 
 
7-Methoxy-2,9-dimethyl-1-phenyl-1,2,9,9a-tetrahydro-3H-imidazo[1,5-a]indol-3-one (2-410) 
According to GP9, N-benzyl-5-methoxy-N,3-dimethyl-1H-indole-1-
carboxamide 2-395, (97 mg, 0.31 mmol), DMPU (0.19 mL, 1.6 
mmol) and LDA (0.32 mL, 0.63 mmol, 2.0 M) in THF (2.1 mL) were 
kept at −78 °C for 2 h. Purification by flash column chromatography 
eluting with (10 to 60% EtOAc in petrol) afforded the title compound 
2-410 as a colourless oil as a single diastereomer (54 mg, 56%) d.r. 
>20:1. Rf 0.16 (30% EtOAc/petrol); νmax /cm-1 (film) 2957, 1708, 
1488, 1274, 1232; 1H NMR (400 MHz, CDCl3) δ 7.45‒7.36 (6 H, m, H2, H12, H13, H14), 6.79‒6.57 
(1 H, m, H3), 6.71‒6.68 (1 H, m, H5), 4.41 (1 H, d, J 5.5, H10), 3.89‒3.85 (1 H, m, H9), 3.78 (3 H, s, 
H17), 3.44 (1 H, p, J 7.4, H7), 2.68 (3 H, s, H15), 1.30 (3 H, d, J 7.0, H8); 13C NMR (101 MHz, CDCl3) 
δ 160.1 (C16), 157.1 (C4), 140.1 (C11), 138.3 (C6), 136.4 (C1), 129.4 (C12/C13), 128.7 (C14), 126.8 
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(C12/C13), 116.7 (C2), 112.6 (C3), 110.1 (C5), 74.1 (C9), 68.8 (C10), 55.9 (C17), 44.6 (C7), 29.1 
(C15), 17.6 (C8); HRMS (ESI+) m/z C19H21N2O2+ requires: 309.1598; found: 309.1613. 
 6-Methoxy-2,9-dimethyl-1-phenyl-1,2,9,9a-tetrahydro-3H-imidazo[1,5-a]indol-3-one (2-411) 
According to GP9, N-benzyl-6-methoxy-N,3-dimethyl-1H-indole-
1-carboxamide X, (155 mg, 0.5 mmol), DMPU (0.30 mL, 2.5 mmol) 
and LDA (0.51 mL, 1.0 mmol, 2.0 M) in THF (3.4 mL) were kept at 
−78 °C for 2 h. Purification by flash column chromatography eluting 
with (10 to 60% EtOAc in petrol) afforded the title compound 2-411 
as a white solid as a single diastereomer (115 mg, 74%) d.r. >20:1. 
Rf 0.21 (20% EtOAc/petrol); Mp 124‒125 °C (CH2Cl2/n-pentane); 
νmax /cm-1 (film) 2958, 1711, 1615, 1591, 1494; 1H NMR (400 MHz, CDCl3) δ 7.46‒7.42 (2 H, m, ArH), 
7.40‒7.35 (3 H, m, ArH), 7.10 (1 H, d, J 2.4, H2), 7.01‒6.98 (1 H, m, H5), 6.59 (1 H, dd, J 8.2, 2.4, 
H4), 4.41 (1 H, d, J 6.5, H10), 3.88 (1 H, dd, J 8.5, 6.5, H9), 3.82 (3 H, s, H17), 3.41 (1 H, p, J 7.0, H7), 
2.67 (3 H, s, H15), 1.26 (3 H, d, J 7.0, H8); 13C NMR (101 MHz, CDCl3) δ 160.2 (C16), 159.5 (C3), 
143.7 (C1), 139.6 (C11), 129.4 (C12/C13), 128.7, (C14) 128.5 (C6), 126.9 (C12/C13), 123.8 (C5), 
110.1 (C4), 101.5 (C2), 74.2 (C9), 69.7 (C10), 55.8 (C17), 43.6 (C7), 29.2 (C15), 18.3 (C8); HRMS 
(ESI+) m/z C19H21N2O2+ requires: 309.1597; found: 309.1608. 
9-(2-(Dibenzylamino)ethyl)-2-methyl-1-phenyl-1,2,9,9a-tetrahydro-3H-imidazo[1,5-a]indol-3-
one (2-414) 
According to GP9, N-benzyl-3-(2-(dibenzylamino)ethyl)-N-methyl-1H-
indole-1-carboxamide 2-401, (60 mg, 0.12 mmol), DMPU (0.075 mL, 0.62 
mmol) and LDA (0.125 mL, 0.25 mmol, 2.0 M) in THF (0.8 mL) were kept 
at −78 °C for 2 h. Purification by flash column chromatography eluting 
with (10 to 50% EtOAc in petrol) afforded the title compound 2-414 as a 
white solid as a single diastereomer (46 mg, 79%) d.r. >20:1. Rf 0.25 (20% 
EtOAc/petrol); Mp 143‒144 °C (CH2Cl2/n-pentane); νmax /cm-1 (film) 
3027, 2923, 2798, 2244, 1709; 1H NMR (400 MHz, CDCl3) δ 7.48 (1 H, 
d, J 7.9, H2), 7.39‒7.18 (17 H, m, ArH), 6.96 (1 H, t, J 7.3, ArH), 6.86 (1 
H, d, J 7.5, ArH), 4.18‒4.16 (1 H, m, H10), 3.94‒3.90 (1 H, m, H9), 3.54‒
3.39 (5 H, m, H7, H18), 2.59 (3 H, s, H15), 2.41‒2.34 (1 H, m, H17a), 
2.29‒2.20 (1 H, m, H17b), 2.14‒2.04 (1 H, m, H8a), 1.69‒1.57 (1 H, m, H8b); 13C NMR (101 MHz, 
CDCl3) δ 159.7 (C16), 143.0 (C11), 139.5 (C1), 139.1 (C19), 135.5 (C6), 129.3, 128.8, 128.4, 128.1, 
127.4, 127.1, 124.0, 123.8 (ArC), 115.7 (C2), 72.6 (C9), 69.7 (C10), 58.5 (C18), 51.7 (C17), 46.9 (C7), 
32.1 (C8), 29.0 (C15); HRMS (ESI+) m/z C33H34N3O+ requires: 488.2696; found: 488.2700.  
9-(2-(2,5-dimethyl-1H-pyrrol-1-yl)ethyl)-2-methyl-1-phenyl-1,2,9,9a-tetrahydro-3H-imidazo[1,5-
a]indol-3-one (2-415) 
According to GP9, N-benzyl-3-(2-(2,5-dimethyl-1H-pyrrol-1-yl)ethyl)-N-
methyl-1H-indole-1-carboxamide 2-402, (80 mg, 0.21 mmol), DMPU 
(0.13 mL, 1.04 mmol) and LDA (0.21 mL, 0.42 mmol, 2.0 M) in THF (1.4 
mL) were kept at −78 °C for 2 h. Purification by flash column 
chromatography eluting with (10 to 60% EtOAc in petrol) afforded the title 
compound 2-415 as a colourless oil a single diastereomer (59 mg, 74%) 
d.r. >20:1. Rf  0.15 (20% EtOAc/petrol); νmax /cm-1 (film) 2913, 2237, 1709, 
1602, 1480; 1H NMR (400 MHz, CDCl3) δ 7.56‒7.53 (1 H, m, H2), 7.48‒
7.40 (5 H, m ArH), 7.30‒7.26 (1 H, m, H4), 7.14 (1 H, d, J 7.4, H5), 7.05 
(1 H, td, J 7.5, 1.1, H4), 5.69 (2 H, s, H20), 4.40 (1 H, d, J 7.1, H10), 4.17‒4.12 (1 H, m, H9), 3.60 (1 
H, ddd, J 14.2, 12.2, 4.8, H17a), 3.46 (1 H, td, J 8.9, 3.8, H7), 3.28 (1 H, ddd, J 14.2, 12.5, 4.8, H17b), 
160 
 
2.66 (3 H, s, H15), 2.23‒2.16 (1 H, m, H8a), 1.94 (6 H, s, H19), 1.76‒1.66 (1 H, m, H8b); 13C NMR 
(101 MHz, CDCl3) δ 159.3 (C16), 142.6 (C1), 138.8 (C11), 134.0 (C6), 129.7 (C12/C13), 129.4 (C14), 
128.7 (C3), 127.6 (C12/C13), 127.0 (C18), 123.9 (C4), 123.8 (C5), 115.6 (C2), 105.4 (C20), 72.4 (C9), 
70.1 (C10), 47.3 (C7), 41.6 (C17), 35.0 (C8), 29.1 (C15), 12.2 (C19); HRMS (ESI+) m/z C25H28N3O+ 
requires: 386.2227; found: 386.2244.  
9-Benzyl-2-methyl-1-phenyl-1,2,9,9a-tetrahydro-3H-imidazo[1,5-a]indol-3-one (2-416) 
According to GP9, N,3-dibenzyl-N-methyl-1H-indole-1-carboxamide 2-
403, (50 mg, 0.14 mmol), DMPU (0.09 mL, 0.71 mmol) and LDA (0.14 
mL, 0.28 mmol, 2.0 M) in THF (0.94 mL) were kept at −78 °C for 2 h. 
Purification by flash column chromatography (eluting with 10 to 60% 
EtOAc in petrol) afforded the title compound 2-416 as a colourless oil as 
an inseparable mixture of diastereomers (32 mg, 64%) d.r. 10:1. Rf 0.27 
(20% EtOAc/petrol); νmax /cm-1 (film) 3028, 2912, 1708, 1602, 1478. 
Diastereomers are assigned as major diastereomer and minor 
diastereomer (Diamaj/Diamin). 1H NMR (400 MHz, CDCl3) δ 7.53 (1 H, d, 
J 7.8, H2), 7.29‒7.01 (11 H, m, ArH), 6.84 (2 H, d, J 6.5, H18/H19), 4.69 (0.09 H, d, J 6.2, H10 Diamin), 
4.64‒4.61 (0.09 H, m, H9 Diamin) 4.12 (0.91 H, dd, J 8.4, 5.4, H9 Diamaj), 4.01 (0.91 H, d, J 5.4, H10 
Diamaj), 3.81 (0.91 H, td, J 9.1, 5.1, H7 Diamaj), 3.70‒3.62 (0.09 H, m, H7 Diamin), 3.36 (1 H, dd, J 14.0, 
5.1, H8a), 2.64 (1 H, dd, J 14.0, 9.8, H8b), 2.53 (3 H, s, H15). Signals reported are for the major 
diastereomer only. 13C NMR (101 MHz, CDCl3) δ 159.7 (C16), 143.4 (C1), 138.9 (C11), 138.4 (C17), 
135.1 (C6), 1291 (ArCH), 128.9 (ArCH), 128.9 (ArCH), 128.4 (ArCH), 128.3 (ArCH), 127.0 (ArCH), 
126.7 (C18/C19), 124.1 (ArCH), 123.8 (ArCH), 116.5 (C2), 72.0 (C10), 68.8 (C9), 51.9 (C7), 40.1 
(C8), 28.8 (C15); HRMS (ESI+) m/z C24H23N2O+ requires: 355.1805; found: 355.1816.  
(±)-N-Methyl-1-phenyl-1,3,4,5-tetrahydro-2H-benzo[c]azepine-2-carboxamide (2-431) 
 
According to GP10, 2-methyl-1-phenyl-1,2,4,5,6,7-hexahydro-3H-
benzo[e][1,3]diazonin-3-one 2-73 (100 mg, 0.36 mmol) and p-toluenesulfonic 
acid monohydrate (6.8 mg, 36 μmol) in CH2Cl2 (3.6 mL) were stirred for 1 h 
at RT. Purification by flash column chromatography eluting (15 to 100% 
EtOAc in petrol) gave the title compound 2-431 as a white solid (70 mg, 70%). 
Rf 0.20 (60% EtOAc/petrol); Mp 200‒201 °C (CH2Cl2/n-pentane); νmax /cm-1 
(film) 3290, 2933, 1608, 1538, 1284; 1H NMR (400 MHz; CDCl3) δ 7.39‒7.09 
(8 H, m, ArH), 6.95 (1 H, d, J 7.4, ArH), 6.35 (1 H, br s, H12), 4.44 (1 H, q, J 4.4, NH), 3.85 (1 H, dt, 
J 14.8, 3.5, H9a), 3.15 (1 H, br t, J 14.8, H9b), 2.80 (2 H, br t, J 6.2, H7), 2.77 (3 H, d, J 4.4, H11), 2.00‒
1.80 (1 H, m, H8a), 1.67‒1.53 (1 H, m, H8b); 13C NMR (101 MHz; CDCl3) δ 159.0 (C10), 140.8 (C1), 
140.1 (C13), 138.9 (C6), 130.5 (ArCH), 130.1 (ArCH), 128.9 (ArCH), 128.1 (ArCH), 128.0 (ArCH), 
127.5 (ArCH), 126.6 (ArCH), 64.1 (C12), 43.5 (C9), 34.0 (C7), 28.0 (C11), 27.3 (C8); HRMS (ESI+) 
m/z C18H20N2NaO+ requires: 303.1468; found: 303.1467; X-ray crystallography data: 
Bond precision: C-C = 0.0015 A Wavelength=0.71073 
Cell: a=8.3785(2) b=16.8762(4) c=20.7555(6) 
 alpha=90 beta=90 gamma=90 
Temperature: 100 K   
 Calculated Reported 
Volume 2934.77(13) 2934.77(13) 
Space group P b c a P b c a 
Hall group -P 2ac 2ab -P 2ac 2ab 
Moiety formula C18 H20 N2 O C18 H20 N2 O 
Sum formula C18 H20 N2 O C18 H20 N2 O 
Mr 280.36 280.36 
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Dx,g cm-3 1.269 1.269 
Z 8 8 
Mu (mm-1) 0.079 0.079 
F000 1200.0 1200.0 
F000' 1200.44  
h,k,lmax 11,23,29 11,23,29 
Nref 4322 4321 
Tmin,Tmax 0.961,0.979 0.674,0.746 
Tmin' 0.961  
Correction method= # Reported T Limits: Tmin=0.674 Tmax=0.746 AbsCorr = MULTI-
SCAN 
 
Data completeness= 1.000 Theta(max)= 30.107 
R(reflections)= 0.0390( 3537) wR2(reflections)= 0.1044( 4321) 




According to GP10, N-benzyl-N-methylindoline-1-carboxamide 2-66 (25 
mg, 9 μmol) and p-toluenesulfonic acid monohydrate (36 mg, 18 μmol) in 
CH2Cl2 (0.9 mL) were stirred for 12 h at RT. Purification by flash column 
chromatography eluting (15 to 100% EtOAc in petrol) gave the title 
compound 2-454 as a white solid (13 mg, 52%). Rf 0.20 (60% EtOAc/petrol); 
Mp 164‒165 °C (CH2Cl2/n-pentane); νmax /cm-1 (film) 3368, 1615, 1540, 
1487, 1242, 702; 1H NMR (500 MHz; CDCl3) δ 7.31‒7.12 (9 H, m, ArH), 
6.35 (1 H, s, H11), 4.49 (1 H, q, J 4.5, NH), 3.64‒3.52 (2 H, m, H8), 2.89 (1 H, ddd, J 15.8, 6.9, 5.4, 
H7a), 2.83 (3 H, d, J 4.5, H10), 2.79 (3 H, ddd, J 15.8, 6.6, 5.5, H7b); 13C NMR (126 MHz; CDCl3) δ 
158.5 (C9), 143.0 (C1), 136.8 (C12), 135.3 (C6), 128.6 (ArCH), 128.5 (ArCH), 128.3 (ArCH), 127.6 
(ArCH), 127.29 (ArCH), 127.25 (C4), 126.5 (C2), 57.9 (C11), 40.3 (C8), 28.4 (C7), 27.9 (C10); HRMS 









According to GP10, 8-chloro-2-methyl-1-phenyl-1,4,5,6-
tetrahydrobenzo[e][1,3]diazocin-3(2H)-one 2-72 (49 mg, 0.16 mmol) 
and p-toluenesulfonic acid monohydrate (2.8 mg, 16 μmol) in CH2Cl2 
(1.6 mL) were stirred for 1 h at RT. Purification by flash column 
chromatography eluting (12 to 100% EtOAc in petrol) gave the title 
compound 2-455 as a white solid (41 mg, 84%). Rf 0.30 (50% 
EtOAc/petrol); Mp 174‒175 °C (CH2Cl2/n-pentane); νmax /cm-1 (film) 
3359, 1620, 1539, 1487, 1242; 1H NMR (500 MHz; CDCl3) δ 7.34‒7.13 (7 H, m, ArH), 7.07 (1 H, d, 
J 8.8, ArH), 6.39 (1 H, s, H11), 4.75 (1 H, q, J 4.7, NH), 3.60 (1 H, dt, J 12.4, 5.8, H8a), 3.48 (1 H, ddd, 
J 12.4, 8.1, 5.0, H8b), 2.90‒2.84 (1 H, m, H7a), 2.82 (3 H, d, J 4.7, H10), 2.73 (1 H, dt, J 16.0, 5.8, H7b); 
13C NMR (126 MHz; CDCl3) δ 158.3 (C9), 142.4 (C1), 137.1 (C12), 135.1 (C6), 132.7 (C4), 129.6 
(ArCH), 128.5 (ArCH), 128.4 (ArCH), 127.6 (ArCH), 127.4 (ArCH), 126.6 (ArCH), 57.1 (C11), 39.4 
(C8), 28.2 (C7), 27.9 (C10); HRMS (ESI+) m/z C17H1735ClN2NaO+ requires: 323.0922; found: 323.0918 
and C17H1737ClN2NaO+ requires: 325.0892; found: 325.0895. 
 
(±)-N-Methyl-5-phenyl-2,3-dihydrobenzo[f][1,4]oxazepine-4(5H)-carboxamide (2-462) 
According to GP10, 6-methyl-7-phenyl-3,4,6,7-
tetrahydrobenzo[h][1,4,6]oxadiazonin-5(2H)-one 2-86 (58 mg, 0.21 mmol) 
and p-toluenesulfonic acid monohydrate (4.0 mg, 21 μmol) in CH2Cl2 (2.0 mL) 
were stirred for 16 h at RT. Purification by flash column chromatography 
eluting (12 to 100% EtOAc in petrol) gave the title compound 2-462 as a white 
solid (26 mg, 45%). Rf 0.17 (50% EtOAc/petrol); Mp 165‒166 °C (CH2Cl2/n-
pentane); νmax /cm-1 (film) 3277, 2923, 1616, 1256, 1209; 1H NMR (400 MHz, 
CDCl3) δ 7.32‒7.22 (4 H, m, ArH), 7.18‒7.16 (1 H, m, ArH), 7.11 (1 H, d, J 7.5, H5), 7.07‒7.03 (2 H, 
m, ArH), 6.42 (1 H, s, H11), 4.62 (1 H, br, NH), 4.11 (1 H, ddd, J 12.8, 5.8, 2.5, H7a), 3.91‒3.82 (2 H, 
m, H7b, H8a), 3.37 (1 H, ddd, J 14.8, 8.0, 2.5, H8b), 2.80 (3 H, d, J 4.5, H10); 13C NMR (101 MHz, 
CDCl3) δ 158.9 (C9), 158.1 (C6), 139.6 (C12), 131.2, 130.5 (C1), 129.4 (ArCH), 128.8 (ArCH), 127.7 
(ArCH), 127.5 (C5), 123.6 (ArCH), 122.0 (ArCH), 70.9 (C7), 62.4 (C11), 44.6 (C8), 28.1 (C10); 




According to GP10, 2-methyl-1-phenyl-1,4,5,6,7,8-
hexahydrobenzo[e][1,3]diazecin-3(2H)-one 2-74 (50 mg, 0.17 mmol) and p-
toluenesulfonic acid monohydrate (3.2 mg, 17 μmol) in CH2Cl2 (1.7 mL) were 
stirred for 1 h at RT. Purification by flash column chromatography eluting (12 
to 100% EtOAc in petrol) gave the title compound 2-463 as a white solid (19 
mg, 38%). Rf 0.25 (50% EtOAc/petrol); Mp 136‒137 °C (CH2Cl2/n-pentane); 
νmax /cm-1 (film) 3389, 2933, 1619, 1525, 729; 1H NMR (400 MHz, CDCl3) δ 
7.36 (2 H, t, J 7.0, H16), 7.38‒7.19 (5 H, m, ArH), 7.03 (1 H, td, J 7.6, 1.8, H4), 6.59 (1 H, d, J 7.6, 
H5), 6.26 (1 H, s, H13), 4.37 (1 H, br, NH), 3.72‒3.64 (1 H, m, H10a), 3.10‒3.04 (1 H, m, H10b), 2.85 
(1 H, ddd, J 12.8, 9.3, 2.7, H5a), 2.76‒2.68 (1 H, m, H5b), 2.73 (3 H, d, J 4.5, H12), 2.02‒1.85 (2 H, m, 
H8a, H9a), 1.63‒1.51 (2 H, m, H8b, H9b); 13C NMR (101 MHz, CDCl3) δ 158.4 (C11), 144.0 (C1), 141.5 
(C14), 138.0 (C6), 130.9 (ArCH), 130.5 (C5), 129.0 (C16), 128.5 (ArCH), 127.6 (ArCH), 127.5 
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(ArCH), 126.1 (C4), 63.0 (C13), 42.3 (C10), 31.2 (C7), 28.9 (C8/C9), 27.9 (C12), 26.9 (C8/C9); HRMS 




According to GP10, 2,5-dimethyl-1-phenyl-1,4,5,6-
tetrahydrobenzo[e][1,3]diazocin-3(2H)-one 2-97 (50 mg, 0.18 mmol) and p-
toluenesulfonic acid monohydrate (3 mg, 0.02 mmol) in CH2Cl2 (1.8 mL) were 
stirred for 16 h at RT. Purification by flash column chromatography eluting (20 
to 100% EtOAc/petrol) gave the title compound 2-456 as a white solid as an 
inseparable mixture of diastereomers (40 mg, 80%) d.r. 1:1. Rf 0.28 (70% 
EtOAc/petrol); Mp 148‒149 °C (CH2Cl2/n-pentane); νmax /cm-1 (film) 
3349,2965, 1633, 1527, 1480; Diastereomers are assigned as diastereomer A and diastereomer B 
(diaA/diaB); 1H NMR (400 MHz, d6-DMSO) δ 7.76 (1 H, d, J 8.0, ArHdiaA), 7.46 (1 H, d, J 7.3, 
ArHdiaA/B), 7.28‒7.00 (10 H, m, ArHdiaA+B), 6.80 (1 H, t, J 7.4, ArHdiaA/B), 6.58‒6.54 (0.5 H, m, NHdiaA), 
6.29‒6.24 (0.5 H, m, NHdiaB), 6.08 (1 H, s, H12diaA+B), 4.56‒4.50 (0.5 H, m, H8diaA), 4.44‒4.37 (0.5 H, 
m, H8diaB), 3.30‒3.24 (0.5 H, m, H7adiaA), 2.96 (0.5 H, dd, J 14.5, 5.6, H7adiaB), 2.64 (1.5 H, d, J 4.3, 
H11diaA), 2.59‒2.53 (2.5 H, m, H7bdiaA, H7bdiaB, H11diaB), 1.10 (1.5 H, d, J 6.4, H9diaB), 0.84 (1.5 H, d, J 
6.1, H9diaA); 13C NMR (101 MHz, d6-DMSO) δ 157.2 (C10diaB), 154.8 (C10diaA), 144.1 (C1diaA), 143.1 
(C1diaB), 137.9 (C13diaA+B), 133.7 (C6diaA), 129.2 (C6diaB), 128.6, 128.0, 127.1, 126.9, 126.6, 126.1, 
125.8, 124.8, 121.0, 114.6 (ArHdiaA+B), 57.6 (C12diaA+B), 53.6 (C8diaB), 46.6 (C8diaA), 35.8 (C7diaA), 34.5 
(C7diaB), 27.4 (C11diaB), 26.8 (C11diaA), 20.6 (C9diaB), 20.3 (C9diaA); HRMS (ESI+) m/z C18H21N2O+ 




According to GP10, 2-methyl-1,5-diphenyl-1,4,5,6-
tetrahydrobenzo[e][1,3]diazocin-3(2H)-one 2-98 (50 mg, 0.15 mmol) and p-
toluenesulfonic acid monohydrate (3 mg, 0.02 mmol) in CH2Cl2 (1.5 mL) 
were stirred for 16 h at RT. Purification by flash column chromatography 
eluting (20% to 100% EtOAc/petrol) gave the title compound 2-457 as a 
white solid as a single diastereomer (44 mg, 88%) d.r. >20:1. Rf 0.26 (60% 
EtOAc/petrol); Mp 177-178 °C (CH2Cl2/n-pentane); νmax /cm-1 (film) 3664, 
2987, 1638, 1393, 1065; 1H NMR (400 MHz, CDCl3) δ 7.49 (1 H, d, J 7.5, 
ArH), 7.29‒7.25 (5 H, m, ArH), 7.20‒7.13 (4 H, m, ArH), 7.11‒7.07 (1 H, m, ArH), 6.90 (2 H, dd, J 
6.7, 2.9, ArH), 6.77 (1 H, d, J 7.4, ArH), 6.61 (1 H, s, H15), 5.34‒5.31 (1 H, m, H8), 4.22 (1 H, d, J 5.0, 
NH), 3.34 (1 H, dd, J 14.7, 6.1, H7a), 2.72‒2.67 (1 H, m, H7b), 2.65 (3 H, d, J 5.0, H14); 13C NMR (101 
MHz, CDCl3) δ 158.8 (C13), 142.8 (C1), 142.4 (C9/C16), 138.9 (C9/C16), 132.7 (C6), 128.8, 128.7, 
128.5, 127.8, 127.6, 127.2, 127.0, 126.8, 126.2, 125.8 (ArCH), 59.2 (C15), 56.9 (C8), 31.1 (C7), 28.0 













According to GP10, 1,2-dimethyl-1-phenyl-1,4,5,6-
tetrahydrobenzo[e][1,3]diazocin-3(2H)-one 2-89 (0.45 g, 1.5 mmol) and 
p-toluenesulfonic acid monohydrate (0.58 g, 3.0 mmol) in CH2Cl2 (15 
mL) were stirred for 16 h at RT yielding the title compound 2-468 as a 
white solid (0.3 g, 67%). No further purification was required. Rf 0.11 
(1% MeOH/CH2Cl2); Mp 110-112 °C (CHCl3); νmax /cm-1 (film) 3327, 
2935, 1629, 1572, 1264; 1H NMR (400 MHz, CDCl3) δ 7.33‒7.23 (9 H, 
m, ArH), 5.80 (1 H, d, J 1.4, H6a), 5.22 (1 H, d, J 1.4, H6b), 4.09 (1 H, br s, NH), 4.01 (1 H, br s, NH), 
3.19 (2 H, q, J 7.0, H14), 2.66 (3 H, d, J 4.5, H16), 2.58 (2 H, t, J 7.0, H13); 13C NMR (101 MHz, 
CDCl3) δ 158.7 (C15), 149.1 (C5), 141.7 (C4), 140.8 (C12), 137.1 (C7), 130.7 (ArCH), 129.9 (ArCH), 
128.6 (ArCH), 128.03 (ArCH), 128.0 (ArCH), 126.63 (ArCH), 126.6 (ArCH), 115.7 (C6), 41.5 (C14), 




According to GP10, 1,2-dimethyl-1-phenyl-1,2,4,5,6,7-hexahydro-
3H-benzo[e][1,3]diazonin-3-one 2-90 (0.15 g, 0.51 mmol) and p-
toluenesulfonic acid monohydrate (0.19 g, 1.0 mmol) in CH2Cl2 (5.1 
mL) were stirred for 16 h at RT yielding the title compound 2-469 as 
a colourless oil (147 mg, 98%). No further purification was required. 
Rf 0.13 (1% MeOH/CH2Cl2); νmax /cm-1 (film) 3054, 2305, 1422, 
1264;1H NMR (400 MHz, CDCl3) δ 7.29‒7.18 (9 H, m, ArH), 5.75 
(1 H, d, J 1.4, H6a), 5.18 (1 H, d, J 1.4, H6b), 4.53‒4.49 (1 H, br, NH), 4.40 (1 H, t, J 5.6, NH), 2.96 (2 
H, td, J 6.9, 5.6, H15), 2.66 (3 H, d, J 4.9, H17), 2.40‒2.36 (2 H, m, H13), 1.62‒1.55 (2 H, m, H14); 
13C NMR (101 MHz, CDCl3) δ 158.9 (C16), 149.3 (C5), 141.3 (C4), 141.0 (C12), 139.6 (C7), 130.7 
(ArCH), 129.3 (ArCH), 128.5 (ArCH), 128.0 (ArCH), 127.9 (ArCH), 126.6 (ArCH), 126.1 (ArCH), 
115.5 (C6), 40.3 (C15), 31.2 (C14), 30.7 (C13), 27.3 (C17); HRMS (ESI+) m/z C19H23N2O+ requires: 




According to GP10, 16b-methyl-5,9,10,11,12,16b-
hexahydrobenzo[7,8][1,3]diazonino[9,1-a]isoquinolin-8(6H)-one 2-94 (37 
mg, 0.12 mmol) and p-toluenesulfonic acid monohydrate (46 mg, 0.24 
mmol) in CH2Cl2 (1.2 mL) were stirred for 48 h at RT yielding the title 
compound 2-470 as a white solid (28 mg, 76%). No further purification was 
required. Rf 0.65 (10% MeOH/CH2Cl2 + 1% NEt3); Mp decomposed >230 
°C (CH2Cl2/n-pentane); νmax /cm-1 (film) 3325, 2925, 1640, 1555, 1262. 1H 
NMR (400 MHz, CDCl3) δ 7.37 (1 H, d, J 7.8, ArH), 7.31‒7.21 (4 H, m, ArH), 7.12‒7.05 (2 H, m, 
ArH), 6.94 (1 H, d, J 7.8, ArH), 5.54 (1 H, s, H20a), 5.27 (1 H, s, H20b), 4.48‒4.40 (1 H, br, NH), 4.30‒
4.25 (1 H, br, NH), 3.59 (2 H, br t, J 6.1, H11), 3.18 (2 H, br t, J 6.1, H12), 3.11 (2 H, br t, J 5.6, H9), 
2.40‒2.36 (2 H, m, H7), 1.69‒1.62 (2 H, m, H8); 13C NMR (101 MHz, CDCl3) δ 158.9 (C10), 148.0 
(C19), 142.7(ArC), 142.6 (ArC), 139.1 (ArC), 136.3 (ArC), 131.1 (ArCH), 129.6 (ArCH), 128.8 
(ArCH), 128.1 (ArCH), 127.9 (ArCH), 127.6 (ArCH), 126.1 (ArCH), 126.05 (ArCH), 121.5 (C20), 
41.1 (C11), 40.2 (C9), 32.4 (C12), 30.8 (C8), 30.4 (C7). HRMS (ESI+) m/z C20H23N2O+ requires: 
307.1805; found: 307.1810. 
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(Z)-8, 14-Diphenyl-5,7,8,9-tetrahydro-6H-dibenzo[d,h][1,3]diazacycloundecin-6-one (2-471) 
 
According to GP10, (6S,14aR)-6,14a-diphenyl-6,7,14,14a-
tetrahydrobenzo[6,7][1,3]diazocino[1,8-a]indol-8(5H)-one 2-102 (57 mg, 
0.14 mmol) and p-toluenesulfonic acid monohydrate (52 mg, 0.27 mmol) in 
CH2Cl2 (1.4 mL) were stirred for 15 min in a microwave at 100 °C. 
Purification by flash column chromatography eluting (10 to 100% 
EtOAc/petrol) gave the title compound 2-471 as a white solid (48 mg, 84%). 
Rf 0.76 (10% MeOH/CH2Cl2 + 1% NEt3); Mp decomposed >230 °C 
(CH2Cl2/n-pentane); νmax /cm-1 (film) 2967, 1662, 1444, 760; 1H NMR (500 
MHz, CDCl3) δ  7.53‒7.52 (2 H, br m, ArH), 7.40‒7.26 (8 H, br m, ArH), 
7.25‒7.18 (5 H, br m, ArH), 6.93 (1 H, br t, J 7.7, ArH), 6.87‒6.80 (2 H, br 
m, ArH), 6.44 (1 H, br s, NH), 6.13 (1 H, br s, H20), 5.56‒5.50 (1 H, br m, H8), 4.70 (1 H, d, J 10.8, 
NH), 3.07 (1 H, dd, J 13.4, 5.7, H7a), 2.70 (1 H, dd, J 13.4, 2.7, H7b); 13C NMR (126 MHz, CDCl3) δ 
156.2 (C13), 145.3 (ArC), 141.2 (ArC), 140.8 (ArC), 138.7 (ArC), 135.12 (ArC), 133.9 (ArC), 135.1 
(ArCH), 135.0 (ArCH), 133.2 (C20), 132.7, 132.5, 129.0, 128.6, 128.0, 127.97, 127.6, 127.2, 127.1, 
126.7, 126.2, 126.0 (ArCH), 51.4 (C8), 40.1 (C7); HRMS (ESI+) m/z C29H24N2NaO+ requires: 
439.1780; found: 439.1780; X-ray crystallography data: 
Bond precision: C-C = 0.0026 A Wavelength=0.71073 
Cell: a=9.7515(3) b=10.4670(3) c=13.3967(4) 
 alpha=88.7235(16) beta=87.0479(16) gamma=73.4928(15) 
Temperature: 100 K   
 Calculated Reported 
Volume 1309.25(7) 1309.25(7) 
Space group P -1 P -1 
Hall group -P 1 -P 1 
Moiety formula C29 H24 N2 O, C H Cl3 C29 H24 N2 O, C H1 Cl3 
Sum formula C30 H25 Cl3 N2 O C30 H25 Cl3 N2 O 
Mr 535.87 535.87 
Dx,g cm-3 1.359 1.359 
Z 2 2 
Mu (mm-1) 0.377 0.377 
F000 556.0 556.0 
F000' 557.06  
h,k,lmax 12,13,17 12,13,17 
Nref 6312 6299 
Tmin,Tmax 0.816,0.917 0.672,0.746 
Tmin' 0.807  
Correction method= # Reported T Limits: Tmin=0.672 Tmax=0.746 AbsCorr = 
MULTI-SCAN 
 
Data completeness= 0.998 Theta(max)= 27.974 
R(reflections)= 0.0443( 4980) wR2(reflections)= 0.1071( 6299) 







1-Methyl-3-(2-(1-phenylvinyl)phenethyl)urea 2-468 (0.8 g, 0.3 mmol) was 
added to a flame-dried flask followed by anhydrous, degassed DMSO (2.9 
mL). Potassium tert-butoxide (32 mg, 0.3 mmol) was added to the flask at 
RT. The reaction mixture was stirred at RT for 16 h or until TLC showed 
consumption of starting material. Water (2 mL) was added to the reaction 
mixture and the aqueous phase was extracted three times with EtOAc. The 
combined organic phases were washed with brine, dried over MgSO4, 
filtered and concentrated in vacuo. Purification by flash column chromatography eluting with (1 to 10% 
MeOH in CH2Cl2) gave the titled compound 2-472 as a colourless oil (66 mg, 83%). Rf 0.13 (1% MeOH/ 
CH2Cl2); νmax /cm-1 (film) 3329, 2925, 1631, 1572, 1267; 1H NMR (400 MHz, CDCl3) δ 7.36‒7.10 (8 
H, br m, ArH), 6.93 (1 H, br d, J 7.4, ArH), 4.55 (1 H, br dd, J 9.6, 5.0, H12), 4.40 (1 H, br m, NH), 
4.17 (1 H, br dd, J 15.0, 5.0, H11a), 3.75‒3.67 (2 H, br m, H11b, H8a), 3.51 (1 H, br m, H8b), 3.31 (1 H, 
ddd, J 14.7, 10.5, 3.8, H7a), 3.01‒2.94 (1 H, br m, H7b), 2.73 (3 H, d, J 4.6, H10); 13C NMR (101 MHz, 
CDCl3) δ 158.7 (C9), 143.3 (C1), 141.5 (C13), 138.6 (C6), 131.2 (ArCH), 130.5 (ArCH), 128.8 (ArCH), 
128.3 (ArCH), 127.1 (ArCH), 126.7 (ArCH), 126.7 (ArCH), 52.3 (C12), 49.8 (C11), 46.6 (C8), 35.5 




To a microwave vial was added N-methyl-1-phenyl-1,3,4,5-tetrahydro-2H-
benzo[c]azepine-2-carboxamide 2-431 (100 mg, 0.36 mmol), ethanol (2 mL) and aq. 
2 M NaOH (2 mL) (1:1 v/v EtOH: 2 M NaOH). The mixture was heated at 140 °C in 
a microwave for 4 h. Once complete, CH2Cl2 was added and the aqueous phase was 
extracted three times with CH2Cl2. The organic phase was dried over MgSO4, filtered 
and concentrated in vacuo. The crude material was purified by flash column 
chromatography, eluting with (1 to 4% MeOH in CH2Cl2) yielding the title 
compound 2-473 as a colourless oil (57 mg, 72%). Rf 0.12 (60% EtOAc/petrol);  νmax 
/cm-1 (film) 3338, 2928, 1618, 1532, 1491; 1H NMR (400 MHz, CDCl3) δ 7.41‒7.29 (5 H, m, ArH), 
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7.21‒7.19 (1 H, m, ArH), 7.16‒7.12 (1 H, m, ArH), 7.03 (1 H, td, J 7.5, 1.5, ArH), 6.64 (1 H, d, J 7.5, 
ArH), 5.21 (1 H, s, H10), 3.40 (1 H, dt, J 13.8, 4.4, H9a), 3.23‒3.12 (2 H, m, H9b, H7a), 2.94 (1 H, ddd, 
J 14.5, 8.1, 2.1, H7b), 1.94‒1.83 (2 H, m, NH, H8a), 1.75‒1.65 (1 H, m, H8b); 13C NMR (101 MHz, 
CDCl3) δ 145.1 (C1), 142.8 (C11), 142.5 (C6), 129.8 (ArCH), 128.5 (ArCH), 127.9 (ArCH), 127.88 
(ArCH), 127.0 (ArCH), 126.95 (ArCH), 126.0 (ArCH), 65.8 (C10), 51.1 (C9), 35.9 (C7), 30.1 (C8); 
HRMS (ESI+) m/z C16H18N+ requires: 224.1433; found: 224.1433. 
 
3.5 In Situ Urea Formation/ Ring Expansion Reaction 
 
• Synthesis of (±)-2-Methyl-1-phenyl-1,2,4,5,6,7-hexahydro-3H-benzo[e][1,3]diazonin-3-
one (2-73) 
 
Scheme 3-1. In situ urea formation ring expansion to synthesise 2-73. 
Conditions A: 
To a solution of 1,2,3,4-tetrahydroquinoline 2-111 (0.10 g, 0.75 mmol), DMPU (0.45 mL, 3.8 mmol) 
and benzyl(methyl)carbamoyl chloride 2-15 (0.15 g, 0.83 mmol) in anhydrous THF (5 mL) was added 
LDA (1.1 mL, 2.3 mmol, 2.0 M) dropwise at −78 °C. The reaction mixture was then warmed to RT and 
left for 16 h. The reaction mixture was quenched with sat. NH4Cl and extracted three times with EtOAc. 
The combined organic phases were washed twice with H2O and then dried over MgSO4, filtered and 
concentrated in vacuo. Purification of the resulting residue by flash column chromatography eluting 
with (40% to 100% EtOAc in petrol) gave the title compound 2-73 as a white solid (0.12 g, 57%). 
Conditions B: 
To a solution of 3,4-tetrahydroquinoline-1(2H)-carbamoyl chloride 2-112 (1.0 g, 5.1 mmol) in 
anhydrous THF (34 mL) was added DMPU (3.1 mL, 26 mmol) at RT under nitrogen. N-Methyl-1-
phenylmethanamine (0.72 mL, 5.6 mmol) was then added which lead to the formation of a thick white 
suspension. The suspension was then cooled to 0 °C, followed by the addition of LDA (7.7 mL, 15 
mmol, 2.0 M (N.B. vigorous stirring is required to ensure the first drops of LDA mix into the solution, 
this is achieved using a large magnetic stirrer bar. The reaction mixture becomes a homogenous solution 
after the first few drops of LDA. The reaction mixture was light yellow initially progressing to a deep 
red colour after LDA addition is complete). The reaction was then stirred for 2 h at 0 °C or until 
consumption of urea 2-45 is observed by TLC. The reaction was then quenched with sat. NH4Cl and 
extracted three times with EtOAc. The combined organic phases were washed twice with H2O and then 
dried over MgSO4, filtered and concentrated in vacuo. Purification of the resulting residue by flash 
column chromatography eluting with (40% to 100% EtOAc in petrol) gave the title compound 2-73 as 
a white solid (1.2 g, 84%). 
Spectroscopic data of the compounds isolated from both the procedures described above matches the 
data obtained for 2-73 starting from pre-isolated urea 2-45. 
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3.6 Ring Contraction in Flow 
 
• Synthesis of (±)-N-Methyl-1-phenyl-1,3,4,5-tetrahydro-2H-benzo[c]azepine-2-
carboxamide (2-431) 
 
Scheme 3-2. Ring contraction of 2-73 in flow. 
Flow reactions were performed using a Uniqsis FlowSyn module. The instrument used a PTFE flow 
path and the OMNIFIT® glass column was manually packed with amberlyst-15 resin (height 1.3 cm). 
(±)-2-Methyl-1-phenyl-1,2,4,5,6,7-hexahydro-3H-benzo[e][1,3]diazonin-3-one 2-73 (0.5 g, 1.78 mmol 
in 10 mL CH2Cl2) was delivered to the system via tubing from a Schott bottle. The flow rate was set to 
0.4 mL/min and the column was heated to 60 °C using the Uniqsis column heater. After passing through 
the column, the solvent was collected in a round bottom flask and the solvent was removed in vacuo, 
resulting the title compound 2-431 as a white solid (0.43 g, 86%). No further purification was needed.  
The reaction was repeated on a 17 mmol scale yielding the title compound 2-431 as a white solid (4.60, 
98%). Spectroscopic data of 2-431 matches that previously stated for 2-431. 
3.7 In situ ReactIR Experiments 
 





Scheme 3-3. Ring expansion of 2-45. 
A ReactIR probe was inserted into a three-necked Schlenk tube equipped with a stirrer bar. The reaction 
vessel was dried via heat gun under vacuum. In a separate flask the urea 2-45 (0.11 g, 0.39 mmol) was 
dissolved in anhydrous THF (0.5 mL) which was then transferred to the reaction vessel via syringe. 
DMPU (0.2 mL, 1.9 mmol) was added to the solution and spectra was allowed to stabilise. The ReactIR 
was started and spectra were recorded every 15 seconds. Once the ReactIR had stabilised the mixture 
was cooled to ‒78 °C. Once the temperature had reached ‒78 °C and a stable IR spectrum was obtained, 
LDA (0.39 mL, 0.78 mmol, 2.0 M) was added dropwise via syringe. The reaction mixture was stirred 






















Figure 3-1. 3D ReactIR trace monitoring peaks at various wavenumbers over the course of the ring 




Figure 3-2. 3D ReactIR trace monitoring peaks at various wavenumbers over the course of the reaction. Peaks 
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Scheme 3-4. Deprotonation of 2-73 with s-BuLi. 
 
A ReactIR probe was inserted into a three-necked Schlenk tube equipped with a stirrer bar. The reaction 
vessel was dried with a heat gun, under vacuum. Anhydrous THF (0.7 mL) was added to the reaction 
vessel under a nitrogen atmosphere at RT and an IR solvent background spectrum was taken. The 
solvent was then removed via syringe from the reaction vessel. In a separate flask the ring expansion 
product 2-73 (0.15 g, 0.54 mmol) was dissolved in anhydrous THF (0.7 mL) which was then transferred 
to the reaction vessel via syringe. The ReactIR was started and spectra were recorded every 15 seconds. 
Once the ReactIR had stabilised the mixture was cooled to ‒78 °C. Once the temperature had reached 
‒78 °C and a stable IR spectrum was obtained, s-BuLi (0.49 mL, 0.54 mmol, 1.1 M in hexanes) was 
added dropwise via syringe. The reaction mixture was stirred for 10 minutes. Another 1 equivalent of 
s-BuLi was added. The reaction mixture was left for a further 30 min at −78 °C before quenching with 
CD3OD (0.7 mL). Spectra were recorded every 15 seconds for a further 20 min. No deuterium 




Figure 3-3. 2D ReactIR trace monitoring peaks at various wavelengths over the course of the deprotonation with 













Figure 3-4. 3D ReactIR trace monitoring peaks at various wavenumbers over the course of the 
deprotonation with s-BuLi. Peaks are tentatively assigned to the intermediates shown. 
 
• Deprotonation of the ring expansion product 2-73 with LDA: 
 
 
Scheme 3-5. Deprotonation of 2-73 with LDA. 
 
A ReactIR probe was inserted into a three-necked Schlenk tube equipped with a stirrer bar. The reaction 
vessel was dried via heat gun under vacuum. Anhydrous THF (0.7 mL) was added to the reaction vessel 
under a nitrogen atmosphere at RT and an IR solvent background spectrum was taken. The solvent was 
then removed via syringe from the reaction vessel. In a separate flask the ring expansion product 2-73 
(0.11 g, 0.39 mmol) was dissolved in anhydrous THF (0.7 mL) which was then transferred to the 
reaction vessel via syringe. The ReactIR was started and spectra were recorded every 15 seconds. Once 
the ReactIR had stabilised the mixture was cooled to ‒78 °C. Once the temperature had reached ‒78 °C 
and a stable IR spectrum was obtained, LDA (0.20 mL, 0.39 mmol, 2.0 M) was added 
dropwise via syringe. The reaction mixture to stirred for 50 minutes. Another 1 equivalent of LDA was 
added. The reaction mixture was left for a further 20 min before another equivalent of LDA was added. 
The reaction was stirred for 20 min at −78 °C before quenching with CD3OD (0.7 mL). No deuterium 





Figure 3-5. 2D ReactIR trace monitoring peaks at various wavelengths over the course of the deprotonation with 





Figure 3-6. 3D ReactIR trace monitoring peaks at various wavenumbers over the course of the deprotonation 












• Dearomatizing cyclisation of N-Benzyl-N,3-dimethyl-1H-indole-1-carboxamide – 
synthesis of 2,9-Dimethyl-1-phenyl-1,2,9,9a-tetrahydro-3H-imidazo[1,5-a]indol-3-one: 
 
Scheme 3-6. Dearomatising cyclisation of 2-375. 
A ReactIR probe was inserted into a three-necked Schlenk tube equipped with a stirrer bar. The reaction 
vessel was dried via heat gun under vacuum. In a separate flask the indole urea 2-375 (0.1 g, 0.35 mmol) 
was dissolved in anhydrous THF (1.0 mL) which was then transferred to the reaction vessel via syringe. 
The ReactIR was started and spectra were recorded every 15 seconds. Once the ReactIR had stabilised 
the mixture was cooled to ‒78 °C. Once the temperature had reached ‒78 °C and a stable IR spectrum 
was obtained, LDA (0.35 mL, 0.69 mmol, 2.0 M) was added dropwise via syringe. The reaction mixture 





















Figure 3-7. 3D ReactIR trace monitoring peaks at various wavenumbers over the course of the 
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